
<html lang="en"     class="pb-page"  data-request-id="b65a985d-9784-434a-ba55-eae5296d8e3c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2006.49.issue-4;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm050936o"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Tyrosine Kinase Inhibitors. 19. 6-Alkynamides of 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-d]pyrimidines as Irreversible Inhibitors of the erbB Family of Tyrosine Kinase Receptors" /></meta><meta name="dc.Creator" content="Sylvester R.  Klutchko,†" /></meta><meta name="dc.Creator" content="Hairong  Zhou,†" /></meta><meta name="dc.Creator" content="R. Thomas  Winters,†" /></meta><meta name="dc.Creator" content="Tuan P.  Tran,†" /></meta><meta name="dc.Creator" content="Alexander J.  Bridges,†" /></meta><meta name="dc.Creator" content="Irene W.  Althaus,†" /></meta><meta name="dc.Creator" content="Danielle M.  Amato,†" /></meta><meta name="dc.Creator" content="William L.  Elliott,†" /></meta><meta name="dc.Creator" content="Paul A.  Ellis,†" /></meta><meta name="dc.Creator" content="Mary Ann  Meade,†" /></meta><meta name="dc.Creator" content="Billy J.  Roberts,†" /></meta><meta name="dc.Creator" content="David W.  Fry,†" /></meta><meta name="dc.Creator" content="Andrea J.  Gonzales,†" /></meta><meta name="dc.Creator" content="Patricia J.  Harvey,†" /></meta><meta name="dc.Creator" content="James M.  Nelson,†" /></meta><meta name="dc.Creator" content="Veronica  Sherwood,†" /></meta><meta name="dc.Creator" content="Hyo-Kyung  Han,†" /></meta><meta name="dc.Creator" content="Gerry  Pace,†" /></meta><meta name="dc.Creator" content="Jeff B.  Smaill,‡" /></meta><meta name="dc.Creator" content="William A.  Denny,‡ and" /></meta><meta name="dc.Creator" content="H. D. Hollis  Showalter*,†,§" /></meta><meta name="dc.Description" content="Structure−activity relationships for inhibition of erbB1, erbB2, and erbB4 were determined for a series of alkynamide analogues of quinazoline- and pyrido[3,4-d]pyrimidine-based compounds. The comp..." /></meta><meta name="Description" content="Structure−activity relationships for inhibition of erbB1, erbB2, and erbB4 were determined for a series of alkynamide analogues of quinazoline- and pyrido[3,4-d]pyrimidine-based compounds. The comp..." /></meta><meta name="dc.Publisher" content=" American Chemical Society " /></meta><meta name="dc.Date" scheme="WTN8601" content="February 1, 2006" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm050936o" /></meta><meta name="dc.Identifier" scheme="crossover-key" content="JMCMAr-49-4-1475" /></meta><meta name="dc.Identifier" scheme="pii" content="S0022-2623(05)00936-2" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2006 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm050936o" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm050936o" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm050936o" /></link>
        
    
    

<title>Tyrosine Kinase Inhibitors. 19. 6-Alkynamides of 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-d]pyrimidines as Irreversible Inhibitors of the erbB Family of Tyrosine Kinase Receptors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm050936o" /></meta><meta property="og:title" content="Tyrosine Kinase Inhibitors. 19. 6-Alkynamides of 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-d]pyrimidines as Irreversible Inhibitors of the erbB Family of Tyrosine Kinase Receptors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/large/jm050936on00001.jpeg" /></meta><meta property="og:description" content=" Structure−activity relationships for inhibition of erbB1, erbB2, and erbB4 were determined for a series of alkynamide analogues of quinazoline- and pyrido[3,4-d]pyrimidine-based compounds. The compounds were prepared by coupling the appropriate 6-aminoquinazolines or 6-aminopyrido[3,4-d]pyrimidines with alkynoic acids, using EDCI·HCl in pyridine. The compounds showed pan-erbB enzyme inhibition but were on average about 10-fold more potent against erbB1 than against erbB2 and erbB4. For cellular inhibition, the nature of the alkylating side chains was an important determinant, with 5-dialkylamino-2-pentynamide type Michael acceptors providing the highest potency. This is suggested to be due to an improved ability of the amine to participate in an autocatalysis of the Michael reaction with enzyme cysteine residues. Pyrido[3,4-d]pyrimidine analogue 39 was selected for in vivo evaluation and achieved tumor regressions at 10 mg/kg in the A431 human epidermoid carcinoma and at 40 mg/kg for the SF767 human glioblastoma and the SKOV3 human ovarian carcinoma. Complete stasis was observed at 40 mg/kg in the BXPC3 human pancreatic carcinoma as well as in the H125 human non-small-cell lung carcinoma.  " /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm050936o"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm050936o">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm050936o&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm050936o&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm050936o&amp;href=/doi/10.1021/jm050936o" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2006</span><span class="cit-fg-volume">, 49</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1475-1485</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/49/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm0509344" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm051145p" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Tyrosine Kinase Inhibitors. 19. 6-Alkynamides of 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-<i>d</i>]pyrimidines as Irreversible Inhibitors of the erbB Family of Tyrosine Kinase Receptors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sylvester+R.++Klutchko">Sylvester R. Klutchko</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hairong++Zhou">Hairong Zhou</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=R.+Thomas++Winters">R. Thomas Winters</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tuan+P.++Tran">Tuan P. Tran</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexander+J.++Bridges">Alexander J. Bridges</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Irene+W.++Althaus">Irene W. Althaus</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Danielle+M.++Amato">Danielle M. Amato</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+L.++Elliott">William L. Elliott</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+A.++Ellis">Paul A. Ellis</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary+Ann++Meade">Mary Ann Meade</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Billy+J.++Roberts">Billy J. Roberts</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+W.++Fry">David W. Fry</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrea+J.++Gonzales">Andrea J. Gonzales</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patricia+J.++Harvey">Patricia J. Harvey</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+M.++Nelson">James M. Nelson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Veronica++Sherwood">Veronica Sherwood</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hyo-Kyung++Han">Hyo-Kyung Han</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gerry++Pace">Gerry Pace</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeff+B.++Smaill">Jeff B. Smaill</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+A.++Denny">William A. Denny</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=H.+D.+Hollis++Showalter">H. D. Hollis Showalter</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047, and Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1020, New Zealand </span></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="JMCMAr" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm050936o&amp;href=/doi/10.1021%2Fjm050936o" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2006</span></span><span class="cit-volume">, 49</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1475–1485</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 1, 2006</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 September 2005</li><li><span class="item_label"><b>Published</b> online</span>1 February 2006</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 February 2006</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm050936o" title="DOI URL">https://doi.org/10.1021/jm050936o</a></div><div class="article_header-article-copyright"><strong>Copyright © 2006 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1475%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSylvester%2BR.%2BKlutchko%252C%2BHairong%2BZhou%252C%2BR.%2BThomas%2BWinters%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D49%26issueNum%3D4%26contentID%3Djm050936o%26title%3DTyrosine%2BKinase%2BInhibitors.%2B19.%2B6-Alkynamides%2Bof%2B4-Anilinoquinazolines%2Band%2B4-Anilinopyrido%255B3%252C4-d%255Dpyrimidines%2Bas%2BIrreversible%2BInhibitors%2Bof%2Bthe%2BerbB%2BFamily%2Bof%2BTyrosine%2BKinase%2BReceptors%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1485%26publicationDate%3DFebruary%2B2006">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm050936o"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2254</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">56</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm050936o" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Tyrosine Kinase Inhibitors. 19. 6-Alkynamides of 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-d]pyrimidines as Irreversible Inhibitors of the erbB Family of Tyrosine Kinase Receptors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Sylvester&quot;,&quot;last_name&quot;:&quot;R. Klutchko&quot;},{&quot;first_name&quot;:&quot;Hairong&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;R.&quot;,&quot;last_name&quot;:&quot;Thomas Winters&quot;},{&quot;first_name&quot;:&quot;Tuan&quot;,&quot;last_name&quot;:&quot;P. Tran&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;J. Bridges&quot;},{&quot;first_name&quot;:&quot;Irene&quot;,&quot;last_name&quot;:&quot;W. Althaus&quot;},{&quot;first_name&quot;:&quot;Danielle&quot;,&quot;last_name&quot;:&quot;M. Amato&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;L. Elliott&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;A. Ellis&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;Ann Meade&quot;},{&quot;first_name&quot;:&quot;Billy&quot;,&quot;last_name&quot;:&quot;J. Roberts&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;W. Fry&quot;},{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;J. Gonzales&quot;},{&quot;first_name&quot;:&quot;Patricia&quot;,&quot;last_name&quot;:&quot;J. Harvey&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;M. Nelson&quot;},{&quot;first_name&quot;:&quot;Veronica&quot;,&quot;last_name&quot;:&quot;Sherwood&quot;},{&quot;first_name&quot;:&quot;Hyo-Kyung&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Gerry&quot;,&quot;last_name&quot;:&quot;Pace&quot;},{&quot;first_name&quot;:&quot;Jeff&quot;,&quot;last_name&quot;:&quot;B. Smaill&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;A. Denny&quot;},{&quot;first_name&quot;:&quot;H.&quot;,&quot;last_name&quot;:&quot;D. Hollis Showalter&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2006&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;01&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;49&quot;,&quot;pages&quot;:&quot;1475-1485&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm050936o&quot;},&quot;abstract&quot;:&quot;Structure−activity relationships for inhibition of erbB1, erbB2, and erbB4 were determined for a series of alkynamide analogues of quinazoline- and pyrido[3,4-d]pyrimidine-based compounds. The compounds were prepared by coupling the appropriate 6-aminoquinazolines or 6-aminopyrido[3,4-d]pyrimidines with alkynoic acids, using EDCI·HCl in pyridine. The compounds showed pan-erbB enzyme inhibition but were on average about 10-fold more potent against erbB1 than against erbB2 and erbB4. For cellular inhibition, the nature of the alkylating side chains was an important determinant, with 5-dialkylamino-2-pentynamide type Michael acceptors providing the highest potency. This is suggested to be due to an improved ability of the amine to participate in an autocatalysis of the Michael reaction with enzyme cysteine residues. Pyrido[3,4-d]pyrimidine analogue 39 was selected for in vivo evaluation and achieved tumor regressions at 10 mg/kg in the A431 human epidermoid carcinoma and at 40 mg/kg for the SF767 human glioblast&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm050936o&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm050936o" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm050936o&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm050936o" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm050936o&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm050936o" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm050936o&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm050936o&amp;href=/doi/10.1021/jm050936o" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm050936o" /></input><a href="/doi/pdf/10.1021/jm050936o" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (189 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm050936o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm050936o%26sid%3Dliteratum%253Aachs%26pmid%3D16480284%26genre%3Darticle%26aulast%3DKlutchko%26date%3D2006%26atitle%3DTyrosine%2BKinase%2BInhibitors.%2B19.%2B6-Alkynamides%2Bof%2B4-Anilinoquinazolines%2Band%2B4-Anilinopyrido%255B3%252C4-d%255Dpyrimidines%2Bas%2BIrreversible%2BInhibitors%2Bof%2Bthe%2BerbB%2BFamily%2Bof%2BTyrosine%2BKinase%2BReceptors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D49%26issue%3D4%26spage%3D1475%26epage%3D1485%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/49/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/medium/jm050936on00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/large/jm050936on00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm050936o&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Structure−activity relationships for inhibition of erbB1, erbB2, and erbB4 were determined for a series of alkynamide analogues of quinazoline- and pyrido[3,4-<i>d</i>]pyrimidine-based compounds. The compounds were prepared by coupling the appropriate 6-aminoquinazolines or 6-aminopyrido[3,4-<i>d</i>]pyrimidines with alkynoic acids, using EDCI·HCl in pyridine. The compounds showed pan-erbB enzyme inhibition but were on average about 10-fold more potent against erbB1 than against erbB2 and erbB4. For cellular inhibition, the nature of the alkylating side chains was an important determinant, with 5-dialkylamino-2-pentynamide type Michael acceptors providing the highest potency. This is suggested to be due to an improved ability of the amine to participate in an autocatalysis of the Michael reaction with enzyme cysteine residues. Pyrido[3,4-<i>d</i>]pyrimidine analogue <b>39</b> was selected for in vivo evaluation and achieved tumor regressions at 10 mg/kg in the A431 human epidermoid carcinoma and at 40 mg/kg for the SF767 human glioblastoma and the SKOV3 human ovarian carcinoma. Complete stasis was observed at 40 mg/kg in the BXPC3 human pancreatic carcinoma as well as in the H125 human non-small-cell lung carcinoma. </p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec fnGroup"><div class="fnGroupItem" id="jm050936oAF2"><span><h4><span class="NLM_fn-symbol">†</span></h4></span><span><p class="last">  Pfizer Global Research and Development.</p></span></div><div class="fnGroupItem" id="jm050936oAF3"><span><h4><span class="NLM_fn-symbol">‡</span></h4></span><span><p class="last">  The University of Auckland.</p></span></div><div class="fnGroupItem" id="jm050936oAF1"><span><h4><span class="NLM_fn-symbol">*</span></h4></span><span><p class="last">  Corresponding author. Telephone:  734-649-5478. Fax:  734-647-8430. E-mail:  <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="96e5fef9e1f7fafed6e3fbfff5feb8f3f2e3b8">[email protected]</a></p></span></div><div class="fnGroupItem" id="jm050936oAF4"><span><h4><span class="NLM_fn-symbol">§</span></h4></span><span><p class="last">  Current address. College of Pharmacy, University of Michigan, Ann Arbor, MI 48109.</p></span></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70183" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70183" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A significant proportion of human tumors overexpress growth factor receptor tyrosine kinase enzymes of the erbB family, and this overexpression is associated with poor prognosis of the disease.<sup><a onclick="showRef(event, 'jm050936ob00001 jm050936ob00002 jm050936ob00003'); return false;" href="javascript:void(0);" class="ref jm050936ob00001 jm050936ob00002 jm050936ob00003">1-3</a></sup> Inhibitors of growth factor signaling through these pathways, especially via erbB1 (EGFr, HER-1) and erbB2 (HER-2, neu), have thus been sought as potential anticancer drugs.<sup><a onclick="showRef(event, 'jm050936ob00004'); return false;" href="javascript:void(0);" class="ref jm050936ob00004">4</a></sup> The most widely studied class of small molecule inhibitors are the 4-anilinoquinazolines<sup><a onclick="showRef(event, 'jm050936ob00005'); return false;" href="javascript:void(0);" class="ref jm050936ob00005">5</a></sup> and related 4-anilinopyrido[<i>d</i>]pyrimidines.<sup><a onclick="showRef(event, 'jm050936ob00006'); return false;" href="javascript:void(0);" class="ref jm050936ob00006">6</a></sup> These have proved to be potent and selective reversible inhibitors of erbB1 receptor tyrosine kinase activity, through competitive binding to the ATP site of the enzyme.<sup><a onclick="showRef(event, 'jm050936ob00007'); return false;" href="javascript:void(0);" class="ref jm050936ob00007">7</a></sup> The 4-anilinoquinazolines gefitinib (ZD-1839, Iressa; <b>1</b>)<sup><a onclick="showRef(event, 'jm050936ob00008 jm050936ob00009'); return false;" href="javascript:void(0);" class="ref jm050936ob00008 jm050936ob00009">8,9</a></sup> and erlotinib (OSI-774, Tarceva; <b>2</b>)<sup><a onclick="showRef(event, 'jm050936ob00010'); return false;" href="javascript:void(0);" class="ref jm050936ob00010">10</a></sup> have both been approved for the treatment of non-small-cell lung cancer (NSCLC). Responses to treatment with gefitinib<sup><a onclick="showRef(event, 'jm050936ob00011 jm050936ob00012'); return false;" href="javascript:void(0);" class="ref jm050936ob00011 jm050936ob00012">11,12</a></sup> and erlotinib<sup><a onclick="showRef(event, 'jm050936ob00013'); return false;" href="javascript:void(0);" class="ref jm050936ob00013">13</a></sup> have particularly been observed in a subgroup of NSCLC patients that were identified to have somatic mutations in the tyrosine kinase domain of erbB1. It has, however, been reported that the binding affinities of gefitinib and erlotinib to nine clinically relevant NSCLC erbB1 mutants are comparable to those of the wild-type receptor,<sup><a onclick="showRef(event, 'jm050936ob00014'); return false;" href="javascript:void(0);" class="ref jm050936ob00014">14</a></sup> supporting the possibility that cells containing an activating mutation are intrinsically more sensitive to erbB1 inhibition.<sup><a onclick="showRef(event, 'jm050936ob00015'); return false;" href="javascript:void(0);" class="ref jm050936ob00015">15</a></sup> A secondary mutation (T790M) in the kinase domain of erbB1 has been reported in three of six cases of acquired resistance to gefitinib and erlotinib treatment.<sup><a onclick="showRef(event, 'jm050936ob00016 jm050936ob00017'); return false;" href="javascript:void(0);" class="ref jm050936ob00016 jm050936ob00017">16,17</a></sup>(See Chart 1<a data-tab="pane-pcw-Figures" href="#jm050936oc00001" id="" class=" internalNav"></a> for formulas.) <div id="_i4"><figure id="jm050936oc00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/medium/jm050936oc00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/large/jm050936oc00001.jpeg" id="_i5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Chart 1.  Formulas </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/large/jm050936oc00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm050936o&amp;id=jm050936oc00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Further development of reversible inhibitors has focused on improving the clinical efficacy of this class of molecules by increasing their potency against erbB2. This has generally been achieved by incorporating additional lipophilic bulk in the 4-position of the aniline ring, such as in Lapatinib (GW572016; <b>3</b>),<sup><a onclick="showRef(event, 'jm050936ob00018'); return false;" href="javascript:void(0);" class="ref jm050936ob00018">18</a></sup> which is a potent dual inhibitor of erbB1 and erbB2 currently in phase III clinical trials against breast cancer.<sup>4</sup> Lapatinib is reported to have a slow inhibitor off-rate consistent with its prolonged effect on down-regulating receptor tyrosine phosphorylation in tumor cells. This slow off-rate may in part be explained by the crystal structure of Lapatinib bound to an inactive-like conformation of erbB1.<sup><a onclick="showRef(event, 'jm050936ob00019'); return false;" href="javascript:void(0);" class="ref jm050936ob00019">19</a></sup> BMS-599626 (<b>4</b>) is another example of a reversible inhibitor with dual activity against erbB1and erbB2 reported to be in phase I clinical trials.<sup><a onclick="showRef(event, 'jm050936ob00020 jm050936ob00021'); return false;" href="javascript:void(0);" class="ref jm050936ob00020 jm050936ob00021">20,21</a></sup> AEE788 (<b>6</b>), an analogue of the dual erbB1/erbB2 inhibitor PKI-166 (<b>5</b>),<sup><a onclick="showRef(event, 'jm050936ob00022'); return false;" href="javascript:void(0);" class="ref jm050936ob00022">22</a></sup> is also in phase I trials and represents the next generation of multitargeted tyrosine kinase inhibitors possessing potent activity against erbB1, erbB2, and the VEGF receptors.<sup><a onclick="showRef(event, 'jm050936ob00023'); return false;" href="javascript:void(0);" class="ref jm050936ob00023">23</a></sup></div><div class="NLM_p">Crystal structures of <b>2</b> binding to the ATP site of the erbB1 kinase domain<sup><a onclick="showRef(event, 'jm050936ob00024'); return false;" href="javascript:void(0);" class="ref jm050936ob00024">24</a></sup> and of the related 4-anilinoquinazoline (<b>7</b>) bound to the related p38 serine-threonine kinase<sup><a onclick="showRef(event, 'jm050936ob00025'); return false;" href="javascript:void(0);" class="ref jm050936ob00025">25</a></sup> show that the quinazoline chromophore binds to a narrow hydrophobic pocket in the N-terminal domain normally occupied by the adenine of ATP. It is stabilized by hydrogen bonds from the enzyme to the quinazoline N1 and N3 atoms (the latter through a bridging water molecule) with positions C-6 and C-7 of the quinazoline pointing toward the mouth of the channel. These observations are broadly supportive of the binding model proposed earlier.<sup>7</sup> This model, in conjunction with a homology model built by the Wyeth group, has been used in the design of the quinoline-3-carbonitriles (e.g., <b>8</b>) by replacing the N3 atom with a cyano group that can displace the bound water molecule.<sup><a onclick="showRef(event, 'jm050936ob00026'); return false;" href="javascript:void(0);" class="ref jm050936ob00026">26</a></sup></div><div class="NLM_p">Because these compounds are considered to work by a blockade of the binding of ATP, which is at high concentrations in cells, the use of irreversible inhibitors is attractive. The <a name="jm004900401476" id="jm004900401476"></a> observation that the erbB family of enzymes contains a unique unpaired cysteine residue (Cys 773 in erbB1, Cys 784 in erbB2, and Cys 778 in erbB4) close to the entrance of the ATP binding site, in a position normally occupied by a glutamine or serine in other kinases,<sup><a onclick="showRef(event, 'jm050936ob00027'); return false;" href="javascript:void(0);" class="ref jm050936ob00027">27</a></sup> prompted work on irreversible inhibitors possessing Michael acceptors at the 6-position, positioned to react with this cysteine.<sup><a onclick="showRef(event, 'jm050936ob00028'); return false;" href="javascript:void(0);" class="ref jm050936ob00028">28</a></sup> Development of this concept<sup><a onclick="showRef(event, 'jm050936ob00029 jm050936ob00030'); return false;" href="javascript:void(0);" class="ref jm050936ob00029 jm050936ob00030">29,30</a></sup> resulted in the drug canertinib dihydrochloride (CI-1033; <b>9</b>), which is currently in phase II clinical trials.<sup><a onclick="showRef(event, 'jm050936ob00031 jm050936ob00032'); return false;" href="javascript:void(0);" class="ref jm050936ob00031 jm050936ob00032">31,32</a></sup> In this compound the Michael acceptor of choice is the acrylamide moiety. Other Michael acceptors have also been evaluated, including vinylsulfonamides, vinylsulfones, vinylsulfines,<sup><a onclick="showRef(event, 'jm050936ob00033'); return false;" href="javascript:void(0);" class="ref jm050936ob00033">33</a></sup> and butynamides.<sup><a onclick="showRef(event, 'jm050936ob00034 jm050936ob00035'); return false;" href="javascript:void(0);" class="ref jm050936ob00034 jm050936ob00035">34,35</a></sup> All but the vinylsulfines had some utility for providing irreversible inhibition of erbB1. Despite <b>9</b> featuring a similar erbB1 selective reversible binding core to gefitinib, it possesses more potent activity against all members of the erbB family (see Tables 1 and 2). Clearly alkylation of the key cysteine of erbB2 and erbB4 can result in improved potency against these receptors. Potent inhibition of erbB3 (which does not contain a cysteine in this region) by this compound is consistent with erbB3 only being able to acquire signaling potential through heterodimerization with another erbB receptor.<sup>4</sup></div><div class="NLM_p">In our initial structure−activity studies around the Michael acceptor we probed the acrylamide nitrogen, the α-carbon, and the β-carbon with a methyl substituent<sup>33</sup> and found that only the acrylamide nitrogen would tolerate an alkyl substituent while still providing fully irreversible inhibition of erbB1. Further elaboration to introduce a soluble side chain at this position was not tolerated. The Wyeth group has independently shown that amines pendent off the α- and β-carbons of the Michael acceptor through a methylene spacer are well-tolerated and can in some instances provide potent irreversible inhibition of erbB1.<sup>34</sup> The dimethylamino crotonamide Michael acceptor of compound <b>10</b> is the most widely studied, with the dimethylamino moiety proposed to serve as an intramolecular base catalyst between the Cys 773 sulfhydryl group and the Michael acceptor through a cyclic five-membered ring mechanism.<sup><a onclick="showRef(event, 'jm050936ob00036'); return false;" href="javascript:void(0);" class="ref jm050936ob00036">34,36</a></sup> Compound <b>10</b> and its dimethylamino butynamide analogue (<b>11</b>) showed potent inhibition of erbB1 (isolated enzyme IC<sub>50</sub>'s 0.011 and 0.006 μM, respectively) and erbB2 (isolated enzyme IC<sub>50</sub>'s 0.301 and 0.014 μM, respectively). </div><div class="NLM_p">Applying the dimethylamino crotonamide Michael acceptor to the quinoline-3-carbonitrile class of compounds has led to EKB-569 (<b>12</b>)<sup>36</sup> which is in clinical trial.<sup><a onclick="showRef(event, 'jm050936ob00037'); return false;" href="javascript:void(0);" class="ref jm050936ob00037">37</a></sup> Interestingly this compound is a potent irreversible inhibitor of erbB1 (isolated enzyme IC<sub>50</sub> = 0.08 μM) but is less effective against erbB2 (isolated enzyme IC<sub>50</sub> = 1.23 μM) suggesting that this Michael acceptor will provide erbB2 potency on a quinazoline core (such as for <b>10</b>) but not on an analogous quinoline-3-carbonitrile core. Application of this Michael acceptor to the 1,7-naphthyridine core as in compound <b>13</b> also provides potent and presumably irreversible inhibition of erbB1; however no erbB2 data have been reported.<sup><a onclick="showRef(event, 'jm050936ob00038'); return false;" href="javascript:void(0);" class="ref jm050936ob00038">38</a></sup> We have previously reported in the 6-acrylamidoquinazoline series that introduction of a benzyloxy or phenoxy substituent at the 4-position of the aniline ring, such as in compounds <b>15</b> and <b>16</b>, is well-tolerated and can provide irreversible inhibitors with cellular potency against erbB1 and erbB2.<sup>29</sup> Optimization of the quinoline-3-carbonitriles to improve their erbB2 potency has proceeded along similar lines <a name="jm004900401477" id="jm004900401477"></a> by introducing a 2-pyridinylmethoxy group in the 4-position of the aniline ring resulting in HKI-272 (<b>14</b>), a potent irreversible inhibitor of both erbB1 and erbB2, which is reported to be in clinical trial.<sup><a onclick="showRef(event, 'jm050936ob00039'); return false;" href="javascript:void(0);" class="ref jm050936ob00039">39</a></sup> HKI-272 and analogues have been shown to be effective in vitro against NSCLC cells that have acquired resistance to gefitinib, encouragingly including those that have the T790M mutation.<sup><a onclick="showRef(event, 'jm050936ob00040'); return false;" href="javascript:void(0);" class="ref jm050936ob00040">40</a></sup></div><div class="NLM_p last">Irreversible inhibitors of the erbB family of tyrosine kinases continue to be of considerable interest clinically. In certain instances the Michael acceptor can confer pan-erbB activity to an otherwise erbB1 selective core structure. In this paper we report on structure−activity relationships for alkynamide analogues of both the quinazoline and pyrido[3,4-<i>d</i>]pyrimidine core structures. We identify a novel Michael acceptor that provides potent pan-erbB activity, and we report data for this against the erbB1, erbB2, and erbB4 kinases. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31304" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31304" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The compounds reported in this paper were made by the generalized routes outlined in Scheme 1. 6-Aminoquinazolines (<b>17a</b><sup><a onclick="showRef(event, 'jm050936ob00041'); return false;" href="javascript:void(0);" class="ref jm050936ob00041">41</a></sup> and <b>17b</b><sup>29</sup>) and the corresponding pyrido[3,4-<i>d</i>]pyrimidines (<b>17c</b>,<sup><a onclick="showRef(event, 'jm050936ob00042'); return false;" href="javascript:void(0);" class="ref jm050936ob00042">42</a></sup><b>17d</b>, <b>17e</b><sup>29</sup>) were coupled with a wide range of alkynoic acids (<b>18a</b><b>−</b><b>m</b>) to provide target compounds <b>19</b><b>−</b><b>40</b> (Table 1). In general, the 6-amino moiety of heterocycles <b>17a</b><b>−</b><b>e</b> was found to be weakly reactive toward the range of activated acids utilized, and this was reflected in the poor yields of purified products (5−32% for quinazolines; 2−28% for pyrido[3,4-<i>d</i>]pyrimidines). The most generalized conditions for this amidation were found to be the use of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI·HCl) in pyridine at room temperature. Optimization of coupling conditions was not extensively explored. </div><div class="NLM_p last">The propargylic acids <b>18a</b><b>−</b><b>i</b> were either commercially available or synthesized by the Wyeth procedure.<sup>34</sup> The homologous pentynoic acids <b>18j</b><b>−</b><b>m</b> were synthesized by modification of a procedure described many years ago,<sup><a onclick="showRef(event, 'jm050936ob00043'); return false;" href="javascript:void(0);" class="ref jm050936ob00043">43</a></sup> with details shown in Scheme 1. Thus, condensation of commercially available 4-(tosyloxy)-1-butyne (<b>41</b>) with a range of secondary amines provided 4-(substituted amino)-1-butynes (<b>42</b>) in nonoptimized yields (31−82%). Subsequent lithiation of <b>42</b> with <i>n</i>-butyllithium in THF or ether and carboxylation provided target pentynoic acids <b>18j</b><b>−</b><b>m</b> in 59−77% yield. These either were coupled to <b>17a</b><b>−</b><b>e</b> as their isolated lithium salts or were converted to their neutral form by passage over an ion-exchange resin. When the lithium salt was utilized, an equivalent of pyridinium hydrochloride was added to buffer the reaction medium. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54484" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54484" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Table 1 lists the structures and kinase inhibitory properties of a series of 6-alkynamide derivatives of both 4-anilinoquinazolines and 4-anilinopyrido[3,4-<i>d</i>]pyrimidines. As in our previous studies,<sup>33</sup> the anilino ring substituent was kept constant (generally 3-chloro-4-fluoro; the substitution pattern used in both gefitinib and canertinib dihydrochloride) to facilitate intercomparisons of the different Michael acceptors. The known compounds <b>9</b> (canertinib dihydrochloride), <b>19</b>, <b>20</b>, and <b>28</b> were also included for wider comparison. </div><div class="NLM_p">All of the compounds in Table 1 were investigated for<a class="ref showTableEvent internalNav" data-ID="jm050936ot00001" href="#jm050936ot00001"></a><a data-tab="pane-pcw-Figures" href="#jm050936oh00001" id="" class=" internalNav"></a> inhibition of erbB1, erbB2, and erbB4, using cytoplasmic fusion proteins made by cloning the erbB1 sequence (Met-668 to Ala-1211), erbB2 (Ile-675 to Val-1256), and erbB4 sequence (Gly-259 to Gly-690) into baculovirus. The IC<sub>50</sub> values shown were determined by an enzyme-linked immunosorbent assay based <a name="jm004900401478" id="jm004900401478"></a> (ELISA-based) receptor tyrosine kinase assay, with poly(Glu-Tyr) as substrate, and are technically apparent IC<sub>50</sub> values.<sup>29</sup> They are an average of at least two separate determinations. <div id="_i8"><figure id="jm050936oh00001" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/medium/jm050936oh00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/large/jm050936oh00001.jpeg" id="_i9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) 1-Ethyl-3-(3‘-dimethylaminopropyl)carbodiimide hydrochloride (EDCI·HCl), pyridine, or DMF, 0−25 °C; (ii) HNR<sub>1</sub>R<sub>2</sub>, DMF, or CH<sub>3</sub>CN or THF, 25−85 °C; (iii) n-BuLi, THF, −78 °C, then CO<sub>2</sub>, ether, −78 to 25 °C.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/large/jm050936oh00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm050936o&amp;id=jm050936oh00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div class="NLM_table-wrap" id="jm050936ot00001"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 1.  Kinase Inhibitory Properties of 6-Substituted 4-Anilinoquinazolines and 4-Anilinopyrido[3,4-<i>d</i>]pyrimidines Bearing Alkynamide Michael Acceptors<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/medium/jm050936ou00001a.gif" alt="" id="_i10" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="5">IC<sub>50</sub> (nM)<i><sup>a</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">compd.</td><td class="colsep2 rowsep2">X</td><td class="colsep2 rowsep2">Y</td><td class="colsep2 rowsep2">Z</td><td class="colsep2 rowsep2">erbB1</td><td class="colsep2 rowsep2">erbB2</td><td class="colsep2 rowsep2">erbB4</td><td class="colsep2 rowsep2">autophos (EGF)<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">autophos (HER)<i><sup>c</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>9</b></td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">3.0 </td><td class="colsep2 rowsep2">20 </td><td class="colsep2 rowsep2">31 </td><td class="colsep2 rowsep2">1.7 </td><td class="colsep2 rowsep2">7.4 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>19</b><b><i><sup>d</sup></i></b><sup></sup></td><td class="colsep2 rowsep2">CH </td><td class="colsep2 rowsep2">3-Br </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">1.6 </td><td class="colsep2 rowsep2">1.9 </td><td class="colsep2 rowsep2">1.7 </td><td class="colsep2 rowsep2">2.7 </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>20</b><b><i><sup>e</sup></i></b><sup></sup></td><td class="colsep2 rowsep2">CH </td><td class="colsep2 rowsep2">3-Br </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">0.2 </td><td class="colsep2 rowsep2">17 </td><td class="colsep2 rowsep2">12 </td><td class="colsep2 rowsep2">2.5 </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>21</b></td><td class="colsep2 rowsep2">CH </td><td class="colsep2 rowsep2">3-Cl, 4-F </td><td class="colsep2 rowsep2">CH<sub>2</sub>OH </td><td class="colsep2 rowsep2">1.4 </td><td class="colsep2 rowsep2">2.1 </td><td class="colsep2 rowsep2">7.3 </td><td class="colsep2 rowsep2">25 </td><td class="colsep2 rowsep2">43 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>22</b></td><td class="colsep2 rowsep2">CH </td><td class="colsep2 rowsep2">3-Cl, 4-F </td><td class="colsep2 rowsep2">CH<sub>2</sub>N(Et)<sub>2</sub></td><td class="colsep2 rowsep2">3.1 </td><td class="colsep2 rowsep2">46 </td><td class="colsep2 rowsep2">310 </td><td class="colsep2 rowsep2">6.8 </td><td class="colsep2 rowsep2">7.5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>23</b></td><td class="colsep2 rowsep2">CH </td><td class="colsep2 rowsep2">3-Cl, 4-F </td><td class="colsep2 rowsep2">CH<sub>2</sub>N(<i>i</i>-Pr)<sub>2</sub></td><td class="colsep2 rowsep2">4.2 </td><td class="colsep2 rowsep2">2.8 </td><td class="colsep2 rowsep2">11 </td><td class="colsep2 rowsep2">11 </td><td class="colsep2 rowsep2">65 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>24</b></td><td class="colsep2 rowsep2">CH </td><td class="colsep2 rowsep2">3-Cl, 4-F </td><td class="colsep2 rowsep2">CH<sub>2</sub>N(<i>n</i>-Bu)<sub>2</sub></td><td class="colsep2 rowsep2">40 </td><td class="colsep2 rowsep2">464 </td><td class="colsep2 rowsep2">624 </td><td class="colsep2 rowsep2">11 </td><td class="colsep2 rowsep2">32 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>25</b></td><td class="colsep2 rowsep2">CH </td><td class="colsep2 rowsep2">3-Cl, 4-F </td><td class="colsep2 rowsep2">CH<sub>2</sub>Nmorpholide </td><td class="colsep2 rowsep2">86 </td><td class="colsep2 rowsep2">300 </td><td class="colsep2 rowsep2">229 </td><td class="colsep2 rowsep2">31 </td><td class="colsep2 rowsep2">173 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>26</b></td><td class="colsep2 rowsep2">CH </td><td class="colsep2 rowsep2">3-Cl, 4-F </td><td class="colsep2 rowsep2">(CH<sub>2</sub>)<sub>2</sub>N(Et)<sub>2</sub></td><td class="colsep2 rowsep2">1.8 </td><td class="colsep2 rowsep2">2.6 </td><td class="colsep2 rowsep2">16 </td><td class="colsep2 rowsep2">4.5 </td><td class="colsep2 rowsep2">23 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>27</b></td><td class="colsep2 rowsep2">CH </td><td class="colsep2 rowsep2">3-Cl, 4-F </td><td class="colsep2 rowsep2">(CH<sub>2</sub>)<sub>2</sub>Nmorpholide </td><td class="colsep2 rowsep2">1.7 </td><td class="colsep2 rowsep2">2.3 </td><td class="colsep2 rowsep2">4.3 </td><td class="colsep2 rowsep2">12 </td><td class="colsep2 rowsep2">7.6 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>28</b><b><i><sup>d</sup></i></b><sup></sup></td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">3-Br </td><td class="colsep2 rowsep2">H </td><td class="colsep2 rowsep2">0.6 </td><td class="colsep2 rowsep2">2.4 </td><td class="colsep2 rowsep2">13 </td><td class="colsep2 rowsep2">15 </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>29</b></td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">3-Cl, 4-F </td><td class="colsep2 rowsep2">Me </td><td class="colsep2 rowsep2">0.3 </td><td class="colsep2 rowsep2">1.1 </td><td class="colsep2 rowsep2">0.5 </td><td class="colsep2 rowsep2">2.5 </td><td class="colsep2 rowsep2">24 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>30</b></td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">3-Cl, 4-F </td><td class="colsep2 rowsep2"><i>n</i>-Pr </td><td class="colsep2 rowsep2">1.7 </td><td class="colsep2 rowsep2">3.8 </td><td class="colsep2 rowsep2">2.4 </td><td class="colsep2 rowsep2">9.6 </td><td class="colsep2 rowsep2">170 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>31</b></td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">3-Cl, 4-F </td><td class="colsep2 rowsep2"><i>n</i>-Bu </td><td class="colsep2 rowsep2">15 </td><td class="colsep2 rowsep2">5.4 </td><td class="colsep2 rowsep2">7.1 </td><td class="colsep2 rowsep2">4.5 </td><td class="colsep2 rowsep2">20 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>32</b></td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">3-Cl, 4-F </td><td class="colsep2 rowsep2">CH<sub>2</sub>N(Et)<sub>2</sub></td><td class="colsep2 rowsep2">15 </td><td class="colsep2 rowsep2">597 </td><td class="colsep2 rowsep2">644 </td><td class="colsep2 rowsep2">48 </td><td class="colsep2 rowsep2">116 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>33</b></td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">3-Cl, 4-F </td><td class="colsep2 rowsep2">CH<sub>2</sub>N(<i>i</i>-Pr)<sub>2</sub></td><td class="colsep2 rowsep2">44 </td><td class="colsep2 rowsep2">>10<sup>3</sup></td><td class="colsep2 rowsep2">538 </td><td class="colsep2 rowsep2">73 </td><td class="colsep2 rowsep2">36 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>34</b></td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">3-Cl, 4-F </td><td class="colsep2 rowsep2">CH<sub>2</sub>N(<i>n</i>-Bu)<sub>2</sub></td><td class="colsep2 rowsep2">17 </td><td class="colsep2 rowsep2">67 </td><td class="colsep2 rowsep2">73 </td><td class="colsep2 rowsep2">49 </td><td class="colsep2 rowsep2">320 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>35</b></td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">3-Cl, 4-F </td><td class="colsep2 rowsep2">CH<sub>2</sub>Nmorpholide </td><td class="colsep2 rowsep2">3.1 </td><td class="colsep2 rowsep2">26 </td><td class="colsep2 rowsep2">6.2 </td><td class="colsep2 rowsep2">14 </td><td class="colsep2 rowsep2">22 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>36</b></td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">3-Cl, 4-F </td><td class="colsep2 rowsep2">(CH<sub>2</sub>)<sub>2</sub>Nmorpholide </td><td class="colsep2 rowsep2">1.3 </td><td class="colsep2 rowsep2">0.8 </td><td class="colsep2 rowsep2">1.0 </td><td class="colsep2 rowsep2">1.8 </td><td class="colsep2 rowsep2">5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>37</b></td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">3-Br, 4-F </td><td class="colsep2 rowsep2">(CH<sub>2</sub>)<sub>2</sub>Nmorpholide </td><td class="colsep2 rowsep2">1.5 </td><td class="colsep2 rowsep2">0.7 </td><td class="colsep2 rowsep2">1.0 </td><td class="colsep2 rowsep2">4.5 </td><td class="colsep2 rowsep2">0.5 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>38</b></td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">3-Cl, 4-F </td><td class="colsep2 rowsep2">(CH<sub>2</sub>)<sub>2</sub>Npiperidine </td><td class="colsep2 rowsep2">0.9 </td><td class="colsep2 rowsep2">2.1 </td><td class="colsep2 rowsep2">1.8 </td><td class="colsep2 rowsep2">4.3 </td><td class="colsep2 rowsep2">2 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>39</b></td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">3-Cl, 4-F </td><td class="colsep2 rowsep2">(CH<sub>2</sub>)<sub>2</sub>N(4-Me-pz)<i><sup>f</sup></i><sup></sup></td><td class="colsep2 rowsep2">0.5 </td><td class="colsep2 rowsep2">0.7 </td><td class="colsep2 rowsep2">1.2 </td><td class="colsep2 rowsep2">1.9 </td><td class="colsep2 rowsep2">1 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>40</b></td><td class="colsep2 rowsep2">N </td><td class="colsep2 rowsep2">3-Br, 4-F </td><td class="colsep2 rowsep2">(CH<sub>2</sub>)<sub>2</sub>N(4-Me-pz)<i><sup>f</sup></i><sup></sup></td><td class="colsep2 rowsep2">1.1 </td><td class="colsep2 rowsep2">0.5 </td><td class="colsep2 rowsep2">0.8 </td><td class="colsep2 rowsep2">2.7 </td><td class="colsep2 rowsep2">3.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Concentration for 50% inhibition of phosphorylation of a Glu/Tyr copolymer (see Experimental Section). Values are the average of at least two separate determinations, with a CV of ±22%.<i><sup>b</sup></i><sup></sup> Inhibition of erbB1 autophosphorylation in NIH3T3 cells transfected with the full-length human erbB1 (see Experimental Section).<i><sup>c</sup></i><sup></sup> Inhibition of heregulin-stimulated erbB autophosphorylation in MDA-MB-453 human breast carcinoma cells (see Experimental Section).<i><sup>d</sup></i><sup></sup> Reference 55.<i><sup>e</sup></i><sup></sup> References 34 and 55.<i><sup>f</sup></i><sup></sup> 4-Methylpiperazine.</p></div></div></div><div class="NLM_p">Overall, for the compounds where there was a full set of data there was a good correlation between the degree of inhibition of the different isozymes, suggesting that the general class of 6-alkynamides is composed of pan-erbB inhibitors (eqs 1−3; data for eq 2 from compounds <b>19</b><b>−</b><b>40</b> of Table 1; data for eqs 1 and 3 omit compound <b>33</b>). These equations also show that the compounds were on average about 10-fold more potent against erbB1 than against erbB2 and erbB4 (coefficient of IC<sub>50</sub> term in eqs 1 and 2).<a class="ref internalNav" href="#jm050936oe00001" aria-label=""></a><span class="NLM_disp-formula" id="jm050936oe00001"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/medium/jm050936oe00001.gif" alt="" id="_i11" /></img></span><a class="ref internalNav" href="#jm050936oe00003" aria-label=""></a><span class="NLM_disp-formula" id="jm050936oe00003"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/medium/jm050936oe00003.gif" alt="" id="_i12" /></img></span><a class="ref internalNav" href="#jm050936oe00005" aria-label=""></a><span class="NLM_disp-formula" id="jm050936oe00005"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/medium/jm050936oe00005.gif" alt="" id="_i13" /></img></span> Over the whole class, there was a less close correlation between the erbB1/EGF autophosphorylation and erbB2/HER autophosphorylation data (<i>r</i> values of 0.61 and 0.64, respectively). However, there was a clear advantage in pan-erbB autophosphorylation potency for compounds bearing the 5-dialkylamino-2-pentynamide class of Michael acceptor (such as <b>26</b>, <b>27</b>, <b>36</b><b>−</b><b>40</b>). These derivatives were more potent inhibitors of both the isolated enzymes and of autophosphorylation in cells with average IC<sub>50</sub> values of 1.25, 1.4, 3.9, 4.5, and 6.1 nM in erbB1, erbB2, erbB4, and EGF- and HER-stimulated autophosphorylation, respectively, compared with average values of 15, 91, 181, 27, and 94 nM, respectively, for all the other compounds in these assays. The latter average figures did not vary greatly if the non-amine-bearing analogues were excluded, suggesting that the important factor was the ability of the amine to participate in an autocatalytic reaction with the key cysteine of the erbB family via a six-membered-ring mechanism, analogous to that reported previously.<sup>34</sup> Compounds <b>37</b>, <b>39</b>, and <b>40</b> have been confirmed as irreversible inhibitors of erbB1 in a modified A431-cellular autophosphorylation assay containing a drug wash-out protocol<sup>28,29</sup> (data not shown). </div><div class="NLM_p">Table 1 also reveals that there is a greater potency in cellular versus enzyme assays for a number of compounds (e.g., <b>24</b> and<b> 33</b>). This is viewed as not being due to mixed erbB inhibition in cells but perhaps to differences in response to different enzyme constructs (i.e., enzyme assays use GST-fusion proteins where GST is fused to the intracellular domain of the erbBs, whereas in the HER-stimulated autophosphorylation cell assay, the wild-type, full length forms are present). </div><div class="NLM_p">Of the compounds evaluated, the pyrido[3,4-<i>d</i>]pyrimidine <b>39</b> had the best overall potencies in both the enzymic and cellular assays and was selected for further studies. Table 2 shows that <b>39</b> has broadly similar in vitro activity to the clinical irreversible inhibitor canertinib dihydrochloride (<b>9</b>) and is significantly more potent (particularly in the erbB2 cellular assay) than the clinically approved reversible inhibitors gefitinib and erlotinib.<a class="ref showTableEvent internalNav" data-ID="jm050936ot00002" href="#jm050936ot00002"></a><a class="ref showTableEvent internalNav" data-ID="jm050936ot00003" href="#jm050936ot00003"></a><a class="ref showTableEvent internalNav" data-ID="jm050936ot00004" href="#jm050936ot00004"></a><a data-tab="pane-pcw-Figures" href="#jm050936of00001" id="" class=" internalNav"></a> Furthermore, compound <b>39</b> is selective for the erbB family of tyrosine kinases over the PDGF, FGF, and insulin receptor tyrosine kinases. The pan-erbB nature of this compound is assessed in three cellular assays:  first, in the EGF-stimulated erbB1 autophosphorylation assay (in erbB1-transfected NIH3T3 cells) (see Figure 1, part A), second, in the ligand-stimulated erbB2 autophosphorylation assay (in T24 NIH fibroblasts <a name="jm004900401479" id="jm004900401479"></a> expressing a chimeric receptor with the extracellular binding domain of erbB1 and the intracellular kinase domain of erbB2) (see Figure 1, part B), and third, in the heregulin-stimulated tyrosine autophosphorylation assay (in erbB2, -3, and -4 expressing MDA-MB-453 cells). Low nanomolar potency across these three assays, as shown for <b>9</b> and <b>39</b>, is considered indicative of pan-erbB inhibition. <div id="_i14"><figure id="jm050936of00001" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/medium/jm050936of00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/large/jm050936of00001.jpeg" id="_i15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 A:  Inhibition of erbB1 tyrosine kinase activity in NIH 3T3 fibroblasts expressing human erbB1. B:  Inhibition of erbB2 tyrosine kinase activity in T24 NIH fibroblasts expressing a chimeric receptor with the extracellular binding domain of erbB1 and the intracellular kinase domain of erbB2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/large/jm050936of00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm050936o&amp;id=jm050936of00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div class="NLM_table-wrap" id="jm050936ot00002"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 2.  Comparison of the in Vitro and Cellular Kinase Activities of Compound <b>39</b> with Other ErbB Family Inhibitors</p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2" colspan="4">IC<sub>50</sub> (nM)</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">activity</td><td class="colsep2 rowsep2"><b>39</b></td><td class="colsep2 rowsep2">canertinib</td><td class="colsep2 rowsep2">gefitinib</td><td class="colsep2 rowsep2">erlotinib </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">EGF receptor (erbB1)<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">0.5 </td><td class="colsep2 rowsep2">3.0 </td><td class="colsep2 rowsep2">3.1 </td><td class="colsep2 rowsep2">0.6 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">ErbB2 receptor<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">0.7 </td><td class="colsep2 rowsep2">20 </td><td class="colsep2 rowsep2">343 </td><td class="colsep2 rowsep2">511 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">PDGF receptor </td><td class="colsep2 rowsep2">>50 000 </td><td class="colsep2 rowsep2">>50 000 </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">FGF receptor </td><td class="colsep2 rowsep2">>50 000 </td><td class="colsep2 rowsep2">>50 000 </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">insulin receptor </td><td class="colsep2 rowsep2">>50 000 </td><td class="colsep2 rowsep2">>50 000 </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">EGF receptor autophosphorylation<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">1.9 </td><td class="colsep2 rowsep2">1.7 </td><td class="colsep2 rowsep2">14.4 </td><td class="colsep2 rowsep2">19.3 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">ligand-regulated erbB2 autophosphorylation<i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">0.8 </td><td class="colsep2 rowsep2">16 </td><td class="colsep2 rowsep2">599 </td><td class="colsep2 rowsep2">299 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">HER-regulated tyrosine autophosphorylation<i><sup>d</sup></i><sup></sup></td><td class="colsep2 rowsep2">1 </td><td class="colsep2 rowsep2">5.1 </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> See footnotes to Table 1.<i><sup>b</sup></i><sup></sup> In erbB1-transfected NIH3T3 cells.<i><sup>c</sup></i><sup></sup> In T24 NIH fibroblasts expressing a chimeric receptor with the extracellular binding domain of erbB1 and the intracellular kinase domain of erbB2.<i><sup>d</sup></i><sup></sup> In MDA-MB-453 human breast carcinoma cells.</p></div></div><div class="NLM_table-wrap" id="jm050936ot00003"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 3.  In Vivo Antitumor Efficacy of <b>39</b> in Mice against a Spectrum of Implanted Human Tumor Xenografts</p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">tumor</td><td class="colsep2 rowsep2">dose<i><sup>a</sup></i><sup></sup> (mg/kg)</td><td class="colsep2 rowsep2">schedule</td><td class="colsep2 rowsep2">weight change (%)<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">T-C<i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">GDI<i><sup>d</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">A431 epidermoid </td><td class="colsep2 rowsep2">10 </td><td class="colsep2 rowsep2">(Q1D × 5) × 2; D15 </td><td class="colsep2 rowsep2">−1.0 </td><td class="colsep2 rowsep2">26.9 </td><td class="colsep2 rowsep2">269 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">BXPC3 pancreatic </td><td class="colsep2 rowsep2">40 </td><td class="colsep2 rowsep2">(Q1D × 5) × 3; D12 </td><td class="colsep2 rowsep2">−0.6 </td><td class="colsep2 rowsep2">16.2 </td><td class="colsep2 rowsep2">108 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">H125 NSC lung </td><td class="colsep2 rowsep2">40 </td><td class="colsep2 rowsep2">D17−31 </td><td class="colsep2 rowsep2">0 </td><td class="colsep2 rowsep2">17.1 </td><td class="colsep2 rowsep2">114 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">SF767 glioblastoma </td><td class="colsep2 rowsep2">40 </td><td class="colsep2 rowsep2">(Q1D × 5) × 3; D15 </td><td class="colsep2 rowsep2">−0.4 </td><td class="colsep2 rowsep2">23.8 </td><td class="colsep2 rowsep2">159 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">SKOV3 ovarian </td><td class="colsep2 rowsep2">40 </td><td class="colsep2 rowsep2">D17−31 </td><td class="colsep2 rowsep2">−6.5 </td><td class="colsep2 rowsep2">21.4 </td><td class="colsep2 rowsep2">187</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Dose is PO.<i><sup>b</sup></i><sup></sup> Maximum treatment related weight loss, expressed as a percent of initial group weight.<i><sup>c</sup></i><sup></sup> T-C is the difference, in days, for the median treated and control tumors to reach a fixed evaluation size, usually 750 mg.<i><sup>d</sup></i><sup></sup> GDI (growth delay index) = [(T-C)/treatment days] × 100.</p></div></div><div class="NLM_table-wrap" id="jm050936ot00004"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 4.  Mean Pharmacokinetic Parameters of <b>39</b> in Rat, Dog, and Monkey, Following a Single Dose Administration</p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">species</td><td class="colsep2 rowsep2">dose mg/kg</td><td class="colsep2 rowsep2">route</td><td class="colsep2 rowsep2"><i>N</i></td><td class="colsep2 rowsep2"><i>C</i><sub>max</sub> ng/mL</td><td class="colsep2 rowsep2"><i>t</i><sub>max</sub> (h)</td><td class="colsep2 rowsep2"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep2 rowsep2">CL (mL/min)/kg</td><td class="colsep2 rowsep2">Vd<sub>ss</sub> (L/kg)</td><td class="colsep2 rowsep2">AUC(0-tlqc) (ng·h/mL)</td><td class="colsep2 rowsep2"><i>F</i> (%) </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">rat </td><td class="colsep2 rowsep2">5 </td><td class="colsep2 rowsep2">iv<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">0.83 </td><td class="colsep2 rowsep2">118.8 </td><td class="colsep2 rowsep2">3.1 </td><td class="colsep2 rowsep2">703 </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">dog </td><td class="colsep2 rowsep2">5 </td><td class="colsep2 rowsep2">iv<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">1.86 </td><td class="colsep2 rowsep2">11.5 </td><td class="colsep2 rowsep2">0.93 </td><td class="colsep2 rowsep2">7470 </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">monkey </td><td class="colsep2 rowsep2">5 </td><td class="colsep2 rowsep2">iv<i><sup>a</sup></i><sup></sup></td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">0.37 </td><td class="colsep2 rowsep2">85.8 </td><td class="colsep2 rowsep2">1.7 </td><td class="colsep2 rowsep2">1190 </td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">rat </td><td class="colsep2 rowsep2">15 </td><td class="colsep2 rowsep2">po<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">56.3 </td><td class="colsep2 rowsep2">4.7 </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">240 </td><td class="colsep2 rowsep2">11.4 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">dog </td><td class="colsep2 rowsep2">15 </td><td class="colsep2 rowsep2">po<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">3 </td><td class="colsep2 rowsep2">4180 </td><td class="colsep2 rowsep2">1.0 </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">15 200 </td><td class="colsep2 rowsep2">67.8 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">monkey </td><td class="colsep2 rowsep2">30 </td><td class="colsep2 rowsep2">po<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">2 </td><td class="colsep2 rowsep2">83.5 </td><td class="colsep2 rowsep2">3.5 </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">485 </td><td class="colsep2 rowsep2">6.75</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> iv dosing vehicle:  5% DMSO/95% 0.05N methanesulfonic acid in saline (rat); 5% DMA/95% 50 mM lactic acid (pH 4.0) (dog and monkey).<i><sup>b</sup></i><sup></sup> po dosing vehicle:  5% PEG/95% methylcellulose (0.5%) (rat); methylcellulose (0.5%) (dog and monkey).</p></div></div></div><div class="NLM_p">Compound <b>39</b> was evaluated for antitumor effects in a variety of implanted human tumor xenografts in immune-deficient mice. These models were chosen due to their expression of erbB receptor family members. A summary of the data is shown (Table 3), depicting the activity obtained at either the maximum tolerated dose (MTD) or the dose where the highest efficacy was obtained. Loss of weight was taken as an indication of toxicity and in general was very mild. The large decrease in weight for SKOV3 implanted mice appears to be due to effects on the mice by the tumor rather than the drug, since untreated tumor-bearing mice had similar weight losses. </div><div class="NLM_p">For <b>39</b> the inhibition of target receptor activation remained significantly inhibited for at least 24 h in tumors after a single dose over a relatively wide dose range. The most sensitive tumor was the A431 human epidermoid carcinoma, where significant tumor regression was clearly evident (Table 3). Tumor regression in response to <b>39</b> was also apparent in the SF767 human glioblastoma and the SKOV3 human ovarian carcinoma. The compound produced complete stasis in the BXPC3 human pancreatic carcinoma as well as in the H125 human non-small-cell lung carcinoma under continuous daily dosing. In general, <b>39</b> was highly active in all five tumor models and was as efficacious as canertinib dihydrochloride (<b>9</b>) in A431 xenografts.<sup>30</sup></div><div class="NLM_p last">Detailed pharmacokinetic studies of <b>39</b> were undertaken in rat, monkey, and dog, and the results are summarized in Table 4. In rat and monkey the plasma clearance was higher than hepatic blood flow; this may be related to low metabolic stability in these species (unpublished data) and possibly to irreversible binding of <b>39</b> to the target. The total amount of the unchanged parent drug excreted into bile and urine was less than 1% in rats, so that the contribution of biliary and renal clearance to the total plasma clearance was minimal. The volume of distribution was higher than total body water in all species, suggesting that <b>39 </b>likely distributed to tissue. It exhibited a short plasma half-life (<2 h) in all three species, although the duration of action did not solely rely on this because of its irreversible inhibition mechanism. The bioavailability of <b>39 </b>(<i>F</i>) was 11.4% in rat and 67.8% in dog following a single oral administration of 15 mg/kg under a fasted condition. In monkeys, the bioavailability was 6.75% at a 30 mg/kg dose (Table 4). </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54057" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54057" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The alkynamides in general are potent inhibitors of erbB1, erbB2, and erbB4, being on average the most potent (10×) against erbB1. Analogues bearing a 5-dialkylamino-2-pentynamide class of Michael acceptor are irreversible inhibitors of erbB1 (and presumably erbB2 and erbB4), and possess a potency advantage (6- to 80-fold) in terms of pan-erbB activity in both isolated enzyme and cellular autophosphorylation assays. This is likely due to an improved ability of the amine to participate in autocatalysis of the Michael reaction with cysteine.<sup>34</sup> The pyrido[3,4-<i>d</i>]pyrimidine <b>39</b> had the best overall potencies in both the enzymatic and cellular assays. This compound was evaluated in a panel of five human tumor xenografts in nude mice, by use of a multiple dose schedule. It was highly active in all the models as measured by the growth delay index. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38878" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38878" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Analyses were performed by the Analytical Department, Pfizer Global Research and Development, Ann Arbor Laboratories. <a name="jm004900401480" id="jm004900401480"></a> Melting points were determined using a Gallenkamp digital melting point apparatus and are as read. NMR spectra were measured on a Varian Unity 400 MHz spectrometer and referenced to Me<sub>4</sub>Si. Mass spectra were recorded on a Finnigan MAT 900Q spectrometer. Column chromatography was carried out with flash silica gel. All reactions were run under an inert atmosphere of nitrogen or argon. All reaction solvents were anhydrous, analytical reagent quality. Solvent drying during extractive workups was carried out with Mg<sub>2</sub>SO<sub>4</sub> unless otherwise noted. 4-(Tosyloxy)-1-butyne (<b>41</b>) was purchased from Lancaster Synthesis. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[(3-Bromophenyl)amino]-6-quinazolinyl]-2-propynamide (19).</b> A stirred solution of 4-[3-bromophenylamino]-6-aminoquinazoline<sup>41</sup> (<b>17a)</b> (158 mg, 0.5 mmol) and propiolic acid (<b>18a</b>) (0.08 mL, 1.1 mmol) in DMF (1.5 mL) was treated with 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI·HCl) (200 mg, 1.04 mmol) under nitrogen at 0 °C. The solution was stirred at 0 °C for 30 min and then quenched with water. The resulting fine precipitate was collected, dissolved in MeOH, and purified by preparative TLC on silica gel. It was eluted with MeOH/CHC1<sub>3</sub> (9:1) to give <b>19</b> as a yellow solid (21 mg, 12%); mp > 310 °C. <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ:  11.18 (br s, 1H), 9.94 (s, 1H), 8.75 (s, 1H), 8.59 (s, 1H), 8.15 (s, 1H), 7.85−7.79 (m, 3H), 7.37−7.28 (m, 2H), 4.53 (s, 1H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  366 (<sup>79</sup>BrM<sup>+</sup>, 13), 367 (<sup>79</sup>BrMH<sup>+</sup>, 50), 368 (<sup>81</sup>BrM<sup>+</sup>, 24), 369 (<sup>81</sup>BrMH<sup>+</sup>, 47). Anal. (C<sub>17</sub>H<sub>11</sub>N<sub>4</sub>BrO) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[(3-Bromophenyl)amino]-6-quinazolinyl]-2-butynam-ide</b><b><sup>34</sup></b><sup></sup><b> (20).</b> A stirred solution of 2-butynoic acid (<b>18b</b>) (196 mg, 2.3 mmol) and EDCI·HCl (385 mg, 2.0 mmol) in DMF (5 mL) was treated with 4-[3-bromophenylamino]-6-aminoquinazoline<sup>41</sup> (<b>17a</b>) (316 mg, 1.0 mmol) over 20 min at 25 °C. The resulting solution was stirred at 25 °C, and two further lots of EDCI·HCl (206 mg, 1.0 mmol) and 2-butynoic acid (82 mg, 1.0 mmol) were added after 14 and 22 h, respectively. The mixture was stirred at 25 °C for an additional 12 h and then quenched with water. The resulting precipitate was collected and dissolved in MeOH and purified by preparative TLC on silica gel. It was eluted with EtOAc/acetone (1:1) to give <b>20</b> as a solid (20 mg, 5%); mp 281−283 °C. <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ:  10.97 (br s, 1H), 9.93 (s, 1H), 8.76 (s, 1H), 8.57 (s, 1H), 8.14 (s, 1H), 7.84−7.76 (m, 3H), 7.34 (t, <i>J</i> = 8.1 Hz, 1H), 7.29 (d, <i>J</i> = 7.8 Hz, 1H), 2.09 (s, 3H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  381 (<sup>79</sup>BrMH<sup>+</sup>, 95), 382 (<sup>81</sup>BrM<sup>+</sup>, 23), 383 (<sup>81</sup>BrMH<sup>+</sup>, 100). Anal. (C<sub>18</sub>H<sub>13</sub>BrN<sub>4</sub>O·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[(3-Chloro-4-fluorophenyl)amino]-6-quinazolinyl]-4-(dibutylamino)-2-butynamide </b><b>(24).</b> A mixture of 6-amino-4-(3-chloro-4-fluoroanilino)quinazoline<sup>29</sup> (<b>17b</b>) (93 mg, 0.32 mmol), pyridine (0.03 mL, 0.37 mmol), and 4-(dibutylamino)-2-butynoic acid (<b>18h</b>) (69 mg, 0.33 mmol) in DMF (1.5 mL) at 0° C was treated with EDCI·HCl (76 mg, 0.40 mmol). The reaction was slowly warmed to room temperature and quenched with water after 7 h. The mixture was extracted with EtOAc, and the combined organic phases were washed with water and brine, dried, and concentrated to a residue that was purified first by silica gel column chromatography (elution with 2.5% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) and then by preparative TLC (elution with 10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>). The purified material was triturated in ether to afford <b>24</b> as a light yellow solid (30 mg, 19%); mp 78−79 °C. <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ:  10.9 (s, 1H), 9.89 (s, 1H), 8.66 (s, 1H), 8.52 (s, 1H), 8.07(dd, <i>J</i> = 6.6, 2.5 Hz, 1H), 7.8−7.7 (m, 3H), 7.39 (t, <i>J</i> = 9.2 Hz, 1H), 3.55 (s, 2H), 1.4−1.2 (m, 8H), 0.84 (t, <i>J</i> = 7.1 Hz, 6H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  482 (M<sup>+</sup>, 100). Anal. (C<sub>26</sub>H<sub>29</sub>ClFN<sub>5</sub>O·0.7H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>4-(Dibutylamino)-2-butynoic acid</b><b>(18h)</b> was synthesized by the Wyeth procedure.<sup>34</sup><sup>1</sup>H NMR (CD<sub>3</sub>OD) δ: 4.18 (s, 2H), 3.23 (m, 4H), 1.69 (m, 4H), 1.43 (dq, <i>J</i> = 15.0, 7.4 Hz, 4H), 1.00 (t, <i>J</i> = 7.4 Hz, 6H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  212 (M<sup>+</sup>, 100), 168 (75). </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[(3-Chloro-4-fluorophenyl)amino]-6-quinazolinyl]-4-hydroxy-2-butynamide (21).</b> A similar reaction of <b>17b</b> and 4-hydroxy-2-butynoic acid<sup><a onclick="showRef(event, 'jm050936ob00044'); return false;" href="javascript:void(0);" class="ref jm050936ob00044">44</a></sup> (<b>18e</b>) provided <b>21</b> as a light yellow solid (23%); mp 231−233 °C. <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ:  11.0 (s, 1H), 9.91 (s, 1H), 8.71 (s, 1H), 8.51 (s, 1H), 8.05 (dd, <i>J</i> = 6.8, 2.7 Hz, 1H), 7.74−7.70 (m, 3H), 7.39 (t, <i>J</i> = 9.3 Hz, 1H), 5.55 (t, <i>J</i> = 6.1 Hz, 1H), 4.28 (d, <i>J</i> = 5.8 Hz, 2H). APCIMS <i>m</i>/<i>z</i> (relative intensity) 371 (M<sup>+</sup>, 100). Anal. (C<sub>18</sub>H<sub>12</sub>ClFN<sub>4</sub>O<sub>2</sub>·0.9H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[(3-Chloro-4-fluorophenyl)amino]-6-quinazolinyl]-4-(diethylamino)-2-butynamide </b><b>(22).</b> A similar reaction of <b>17b</b> and 4-(diethylamino)-2-butynoic acid<sup>34</sup> (<b>18f</b>) provided <b>22</b> as a light yellow solid (9%); mp 108−110 °C. <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ:  10.9 (s, 1H), 9.89 (s, 1H), 8.65 (s, 1H), 8.52 (s, 1H), 8.07 (dd, <i>J</i> = 6.8, 2.5 Hz, 1H), 7.8−7.73 (m, 3H), 7.39 (t, <i>J</i> = 9.2 Hz, 1H), 3.57 (s, 2H), 2.49 (q, <i>J</i> = 7.1 Hz, 4H), 0.97 (t, <i>J</i> = 7.1 Hz, 6H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  426.1(M<sup>+</sup>, 100). Anal. (C<sub>22</sub>H<sub>21</sub>ClFN<sub>5</sub>O·0.3C<sub>3</sub>H<sub>6</sub>O·0.8H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[(3-Chloro-4-fluorophenyl)amino]-6-quinazolinyl]-4-(bis(1-methylethyl)amino)-2-buty</b><b>namide (23). A </b>similar reaction of <b>17b</b> and 4-[bis(1-methylethyl)amino]-2-butynoic acid<sup>34</sup> (<b>18g</b>) provided <b>23</b> as a light yellow solid (32%); mp 120−122 °C. <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ:  10.87 (s, 1H), 9.88 (s, 1H), 8.66 (s, 1H), 8.51 (s, 1H), 8.07 (dd, <i>J</i> = 6.9, 2.7 Hz, 1H), 7.79−7.72 (m, 3H), 7.39 (t, <i>J</i> = 9.3 Hz, 1H), 3.55 (s, 2H), 3.3−3.07 (m, 2H), 1.01 (d, <i>J</i> = 6.6 Hz, 12H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  454 (M<sup>+</sup>, 100). Anal. (C<sub>24</sub>H<sub>25</sub>ClFN<sub>5</sub>O·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[(3-Chloro-4-fluorophenyl)amino]-6-quinazolinyl]-4-(4-morpholinyl)-2-butynamide </b><b>(25).</b> A similar reaction of <b>17b</b> and 4-(4-morpholinyl)-2-butynoic acid<sup>34</sup> (<b>18i</b>) provided <b>25</b> as an off-white powder (20%); mp 167−169 °C. <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ:  11.02 (s, 1H), 9.93 (s, 1H), 8.69 (s, 1H), 8.55 (s, 1H), 8.10 (dd, <i>J</i> = 6.8, 2.7 Hz, 1H), 7.84−7.77 (m, 3H, H-8), 7.43 (t, <i>J</i> = 9.2 Hz, 1H), 3.61 (br, 4H), 3.55 (s, 2H), 2.53 (br, 4H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  440 (M<sup>+</sup>, 100). Anal. (C<sub>22</sub>H<sub>21</sub>ClFN<sub>5</sub>O·0.3C<sub>3</sub>H<sub>6</sub>O·0.3H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[(3-Chloro-4-fluorophenyl)amino]-6-quinazolinyl]-5-(4-diethylamino)-2-pentynamide </b><b>(26).</b> A similar reaction of <b>17b</b> and 5-(diethylamino)-2-pentynoic acid (<b>18j</b>) provided <b>26</b> as a tan powder (11%); mp 138−140 °C. <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ:  10.87 (s, 1H), 9.89 (s, 1H), 8.68 (s, 1H), 8.51(s, 1H), 8.05 (dd, <i>J</i> = 6.9, 2.7 Hz, 1H), 7.74−7.71 (m, 3H), 7.41 (t, <i>J</i> = 9.1 Hz, 1H), 2.69 (t, <i>J</i> = 7.2 Hz, 2H), 0.93 (t, <i>J</i> = 7.1 Hz, 6H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  440 (M<sup>+</sup>, 100). Anal. (C<sub>23</sub>H<sub>23</sub>ClFN<sub>5</sub>O·0.3H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[(3-Chloro-4-fluorophenyl)amino]-6-quinazolinyl]-5-(4-morpholinyl)-2-pentynamide </b><b>(27).</b> A similar reaction of <b>17b</b> and 5-(4-morpholinyl)-2- pentynoic acid (<b>18k</b>) provided <b>27</b> as a cream powder (11%); mp 155−157 °C. <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ:  10.9 (s, 1H), 9.89 (s, 1H), 8.67 (s, 1H), 8.51 (s, 1H), 8.05 (dd, <i>J</i> = 6.9, 2.5 Hz, 1H), 7.4−7.71 (m, 3H), 7.39 (t, <i>J</i> = 9.1 Hz, 1H), 3.53 (t, <i>J</i> = 4.4 Hz, 4H), 2.58−2.53 (m, 4H), 2.38−2.34 (m, 4H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  454 (M<sup>+</sup>, 100). Anal. (C<sub>23</sub>H<sub>21</sub>ClFN<sub>5</sub>O<sub>2</sub>·0.6H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[(3-Bromophenyl)amino]pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-2-propynamide (28).</b> A stirred solution of 6-amino-4-[(3-bromophenyl)amino]pyrido[3,4-<i>d</i>]pyrimidine<sup>42</sup> (<b>17c</b>) (94 mg, 0.3 mmol) and propiolic acid (<b>18a</b>) (66 μL, 1.05 mmol) in pyridine (1.2 mL) under nitrogen at −20 °C was treated with EDCI·HCl (294 mg, 1.5 mmol). After 2.25 h, additional propiolic acid (33 μL) and EDCI·HCl (147 mg) were added, and after a total reaction time of 7.5 h the mixture was diluted with DMF and then poured into EtOAc/water (1:1). The aqueous phase was extracted with EtOAc (2×), and the combined organic phases were washed with brine (2×), dried, and filtered through silica gel. The filtrate was concentrated and purified by column chromatography, then eluted with EtOAc. Product fractions were pooled and concentrated and the residue was triturated in EtOAc/<i>tert</i>-butyl methyl ether (1:1) to provide <b>28</b> (16 mg, 14%); mp >150 °C (dec). <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ:  11.69 (s, 1H), 10.31 (s, 1H), 9.05 (s, 1H), 8.83 (s, 1H), 8.68 (s, 1H), 8.15 (s, 1H), 7.87 (d, <i>J</i> = 7.2 Hz, 1H), 7.40−7.33 (m, 2H), 4.54 (s, 1H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  367 (<sup>79</sup>BrM<sup>+</sup>, 28), 368 (<sup>79</sup>BrMH<sup>+</sup>, 100), 369 (<sup>81</sup>BrM<sup>+</sup>, 50), 370 (<sup>81</sup>BrMH<sup>+</sup>, 14). Anal. (C<sub>16</sub>H<sub>10</sub>BrN<sub>5</sub>O·0.2H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[(3-Chloro-4-fluorophenyl)amino]pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-2-butynamide (29).</b> A −30 °C stirred solution of 6-amino-4-[(3-chloro-4-fluorophenyl)amino]pyrido[3,4-<i>d</i>]pyrimidine<sup>29</sup> (<b>17d</b>) (0.290 g, 1.0 mmol), 2-butynoic acid (<b>18b</b>) (0.092 g, <a name="jm004900401481" id="jm004900401481"></a> 1.1 mmol), and pyridine (5 mL) was treated with EDCI·HCl (0.242 g, 1.26 mmol). After it was stirred overnight, the dark solution was poured into 40 mL of saturated aqueous NaHCO<sub>3</sub>. The formed precipitate was collected, washed with water, and then dissolved in CHCl<sub>3</sub>/MeOH (10:1). The solution was purified by column chromatography and was eluted with CHCl<sub>3</sub>/MeOH (20:1) to obtain nearly pure product, which was dissolved in MeOH/CH<sub>2</sub>Cl<sub>2</sub> (4:1). The solution was clarified with charcoal and concentrated to 5 mL at which point crystallization occurred. The precipitate was collected, washed with MeOH and then ether, and dried to provide <b>29</b> (0.04 g, 11%); mp 258−261 °C. <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ:  11.38 (s, 1H), 10.28 (s, 1H), 8.97 (s, 1H), 8.74 (s, 1H), 8.59 (s, 1H), 8.07 (m, 1H), 7.74 (m, 1H), 7.41 (t, <i>J</i> = 9 Hz, 1H), 2.02 (s, 3H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  356 (M<sup>+</sup>, 100). Anal. (C<sub>17</sub>H<sub>11</sub>ClFN<sub>5</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[(3-Chloro-4-fluorophenyl)amino]pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-2-hexynamide (30).</b> A similar reaction of <b>17d</b> (0.290 g, 1.0 mmol), 2-hexynoic acid (<b>18c</b>) (0.123 g, 1.1 mmol), EDCI·HCl (0.242 g, 1.26 mmol), and pyridine (5 mL) followed by workup and crystallization from EtOAc provided <b>30</b> (0.043 g, 11%); mp 233−235 °C. <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ:  11.41 (s, 1H), 10.27 (s, 1H), 8.97 (s, 1H), 8.74 (s, 1H), 8.59 (s, 1H), 8.07 (m, 1H), 7.75 (m, 1H), 7.41 (t, <i>J</i> = 9 Hz, 1H), 2.37 (t, <i>J</i> = 7 Hz, 2H), 1.53 (q, <i>J</i> = 7 Hz, 2H), 0.96 (t, <i>J</i> = 7 Hz, 3H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  384 (M<sup>+</sup>, 100). Anal. (C<sub>19</sub>H<sub>15</sub>ClFN<sub>5</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[(3-Chloro-4-fluorophenyl)amino]pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-2-heptynamide (31).</b> A similar reaction of <b>17d</b> (0.29 g, 1.0 mmol), 2-heptynoic acid (<b>18d</b>) (0.139 g, 1.1 mmol), EDCI·HCl (0.242 g, 1.26 mmol), and pyridine (5 mL) followed by workup, chromatography, and crystallization from EtOAc gave <b>31</b> (0.025 g, 6%); mp 220−225 °C. <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ:  11.40 (s, 1H), 10.27 (s, 1H), 8.97 (s, 1H), 8.74 (s, 1H), 8.59 (s, 1H), 8.07 (m, 1H), 7.74 (m, 1H), 7.41 (t, <i>J</i> = 9 Hz, 1H), 2.39 (t, <i>J</i> = 7 Hz, 2H), 1.49 (m, 2H), 1.39 (m, 2H), 0.86 (t, <i>J</i> = 7 Hz, 3H). Anal. (C<sub>20</sub>H<sub>17</sub>ClFN<sub>5</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[(3-Chloro-4-fluorophenyl)amino]pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-4-(diethylamino)-2-but</b><b>ynamide (32).</b> A similar reaction of <b>17d</b> (0.602 g, 2.08 mmol), 4-(diethylamino)-2-butynoic acid<sup>34</sup> (<b>18f</b>) (0.67 g, 4.16 mmol), EDCI·HCl (1.04 g, 5.41 mmol), and pyridine (5 mL) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL), followed by workup and chromatography, gave <b>32</b> (0.047 g, 5%); mp 234−236 °C. <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ:  11.52 (s, 1H), 10.26 (s, 1H), 8.97 (s, 1H), 8.75 (s, 1H), 8.60 (s, 1H), 8.07 (m, 1 H), 7.75 (m, 1H), 7.41 (t, <i>J</i> = 9 Hz, 1H), 3.55 (s, 2H), 2.48 (m, 4H), 0.96 (t, <i>J</i> = 7 Hz, 6H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  427 (M<sup>+</sup>, 100). Anal. (C<sub>21</sub>H<sub>20</sub>ClFN<sub>6</sub>O·1.0H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[(3-Chloro-4-fluorophenyl)amino]pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-4-(bis(1-methylethyl)a</b><b>mino)-2-butynamide (33).</b> A similar reaction of <b>17d</b> (0.580 g, 2.0 mmol), 4-[bis(1-methylethyl)amino]-2-butynoic acid<sup>34</sup> (<b>18g</b>) (0.440 g, 2.2 mmol), EDCI·HCl (0.480 g, 2.5 mmol), and pyridine (10 mL), followed by workup, chromatography, and crystallization from EtOAc, gave <b>33</b> (0.11 g, 12%); mp 200−230 °C (dec). <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ:  11.46 (s, 1H), 10.26 (s, 1H), 8.98 (s, 1H), 8.75 (s, 1H), 8.60 (s, 1H), 8.07 (m, 1H), 7.74 (m, 1H), 7.42 (t, <i>J</i> = 9 Hz, 1H), 3.54 (s, 2H), 3.10 (m, 2H), 1.00 (m, 12H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  455 (M<sup>+</sup>, 100). Anal. (C<sub>23</sub>H<sub>24</sub>ClFN<sub>6</sub>O·H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[(3-Chloro-4-fluorophenyl)amino]pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-4-(dibutylamino)-2-but</b><b>ynamide (34).</b> A similar reaction of <b>17d</b> (0.145 g, 0.5 mmol), 4-(dibutylamino)-2-butynoic acid (<b>18h</b>) (0.116 g, 0.55 mmol), EDCI·HCl (0.120 g, 0.63 mmol), and pyridine (2.5 mL), followed by workup, chromatography, and crystallization from EtOAc, gave <b>34</b> (0.063 g, 28%); mp 172−174 °C (dec). <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ:  11.56 (s, 1H), 10.30 (s, 1H), 9.02 (s, 1H), 8.79 (s, 1H), 8.64 (s, 1H), 8.10 (m, 1H), 7.81 (m, 1H), 7.46 (t, <i>J</i> = 9 Hz, 1H), 3.57 (s, 2H), 2.42 (m, 4H), 1.35 (m, 8H), 0.87 (m, 6H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  483 (M<sup>+</sup>, 100). Anal. (C<sub>25</sub>H<sub>28</sub>ClFN<sub>6</sub>O·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[(3-Chloro-4-fluorophenyl)amino]pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-4-(4-morpholinyl)-2-bu</b><b>tynamide (35).</b> A similar reaction of <b>17d</b> (0.515 g, 1.78 mmol), 4-(4-morpholinyl)-2-butynoic acid<sup>34</sup> (<b>18i</b>) (0.445 g, 2.541 mmol), EDCI·HCl (0.633 g, 3.30 mmol), and pyridine (5 mL) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL), followed by workup, chromatography, and trituration from CH<sub>2</sub>Cl<sub>2</sub>/<i>tert</i>-butylmethyl ether provided <b>35</b> (0.036 g, 5%); mp 198 °C (dec). <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ:  11.58 (s, 1H), 10.28 (s, 1H), 8.97 (s, 1H), 8.75 (s, 1H), 8.58 (s, 1H), 8.06 (m, 1H), 7.74 (m, 1H), 7.41 (t, <i>J</i> = 9 Hz, 1H), 3.56 (m, 4H), 3.49 (s, 2H), 2.45 (m, 4H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  441 (M<sup>+</sup>, 100). Anal. (C<sub>21</sub>H<sub>18</sub>ClFN<sub>6</sub>O<sub>2</sub>·0.4CH<sub>2</sub>Cl<sub>2</sub>·0.3MTBE) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[(3-Chloro-4-fluorophenyl)amino]pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-5-(4-morpholinyl)-2-pe</b><b>ntynamide (36).</b> A similar reaction of <b>17d</b> (0.290 g, 1.0 mmol), 5-(4-morpholinyl)-2-pentynoic acid (<b>18k</b>) (0.202 g, 1.1 mmol), EDCI·HCl (0.242 g, 1.26 mmol), and pyridine (5 mL), followed by workup, chromatography, and crystallization from EtOAc, gave <b>36</b> (0.090 g, 20%); mp 205−209 °C (dec). <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ:  11.45 (s, 1H), 10.32 (s, 1H), 9.01 (s, 1H), 8.78 (s, 1H), 8.63 (s, 1H), 8.11 (m, 1H), 7.80 (m, 1H), 7.45 (t, <i>J</i> = 9 Hz, 1H), 3.55 (m, 4H), 2.48 (m, 4H), 2.40 (m, 4H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  455 (M<sup>+</sup>, 100). Anal. (C<sub>22</sub>H<sub>20</sub>ClFN<sub>6</sub>O<sub>2</sub>·0.2H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[(3-Bromo-4-fluorophenyl)amino]pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-5-(4-morpholinyl)-2-pe</b><b>ntynamide (37).</b> A similar reaction of 6-amino-4-[(3-bromo-4-fluorophenyl)amino]pyrido[3,4-<i>d</i>]pyrimidine<sup>29</sup> (<b>17e</b>) (0.334 g, 1.0 mmol), 5-(4-morpholinyl)-2-pentynoic acid (<b>18k</b>) (0.202 g, 1.1 mmol), EDCI·HCl (0.242 g, 1.26 mmol), and pyridine (5 mL), followed by workup and chromatography, gave <b>37</b> (0.042 g, 8%); mp 190−192 °C (dec). <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ:  11.40 (s, 1H), 10.26 (s, 1H), 8.97 (s, 1H), 8.74 (s, 1H), 8.59 (s, 1H), 8.15 (m, 1H), 7.81 (m, 1H), 7.38 (t, <i>J</i> = 9 Hz, 1H), 3.52 (m, 4H), 2.55 (m, 4H), 2.38 (m, 4H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  501 (<sup>81</sup>BrMH<sup>+</sup>, 100). Anal. (C<sub>22</sub>H<sub>20</sub>BrFN<sub>6</sub>O<sub>2</sub>·0.3CHCl<sub>3</sub>) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[(3-Chloro-4-fluorophenyl)amino]pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-5-(1-piperidinyl)-2-pen</b><b>tynamide (38).</b> A similar reaction of <b>17d</b> (4.70 g, 16.2 mmol), 5-(1-piperidinyl)-2-pentynoic acid, lithium salt (<b>18l</b>) (6.03 g, 32.2 mmol), pyridine hydrochloride (4.62 g, 40 mmol), EDCI·HCl (7.70 g, 40 mmol), and pyridine (80 mL), followed by workup, chromatography, and crystallization from EtOAc, gave <b>38</b> (0.35 g, 5%); mp 290−300 °C (dec). <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ:  11.40 (s, 1H), 10.27 (s, 1H), 8.97 (s, 1H), 8.74 (s, 1H), 8.59 (s, 1H), 8.07 (m, 1H), 7.74 (m, 1H), 7.42 (t, <i>J</i> = 9 Hz, 1H), 2.52 (m, 2H), 2.50 (m, 2H), 2.33 (m, 4H), 1.43 (m, 4H), 1.31 (m, 2H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  453 (M<sup>+</sup>, 100). Anal. (C<sub>23</sub>H<sub>22</sub>ClFN<sub>6</sub>O·H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[(3-Chloro-4-fluorophenyl)amino]pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-5-(4-methyl-1-piperazi</b><b>nyl)-2-pentynamide (39)</b><b>.</b><b> A </b>similar reaction of <b>17d</b> (2.35 g, 8.1 mmol), 5-(4-methyl-1-piperazinyl)-2-pentynoic acid, lithium salt (<b>18m</b>) (3.49 g, 16 mmol), pyridine hydrochloride (2.31 g, 20 mmol), EDCI·HCl (3.85 g, 20 mmol), and pyridine (40 mL), followed by workup, chromatography, and crystallization from EtOAc, gave <b>39</b> (0.78 g, 20%); mp 170−180 °C. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ:  8.93 (s, 1H), 8.71 (s, 1H), 8.57 (s, 1H), 8.05 (m, 1H), 7.70 (m, 1H), 7.26 (t, <i>J</i> = 9 Hz, 1H), 2.68 (m, 4H), 2.55 (br m, 8H), 2.28 (s, 3H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  468 (M<sup>+</sup>, 100). Anal. (C<sub>23</sub>H<sub>23</sub>ClFN<sub>7</sub>O·0.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-[4-[(3-Bromo-4-fluorophenyl)amino]pyrido[3,4-</b><b><i>d</i></b><b>]pyrimidin-6-yl]-5-(4-methyl-1-piperazi</b><b>nyl)-2-pentynamide (40)</b><b>.</b> A similar reaction of <b>17e</b> (0.334 g, 1.0 mmol), 5-(4-methyl-1-piperazinyl)-2-pentynoic acid (<b>18m</b>) (0.216 g, 1.1 mmol), EDCI·HCl (0.242 g, 1.3 mmol), and pyridine (5 mL), followed by workup, chromatography, and crystallization from EtOAc, gave <b>40</b> (0.027 g, 5%); mp 190−195 °C. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ:  8.96 (s, 1H), 8.73 (s, 1H), 8.59 (s, 1H), 8.10 (m, 1H), 7.78 (m, 1H), 7.26 (t, <i>J</i> = 9 Hz, 1H), 2.68 (m, 4H), 2.55 (br m, 8H), 2.30 (s, 3H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  514 (<sup>81</sup>BrMH<sup>+</sup>, 100). Anal. (C<sub>23</sub>H<sub>23</sub>BrFN<sub>7</sub>O·0.8H<sub>2</sub>O) C, H, N. Alternatively, a similar reaction of <b>17e</b> (0.538 g, 1.61 mmol), 5-(4-methyl-1-piperazinyl)-2-pentynoic acid, lithium salt (<b>18m</b>) (0.697 g, 3.22 mmol), pyridine hydrochloride (0.462 g, 4.00 mmol), EDCI·HCl (0.770 g, 4.0 mmol), and pyridine (8 mL) provided pure <b>40</b> (35% yield). Anal. (C<sub>23</sub>H<sub>23</sub>BrFN<sub>7</sub>O·H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><a name="jm004900401482" id="jm004900401482"></a><b>Synthesis of 5-(Aminosubstituted)-2-pentynoic Acids.</b><b>5-(1-Piperidinyl)-2-pentynoic Acid </b><b>(18l).</b> 1-(3-Butynyl)piperidine (<b>42</b>; R<sub>1</sub>, R<sub>2</sub> = piperidinyl) was synthesized as previously reported.<sup><a onclick="showRef(event, 'jm050936ob00045'); return false;" href="javascript:void(0);" class="ref jm050936ob00045">45</a></sup><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ:  1.38 (ddd, <i>J</i> = 11.3, 6.0, 5.8 Hz, 2H), 1.54 (dt, <i>J</i> = 11.3, 5.8 Hz, 4H), 1.92 (t, <i>J</i> = 2.7, Hz, 1H), 2.34 (m, 6H), 2.53 (m, 2H). </div><div class="NLM_p">A stirred −78 °C solution of <b>42</b> (R<sub>1</sub>, R<sub>2</sub> = piperidinyl) (2.56 g, 18.7 mmol) in ether (65 mL) was treated with <i>n</i>-BuLi (2.3 mL of a 10 M solution in hexanes). After 3 h at −78 °C, powdered CO<sub>2</sub> was added to bring the solution volume to ca. 250 mL while maintaining the temperature at −78 °C. The cooling bath was removed, and the mixture was stirred until all excess CO<sub>2</sub> had evaporated (ca. 16 h). The resultant lithium salt was collected by filtration and then dissolved in 30 mL of water. The solution was adjusted to pH 5 with 5% aq HCl and then loaded onto a column of 29 g of Dowex 50X8-200 ion-exchange resin (H<sup>+</sup> form, prewashed with 800 mL of deionized water). The column was eluted with ca. 2 column volumes of water and then with 500 mL of 0.2 N aq NH<sub>4</sub>OH, while 8 mL fractions were collected. The fractions containing product were pooled and concentrated under reduced pressure to leave a residue that was coevaporated twice with MeOH to leave <b>18l</b> (2.42 g, 72%) as a light orange solid, which was utilized without further processing. <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ:  1.28 (m, 1H), 1.58 (m, 1H), 1.65 (m, 4H), 2.82 (m, 2H), 2.91 (t, <i>J</i> = 7.5 Hz, 2H), 3.17 (t, <i>J</i> = 7.5 Hz, 2H), 3.33 (d, <i>J</i> = 12.2 Hz, 2H). </div><div class="NLM_p"><b>5-(4-Methyl-1-piperazinyl)-2-pentynoic Acid</b><b>(18m).</b> Utilizing a method similar to that of Turner et al.,<sup><a onclick="showRef(event, 'jm050936ob00046'); return false;" href="javascript:void(0);" class="ref jm050936ob00046">46</a></sup> we stirred a mixture of 4-(tosyloxy)-1-butyne (<b>41</b>) (8.80 g, 40 mmol), <i>N</i>-methylpiperazine (8.02 g, 80 mmol), dry, powdered K<sub>2</sub>CO<sub>3</sub> (25 g), and DMF (25 mL) overnight at room temperature. Ether (100 mL) was added, the mixture was filtered, and the filter cake was washed with ether. The filtrate was concentrated at 20 mm and 40 °C to remove ether and most of the DMF, and residual DMF was removed by silica gel chromatography and eluted sequentially with CHCl<sub>3</sub>/hexanes (1:1), then CHCl<sub>3</sub> (to remove DMF), and finally CHCl<sub>3</sub>/MeOH (10:1) to strip off the product. Concentration of product fractions provided <b>42</b> (R<sub>1</sub>, R<sub>2</sub> = 4-methyl-1-piperazinyl) (3.78 g, 62%) as an oil, which was utilized without further processing. <sup>1</sup>H NMR (D<sub>2</sub>O) δ:  2.38 (t, <i>J</i> = 7 Hz, 2H), 2.19 (t, <i>J</i> = 7 Hz, 2H), 2.06 (s, 1H), 2.01 (s, 3H), 1.9−2.7 (br m, 8H). APCIMS <i>m</i>/<i>z</i> (relative intensity): 153 (MH<sup>+</sup>, 100). </div><div class="NLM_p">A stirred −78 °C solution of <b>42</b> (R<sub>1</sub>, R<sub>2</sub> = 4-methyl-1-piperazinyl) (1.06 g, 7 mmol) in dry THF (15 mL) was treated with <i>n</i>-BuLi (5.0 mL of 1.6 M solution in hexane). The mixture was stirred for 1 h at −78 °C, and then dry CO<sub>2</sub> gas was bubbled in at a moderate rate at −78 °C for 1 h and then while allowing the mixture to warm to room temperature. After further stirring for 1 h at room temperature, the solution was ice-cooled and treated with 1 N aq HCl (8 mL). The mixture was concentrated, and the residue was coevaporated with absolute EtOH (2 × 25 mL). The resulting sticky solid was dissolved in hot absolute EtOH (15 mL), and ether (4 mL) was added to precipitate a solid. The solid, free of LiCl, was collected and then recrystallized by dissolution in warm water (1 mL) followed by addition of MeCN (3 mL). The product was collected, washed with MeCN (1 mL) and ether, and dried to give <b>18m</b> (0.97 g, 67%); mp 207−209 °C (dec). <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ:  3.2 (br m, 4H), 2.8−3.0 (br m, 4H), 2.80 (s, 3H), 2.76 (t, <i>J</i> = 7 Hz, 2H), 2.52 (t, <i>J</i> = 7 Hz, 2H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  197 (MH<sup>+</sup>, 100). Anal. (C<sub>10</sub>H<sub>16</sub>N<sub>2</sub>O<sub>2</sub>·0.6H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>5-(4-Methyl-1-piperazinyl)-2-pentynoic Acid, Lithium Salt (18m).</b> A stirred −65 °C solution of <b>42</b> (R<sub>1</sub>, R<sub>2</sub> = 4-methyl-1-piperazinyl) (50 g, 0.33 mol) and dry THF (155 mL) was treated with <i>n</i>-BuLi (135 g of a 1.6 M solution in hexanes) followed by dry CO<sub>2</sub> (15 g, 395 mmol). The mixture was stirred at −65 °C for ca. 3 h, warmed to 25 °C, and then diluted with 110 mL of isopropyl alcohol and 10 mL of water. After warming to reflux, the solution was cooled to allow crystallization, and then the product was collected by filtration and vacuum-dried at ca. 65 °C to give <b>18m</b>, lithium salt (50 g, 75%) hydrated with ≤2% water. </div><div class="NLM_p"><b>5-(Diethylamino)-2-pentynoic Acid (18j).</b> A similar reaction of <i>n</i>-BuLi (2.7 mL of a 2.18 M solution in THF), 4-(diethylamino)-1-butyne<sup><a onclick="showRef(event, 'jm050936ob00047'); return false;" href="javascript:void(0);" class="ref jm050936ob00047">47</a></sup> (<b>42</b>; R<sub>1</sub> = R<sub>2</sub> = ethyl) (0.816 g, 6.5 mmol), and THF (20 mL) at −78 °C, followed by carboxylation and workup, gave <b>18j</b> as a light yellow solid (0.652 g, 59% yield), which was utilized directly without further processing. <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ:  3.79 (br, 1H), 2.85 (t. <i>J</i> = 7.3 Hz, 2H), 2.74 (q, <i>J</i> = 7.0, 5.0 Hz, 4H), 2.52−2.4 (m, 2H), 1.03 (t. <i>J</i> = 7.2 Hz, 6H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  170 (MH<sup>+</sup>, 100). </div><div class="NLM_p"><b>5-(4-Morpholinyl)-2-pentynoic Acid (18k). </b>A similar reaction of <i>n</i>-BuLi (15 mL of a 2.18 M solution in THF), 4-(3-butynyl)morpholine<sup>30</sup> (<b>42</b>; R<sub>1</sub>, R<sub>2</sub> = morpholinyl) (5.06 g, 36 mmol), and THF (100 mL), followed by carboxylation and workup, gave <b>18k</b> as a dull yellow solid (5.08 g, 77%), which was used directly without further processing. <sup>1</sup>H NMR [(CD<sub>3</sub>)<sub>2</sub>SO] δ:  7.2−7.4 (br, 1H), 3.54 (m, 4H), 2.49−2.36 (m, 8H). APCIMS <i>m</i>/<i>z</i> (relative intensity):  184 (MH<sup>+</sup>, 100). </div><div class="NLM_p"><b>ELISA-Based erbB Kinase Assay. </b>The erbB1, erbB2, and erbB4 cytoplasmic fusion proteins were made by cloning the erbB1 sequence (Met-668 to Ala-1211), erbB2 (Ile-675 to Val-1256), and erbB4 sequence (Gly-259 to Gly-690) into the baculoviral vector pFastBac using PCR. Proteins were expressed in baculovirus-infected Sf9 insect cells as GST fusion proteins. The proteins were purified by affinity chromatography using glutathione sepharose beads. Inhibition of erbB tyrosine kinase activity was assessed using an ELISA-based receptor tyrosine kinase assay. Kinase reactions (50 mM HEPES, pH 7.4, 125 mM NaCl, 10 mM MgCl<sub>2</sub>, 100 μM sodium orthovanadate, 2 mM dithiothreitol, 20 μM ATP, test compound or vehicle control, and 1−5 nM GST-erbB per 50 μL of reaction mixture) were run in 96-well plates coated with 0.25 mg/mL poly-Glu-Tyr (Sigma). The reactions were incubated for 6 min at room temperature while being shaken. Kinase reactions were stopped by removal of the reaction mixture, then the wells were washed with wash buffer (0.1% Tween 20 in PBS). Phosphorylated tyrosine residues were detected by adding 0.2 μg/mL anti-phosphotyrosine antibody (Oncogene Ab-4; 50 μL/well) coupled to horseradish peroxidase (HRP) diluted in PBS containing 3% BSA and 0.05% Tween 20 for 25 min while being shaken at room temperature. The antibody was removed, and plates were washed in wash buffer. HRP substrate (SureBlue3,3‘,5,5‘-tetramethyl benzidine or TMB, Kirkegaard & Perry Labs) was added (50 μL per well) and incubated for 10−20 min while it was shaken at room temperature. The TMB reaction was stopped with the addition of 50 μL of stop solution (0.09 N H<sub>2</sub>SO<sub>4</sub>). The signal was quantified by measuring absorbance at 450 nm. IC<sub>50</sub> values were determined for test compounds using the median effect method.<sup><a onclick="showRef(event, 'jm050936ob00048'); return false;" href="javascript:void(0);" class="ref jm050936ob00048">48</a></sup></div><div class="NLM_p"><b>Inhibition of erbB1 and erbB2 Autophosphorylation in Cells Using BioVeris Technology.</b> Inhibition of erbB1 tyrosine kinase activity was evaluated in NIH3T3 cells transfected with the full-length human erbB1 receptor, and inhibition of erbB2 tyrosine kinase activity was evaluated in T24 NIH 3T3 cells transfected with a chimeric receptor with the extracellular binding domain of erbB1 and the intracellular kinase domain of erbB2. The derivation of these lines has been previously described by Cohen et al.<sup><a onclick="showRef(event, 'jm050936ob00049'); return false;" href="javascript:void(0);" class="ref jm050936ob00049">49</a></sup> Cells were plated in a 96-well plate at a density of 20 000 cells per well in DMEM/F12 media (Gibco BRL) containing 10% fetal bovine serum (Gibco, BRL) and 10 ng/mL Gentamicin (Gibco, BRL). Cells were cultured at 37 °C in 5% CO<sub>2</sub>. Prior to drug treatment, the cells were cultured in serum-free medium for 12−24 h. The cells were then treated with the test compound dissolved in DMSO for 2 h (final DMSO concentration of <0.5%) at 37 °C and 5% CO<sub>2</sub>. After the 2 h drug treatment, the cells were stimulated with 100 ng/mL EGF (Sigma) for 10 min at 37 °C and 5% CO<sub>2</sub>. The medium was removed, and the cells were immediately lysed in buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 1 mM EDTA, 1% Triton, 10 mM β-glycerophosphate, 0.1 mM NaVa, 1 mM NaF, 0.25% deoxycholic acid, 10 μg/mL aprotinin, 10 μg/mL leupeptin) for 15 min at room temperature, mixing gently. </div><div class="NLM_p">Inhibition of erbB1 autophosphorylation was detected using BioVeris technology. Anti-erbB1 antibody tagged with biotin was added to the lysates to capture erbB1 (NeoMarkers Clone 528; 100 ng/mL per well). An antiphospho-erbB1 antibody (Cell Signaling p-Y1068; 100 ng/mL per well) labeled with ruthenium (BioVeris) <a name="jm004900401483" id="jm004900401483"></a> was simultaneously added to detect phosphorylated erbB1. Plates were mixed gently for 60 min at room temperature. Magnetic beads coated with streptavidin (Dynabeads M 289 streptavidin, Dynal Biotech Inc.) were added at a final concentration of 50 ng/mL and mixed gently at room temperature for 30 min. The antibodies and beads were diluted in the following buffer:  150 mM NaCl, 50 mM Tris-HCl pH 7.4, 1% BSA, 0.02% Na azide. After the incubation, samples were analyzed using a BioVeris M8 analyzer. IC<sub>50</sub> determinations were determined using the median effect method. </div><div class="NLM_p">Inhibition of erbB2 autophosphorylation was also detected using BioVeris technology. Anti-erbB1 tagged with biotin was added to the lysate to capture erbB1/erbB2 chimeric protein (NeoMarkers Clone 528; 200 ng/mL per well). An antiphospho-erbB2 antibody (Cell Signaling p-Y1248, 200 ng/mL per well) labeled with ruthenium (BioVeris) was simultaneously added to detect phosphorylated erbB2. The remaining methods followed procedures outlined for inhibition of erbB1 autophosphorylation. </div><div class="NLM_p"><b>Inhibition of EGF and Heregulin-Stimulated erbB Autophosphorylation in Cells Using </b><b>Western Blotting. </b>Inhibition of EGF-stimulated or heregulin-stimulated erbB receptor autophosphorylation was assessed in either NIH 3T3 fibroblasts expressing full length human erbB1, the T24 NIH 3T3 fibroblasts expressing a chimeric receptor with the extracellular binding domain of erbB1 and the intracellular kinase domain of erbB2, or the human breast carcinoma cell line MDA-MB-453 by antiphosphotyrosine Western blots. Western blotting procedures have been previously described.<sup><a onclick="showRef(event, 'jm050936ob00050'); return false;" href="javascript:void(0);" class="ref jm050936ob00050">50</a></sup> To detect phospho-erbB1, an antiphospho-erbB1 antibody was used (p-Y1068, Cell Signaling). To detect phospho-erbB2, an antiphospho-erbB2 antibody was used (p-Y1248, Cell Signaling). To detect phospho-erbB signals in MDA-MB-453 cells, an antiphospho-Tyr antibody was used as described.<sup>50</sup> Band intensities from the anti-phosphotyrosine Western blots were determined using a Molecular Dynamics laser densitometer and expressed as percent control. IC<sub>50</sub> determinations were determined using the median effect method. </div><div class="NLM_p"><b>Pharmacokinetics. </b>All animals were fasted overnight prior to dosing the next morning, and food was withheld until 4 h following dosing. Water was allowed ad libitum throughout the study. For each study, blood samples were collected from a jugular cannula into EDTA/ascorbic acid tubes. Sampling occurred prior to dosing and at 7−9 different time points up to 24 h after the iv and the po dose. Plasma drug concentration was determined by a LC/MS/MS assay. Briefly, <b>39</b> was isolated from plasma using protein precipitation with acetonitrile. Supernatant was injected directly into an amide column with mobile phase consisting of acetonitrile/10 mM ammonium formate (pH = 4.0) (35:65, v/v), with mass spectrometric detection. Drug concentration below the limit of quantitation (<6.5 ng/mL) was treated as zero for pharmacokinetic and statistical calculations. </div><div class="NLM_p"><b>In Vivo </b><b>Antitumor</b><b> Effects of 39. </b>Immune-deficient CB.17 SCID mice and nude mice (NCr nu/nu) were purchased from Charles River. Mice were housed in microisolator cages within a barrier facility on a 12 h light/dark cycle and received food and water ad libitum. Animal housing was in accord with AAALAC guidelines. All experimental protocols involving animals were approved by the institutional animal care and use committee. The A431 epidermoid carcinoma, the H125 non-small-cell lung carcinoma line, and the SKOV3 ovarian carcinoma line were maintained by serial passage in nude mice (NCr nu/nu). The SF-767 glioblastoma and the BxPC-3 pancreatic tumor lines were maintained by serial passage in SCID mice. </div><div class="NLM_p last">Tumors were implanted subcutaneously in immune-deficient mice and allowed to grow to a size of 100−150 mg before dosing was initiated. The drug was dissolved in 0.05 N Na lactate buffer, pH 4.0, and the route of drug administration for all studies was oral. Animals were dosed either daily for 14 days or daily 5 days a week for 2−3 weeks. Tumor measurements were made 2−3 times per week until tumors reached 750 mg. Efficacy was assessed by tumor growth delay (T-C) and tumor growth delay index (GDI). Tumor growth delay is the difference, in days, for the treated (T) and control (C) tumors to reach 750 mg. Calculation of tumor growth delay (T-C) was performed as described previously.<sup><a onclick="showRef(event, 'jm050936ob00051 jm050936ob00052 jm050936ob00053 jm050936ob00054'); return false;" href="javascript:void(0);" class="ref jm050936ob00051 jm050936ob00052 jm050936ob00053 jm050936ob00054">51-54</a></sup> Efficacy was also assessed by calculating the growth delay index (GDI), which allows for a better comparison of the magnitude of tumor growth suppression between studies since it factors in differences in dosing schedules. GDI is calculated by dividing the T-C by the number of treatment days and multiplying by 100%. A GDI of 0 indicates no effect; a GDI below 100 indicates a slowing of tumor growth, but growth is still occurring during treatment. A GDI of 100 would mean complete tumor stasis, and a GDI above 100 means that drug treatment delayed tumor growth for longer than the duration of treatment. Compound <b>39</b> was considered to have activity if it could produce a GDI of greater than 50. </div></div><div class="NLM_back"><div class="article_supporting-info" id=""><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm050936o/suppl_file/jm050936osi20051122_022554.pdf">jm050936osi20051122_022554.pdf (13.78 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm050936o" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52106" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52106" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><ul></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sylvester R. Klutchko</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047, and Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1020, New Zealand </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hairong Zhou</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047, and Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1020, New Zealand </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">R. Thomas Winters</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047, and Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1020, New Zealand </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tuan P. Tran</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047, and Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1020, New Zealand </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander J. Bridges</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047, and Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1020, New Zealand </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irene W. Althaus</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047, and Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1020, New Zealand </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Danielle M. Amato</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047, and Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1020, New Zealand </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William L. Elliott</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047, and Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1020, New Zealand </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul A. Ellis</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047, and Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1020, New Zealand </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary Ann Meade</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047, and Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1020, New Zealand </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Billy J. Roberts</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047, and Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1020, New Zealand </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David W. Fry</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047, and Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1020, New Zealand </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea J. Gonzales</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047, and Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1020, New Zealand </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patricia J. Harvey</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047, and Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1020, New Zealand </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James M. Nelson</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047, and Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1020, New Zealand </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Veronica Sherwood</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047, and Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1020, New Zealand </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hyo-Kyung Han</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047, and Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1020, New Zealand </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gerry Pace</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047, and Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1020, New Zealand </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeff B. Smaill</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047, and Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1020, New Zealand </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William A. Denny</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047, and Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1020, New Zealand </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">H. D. Hollis Showalter</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Michigan Laboratories, 2800 Plymouth Road, Ann Arbor, Michigan 48106-1047, and Auckland Cancer Society Research Centre, School of Medical Sciences, The University of Auckland, Private Bag 92019, Auckland 1020, New Zealand </span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54085" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54085" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was partially supported by the Auckland Division of the Cancer Society of New Zealand. The T24 NIH 3T3 lines were a gift from Dr. Bruce Cohen at the National Cancer Institute, Bethesda, MD. </p></div><div class="refs-header-label"><a name="jm004900401484" id="jm004900401484"></a><a name="jm004900401485" id="jm004900401485"></a></div><p class="references-count">
            This article references 55 other publications.
        </p><ol id="references" class="useLabel"><li id="jm050936ob00001"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00001'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="jm050936ob00001_1"><span><span class="NLM_string-ref">Lemmon, M. A. The EGF receptor family as therapeutic targets in breast cancer. <i>  Breast Dis.</i><b>2003</b>, <i>18</i>, 33−43.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=43&author=M.+A+Lemmon&title=The+EGF+receptor+family+as+therapeutic+targets+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLemmon%26aufirst%3DM.%2BA%26atitle%3DThe%2520EGF%2520receptor%2520family%2520as%2520therapeutic%2520targets%2520in%2520breast%2520cancer%26jtitle%3DBreast%2520Dis.%26date%3D2003%26volume%3D18%26spage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00002"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00002'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="jm050936ob00002_1"><span><span class="NLM_string-ref">Ang, K. K.; Andratschke, N. H.; Milas, L. Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy. <i>  Int. J. Radiat. Oncol., </i><i>Biol., Phys</i>. <b>2004</b>, <i>58</i>, 959−965.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2004&pages=965&author=K.+K.+Ang&author=N.+H.+Andratschke&author=L+Milas&title=Epidermal+growth+factor+receptor+and+response+of+head-and-neck+carcinoma+to+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAng%26aufirst%3DK.%2BK.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%2520and%2520response%2520of%2520head-and-neck%2520carcinoma%2520to%2520therapy%26jtitle%3DInt.%2520J.%2520Radiat.%2520Oncol.%252C%2520Biol.%252C%2520Phys.%26date%3D2004%26volume%3D58%26spage%3D965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00003"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00003'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="jm050936ob00003_1"><span><span class="NLM_string-ref">Meert, A. P.; Martin, B.; Paesmans, M.; Berghmans, T.; Mascaux, C.; Verdebout, J.-M.; Delmotte, P.; Lafitte, J.-J.; Sculier, J.-P. The Role of HER-2/neu expression on the survival of patients with lung cancer:  a systematic review of the literature<i>. Br. J. Cancer</i><b>2003</b>, <i>89</i>, 959−965.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2003&pages=965&author=A.+P.+Meert&author=B.+Martin&author=M.+Paesmans&author=T.+Berghmans&author=C.+Mascaux&author=J.-M.+Verdebout&author=P.+Delmotte&author=J.-J.+Lafitte&author=J.-P+Sculier&title=The+Role+of+HER-2%2Fneu+expression+on+the+survival+of+patients+with+lung+cancer%3A%E2%80%89+a+systematic+review+of+the+literature"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeert%26aufirst%3DA.%2BP.%26atitle%3DThe%2520Role%2520of%2520HER-2%252Fneu%2520expression%2520on%2520the%2520survival%2520of%2520patients%2520with%2520lung%2520cancer%253A%25E2%2580%2589%2520a%2520systematic%2520review%2520of%2520the%2520literature%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2003%26volume%3D89%26spage%3D965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00004"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00004'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="jm050936ob00004_1"><span><span class="NLM_string-ref">Hynes, N. E.; Lane, H. A. ErbB receptors and cancer:  The complexity of targeted inhibitors. <i>  Nat. Rev. Cancer</i><b>2005</b>, <i>5</i>, 341−354.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=354&author=N.+E.+Hynes&author=H.+A+Lane&title=ErbB+receptors+and+cancer%3A%E2%80%89+The+complexity+of+targeted+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHynes%26aufirst%3DN.%2BE.%26atitle%3DErbB%2520receptors%2520and%2520cancer%253A%25E2%2580%2589%2520The%2520complexity%2520of%2520targeted%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00005"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00005'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="jm050936ob00005_1"><span><span class="NLM_string-ref">Denny, W. A. The 4-anilinoquinazoline class of inhibitors of the erbB family of receptor tyrosine kinases. <i>  Farmaco</i><b>2001</b>, <i>56</i>, 51−56.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2001&pages=56&author=W.+A+Denny&title=The+4-anilinoquinazoline+class+of+inhibitors+of+the+erbB+family+of+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDenny%26aufirst%3DW.%2BA%26atitle%3DThe%25204-anilinoquinazoline%2520class%2520of%2520inhibitors%2520of%2520the%2520erbB%2520family%2520of%2520receptor%2520tyrosine%2520kinases%26jtitle%3DFarmaco%26date%3D2001%26volume%3D56%26spage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00006"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00006'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="jm050936ob00006_1"><span><span class="NLM_string-ref">Cockerill, S.; Stubberfield, C.; Stables, J.; Carter, M.; Guntrip, S.; Smith, K.; McKeown, S.; Shaw, R.; Topley, P.; Thomsen, L.; Affleck, K.; Jowett, A.; Hayes, D.; Willson, M.; Woollard, P.; Spalding, D. Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and c-erbB-2. <i>  Bioorg. Med. Chem. Lett.</i><b>2001</b>, <i>11</i>, 1401−1405.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=1405&author=S.+Cockerill&author=C.+Stubberfield&author=J.+Stables&author=M.+Carter&author=S.+Guntrip&author=K.+Smith&author=S.+McKeown&author=R.+Shaw&author=P.+Topley&author=L.+Thomsen&author=K.+Affleck&author=A.+Jowett&author=D.+Hayes&author=M.+Willson&author=P.+Woollard&author=D+Spalding&title=Indazolylamino+quinazolines+and+pyridopyrimidines+as+inhibitors+of+the+EGFr+and+c-erbB-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCockerill%26aufirst%3DS.%26atitle%3DIndazolylamino%2520quinazolines%2520and%2520pyridopyrimidines%2520as%2520inhibitors%2520of%2520the%2520EGFr%2520and%2520c-erbB-2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D1405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00007"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00007'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="jm050936ob00007_1"><span><span class="NLM_string-ref">Palmer, B. D.; Trumpp-Kallmeyer, S.; Fry, D. W.; Nelson, J. M.; Showalter, H. D. H.; Denny, W. A. Tyrosine kinase inhibitors. 11. Soluble analogues of pyrrolo- and pyrazinoquinazolines as EGFR inhibitors:  synthesis, biological evaluation, and modelling of the mode of binding. <i>  J. Med. </i><i>Chem. </i><b>1997</b>, <i>40</i>, 1519−1529.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1529&author=B.+D.+Palmer&author=S.+Trumpp-Kallmeyer&author=D.+W.+Fry&author=J.+M.+Nelson&author=H.+D.+H.+Showalter&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+11.+Soluble+analogues+of+pyrrolo-+and+pyrazinoquinazolines+as+EGFR+inhibitors%3A%E2%80%89+synthesis%2C+biological+evaluation%2C+and+modelling+of+the+mode+of+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252011.%2520Soluble%2520analogues%2520of%2520pyrrolo-%2520and%2520pyrazinoquinazolines%2520as%2520EGFR%2520inhibitors%253A%25E2%2580%2589%2520synthesis%252C%2520biological%2520evaluation%252C%2520and%2520modelling%2520of%2520the%2520mode%2520of%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00008"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00008'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="jm050936ob00008_1"><span><span class="NLM_string-ref">Vansteenkiste, J. F. Gefitinib (Iressa):  a novel treatment for non-small-cell lung cancer. <i>  Expert Rev. Anticancer Ther.</i><b>2004</b>, <i>4</i>, 5−17.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=17&author=J.+F.+Vansteenkiste&author=+Gefitinib&title=a+novel+treatment+for+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVansteenkiste%26aufirst%3DJ.%2BF.%26atitle%3Da%2520novel%2520treatment%2520for%2520non-small-cell%2520lung%2520cancer%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2004%26volume%3D4%26spage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00009"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00009'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="jm050936ob00009_1"><span><span class="NLM_string-ref">Tiseo, M.; Loprevite, M.; Ardizzoni, A. Epidermal growth factor receptor inhibitors:  a new prospective in the treatment of lung cancer. <i>  Curr. Med. </i><i>Chem:  Anti-Cancer Agents</i><b>2004</b>, <i>4</i>, 139−148.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+Tiseo&author=M.+Loprevite&author=A.+Ardizzoni&title=Epidermal+growth+factor+receptor+inhibitors%3A%E2%80%89+a+new+prospective+in+the+treatment+of+lung+cancer.+Curr.+Med.+Chem%3A%E2%80%89+Anti-Cancer+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DTiseo%26aufirst%3DM.%26btitle%3DEpidermal%2520growth%2520factor%2520receptor%2520inhibitors%253A%25E2%2580%2589%2520a%2520new%2520prospective%2520in%2520the%2520treatment%2520of%2520lung%2520cancer.%2520Curr.%2520Med.%2520Chem%253A%25E2%2580%2589%2520Anti-Cancer%2520Agents%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00010"><div class="reference"><div class="NLM_citation" id="jm050936ob00010_1"><span><span class="NLM_string-ref">Bonomi, P. Erlotinib:  a new therapeutic approach for non-small-cell lung cancer. <i>  Expert Opin. Invest. Drugs</i><b>2003</b>, <i>12</i>, 1395−1401.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=1401&author=P.+Bonomi&author=+Erlotinib&title=a+new+therapeutic+approach+for+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonomi%26aufirst%3DP.%26atitle%3Da%2520new%2520therapeutic%2520approach%2520for%2520non-small-cell%2520lung%2520cancer%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2003%26volume%3D12%26spage%3D1401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00011"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00011'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="jm050936ob00011_1"><span><span class="NLM_string-ref">Lynch, T. J.; Bell, D. W.; Sordella, R.; Gurubhagavatula, S.; Okimoto, R. A.; Brannigan, B. W.; Harris, P. L.; Haserlat, S. M.; Supko, J. G.; Haluska, F. G.; Louis, D. N.; Christiani, D. C.; Settleman, J.; Haber, D. A. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. <i>  N. Engl. J. Med.</i><b>2004</b>, <i>350</i>, 2129−2139.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=2139&author=T.+J.+Lynch&author=D.+W.+Bell&author=R.+Sordella&author=S.+Gurubhagavatula&author=R.+A.+Okimoto&author=B.+W.+Brannigan&author=P.+L.+Harris&author=S.+M.+Haserlat&author=J.+G.+Supko&author=F.+G.+Haluska&author=D.+N.+Louis&author=D.+C.+Christiani&author=J.+Settleman&author=D.+A+Haber&title=Activating+mutations+in+the+epidermal+growth+factor+receptor+underlying+responsiveness+of+non-small-cell+lung+cancer+to+gefitinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DT.%2BJ.%26atitle%3DActivating%2520mutations%2520in%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520underlying%2520responsiveness%2520of%2520non-small-cell%2520lung%2520cancer%2520to%2520gefitinib%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D2139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00012"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00012'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="jm050936ob00012_1"><span><span class="NLM_string-ref">Paez, J. G.; Jaenne, P. A.; Lee, J. C.; Tracy, S.; Greulich, H.; Gabriel, S.; Herman, P.; Kaye, F. J.; Lindeman, N.; Boggon, T. J.; Naoki, K.; Sasaki, H.; Fujii, Y.; Eck, M. J.; Sellers, W. R.; Johnson, B. E.; Meyerson, M. EGFR mutations in lung cancer:  Correlation with clinical response to gefitinib therapy. <i>  Science</i><b>2004</b>, <i>304</i>, 1497−1500.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2004&pages=1500&author=J.+G.+Paez&author=P.+A.+Jaenne&author=J.+C.+Lee&author=S.+Tracy&author=H.+Greulich&author=S.+Gabriel&author=P.+Herman&author=F.+J.+Kaye&author=N.+Lindeman&author=T.+J.+Boggon&author=K.+Naoki&author=H.+Sasaki&author=Y.+Fujii&author=M.+J.+Eck&author=W.+R.+Sellers&author=B.+E.+Johnson&author=M+Meyerson&title=EGFR+mutations+in+lung+cancer%3A%E2%80%89+Correlation+with+clinical+response+to+gefitinib+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaez%26aufirst%3DJ.%2BG.%26atitle%3DEGFR%2520mutations%2520in%2520lung%2520cancer%253A%25E2%2580%2589%2520Correlation%2520with%2520clinical%2520response%2520to%2520gefitinib%2520therapy%26jtitle%3DScience%26date%3D2004%26volume%3D304%26spage%3D1500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00013"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00013'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="jm050936ob00013_1"><span><span class="NLM_string-ref">Pao, W.; Miller, V.; Zakowski, M.; Doherty, J.; Politi, K.; Sarkaria, I.; Singh, B.; Heelan, R.; Rusch, V.; Fulton, L.; Mardis, E.; Kupfer, D.; Wilson, R.; Kris, M.; Varmus, H. EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib. <i>  Proc. Natl. Acad. Sci. U.S.A.</i><b>2004</b>, <i>101</i>, 13306−13311.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=13311&author=W.+Pao&author=V.+Miller&author=M.+Zakowski&author=J.+Doherty&author=K.+Politi&author=I.+Sarkaria&author=B.+Singh&author=R.+Heelan&author=V.+Rusch&author=L.+Fulton&author=E.+Mardis&author=D.+Kupfer&author=R.+Wilson&author=M.+Kris&author=H.+Varmus&title=%E2%80%9Cnever+smokers%E2%80%9D+and+are+associated+with+sensitivity+of+tumors+to+gefitinib+and+erlotinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPao%26aufirst%3DW.%26atitle%3D%25E2%2580%259Cnever%2520smokers%25E2%2580%259D%2520and%2520are%2520associated%2520with%2520sensitivity%2520of%2520tumors%2520to%2520gefitinib%2520and%2520erlotinib%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D13311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00014"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00014'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="jm050936ob00014_1"><span><span class="NLM_string-ref">Fabian, M. A.; Biggs, W. H., III; Treiber, D. K.; Atteridge, C. E.; Azimioara, M. D.; Benedetti, M. G.; Carter, T. A.; Ciceri, P.; Edeen, P. T.; Floyd, M.; Ford, J. M.; Galvin, M.; Gerlach, J. L.; Grotzfeld, R. M.; Herrgard, S.; Insko, D. E.; Insko, M. A.; Lai, A. G.; Lelias, J.-M.; Mehta, S. A.; Milanov, Z. V.; Velasco, A. M.; Wodicka, L. M.; Patel, H. K.; Zarrinkar, P. P.; Lockhart, D. J. A small molecule-kinase interaction map for clinical kinase inhibitors. <i>  Nat. Biotechnol</i>. <b>2005</b>, <i>23</i>, 329−336.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=336&author=M.+A.+Fabian&author=W.+H.+Biggs&author=D.+K.+Treiber&author=C.+E.+Atteridge&author=M.+D.+Azimioara&author=M.+G.+Benedetti&author=T.+A.+Carter&author=P.+Ciceri&author=P.+T.+Edeen&author=M.+Floyd&author=J.+M.+Ford&author=M.+Galvin&author=J.+L.+Gerlach&author=R.+M.+Grotzfeld&author=S.+Herrgard&author=D.+E.+Insko&author=M.+A.+Insko&author=A.+G.+Lai&author=J.-M.+Lelias&author=S.+A.+Mehta&author=Z.+V.+Milanov&author=A.+M.+Velasco&author=L.+M.+Wodicka&author=H.+K.+Patel&author=P.+P.+Zarrinkar&author=D.+J+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00015"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00015'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="jm050936ob00015_1"><span><span class="NLM_string-ref">Sordella, R.; Bell, D. W.; Haber, D. A.; Settleman, J. Gefitinib-sensitizing mutations in lung cancer activate anti-apoptotic pathways. <i>  Science</i><b>2004</b>, <i>305</i>, 1163−1167.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=1167&author=R.+Sordella&author=D.+W.+Bell&author=D.+A.+Haber&author=J+Settleman&title=Gefitinib-sensitizing+mutations+in+lung+cancer+activate+anti-apoptotic+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSordella%26aufirst%3DR.%26atitle%3DGefitinib-sensitizing%2520mutations%2520in%2520lung%2520cancer%2520activate%2520anti-apoptotic%2520pathways%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D1167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00016"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00016'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="jm050936ob00016_1"><span><span class="NLM_string-ref">Kobayashi, S.; Boggon, T. J.; Dayaram, T.; Jaenne, P. A.; Kocher, O.; Meyerson, M.; Johnson, B. E.; Eck, M. J.; Tenen, D. G.; Halmos, B. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. <i>  N. Engl. </i><i>J. Med.</i><b>2005</b>, <i>352</i>, 786−792.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=792&author=S.+Kobayashi&author=T.+J.+Boggon&author=T.+Dayaram&author=P.+A.+Jaenne&author=O.+Kocher&author=M.+Meyerson&author=B.+E.+Johnson&author=M.+J.+Eck&author=D.+G.+Tenen&author=B+Halmos&title=EGFR+mutation+and+resistance+of+non-small-cell+lung+cancer+to+gefitinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DS.%26atitle%3DEGFR%2520mutation%2520and%2520resistance%2520of%2520non-small-cell%2520lung%2520cancer%2520to%2520gefitinib%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00017"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00017'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="jm050936ob00017_1"><span><span class="NLM_string-ref">Pao, W.; Miller, V. A.; Politi, K. A.; Riely, G. J.; Somwar, R.; Zakowski, M. F.; Kris, M. G.; Varmus, H. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. <i>  PLoS Med</i>. <b>2005</b>, <i>2</i>, 225−235.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=235&author=W.+Pao&author=V.+A.+Miller&author=K.+A.+Politi&author=G.+J.+Riely&author=R.+Somwar&author=M.+F.+Zakowski&author=M.+G.+Kris&author=H+Varmus&title=Acquired+resistance+of+lung+adenocarcinomas+to+gefitinib+or+erlotinib+is+associated+with+a+second+mutation+in+the+EGFR+kinase+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPao%26aufirst%3DW.%26atitle%3DAcquired%2520resistance%2520of%2520lung%2520adenocarcinomas%2520to%2520gefitinib%2520or%2520erlotinib%2520is%2520associated%2520with%2520a%2520second%2520mutation%2520in%2520the%2520EGFR%2520kinase%2520domain%26jtitle%3DPLoS%2520Med.%26date%3D2005%26volume%3D2%26spage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00018"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00018'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="jm050936ob00018_1"><span><span class="NLM_string-ref">Rusnak, D. W.; Lackey, K.; Affleck, K.; Wood, E. R.; Alligood, K. J.; Rhodes, N.; Keith, B. R.; Murray, D. M.; Knight, W. B.; Mullin, R. J.; Gilmer, T. M. The effects of the novel, reversible epidermal growth factor receptor/erbB-2 tyrosine kinase inhibitor, GW572016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo. <i>  Mol. Cancer Ther</i>. <b>2001</b>, <i>1</i>, 85−94.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=94&author=D.+W.+Rusnak&author=K.+Lackey&author=K.+Affleck&author=E.+R.+Wood&author=K.+J.+Alligood&author=N.+Rhodes&author=B.+R.+Keith&author=D.+M.+Murray&author=W.+B.+Knight&author=R.+J.+Mullin&author=T.+M+Gilmer&title=The+effects+of+the+novel%2C+reversible+epidermal+growth+factor+receptor%2FerbB-2+tyrosine+kinase+inhibitor%2C+GW572016%2C+on+the+growth+of+human+normal+and+tumor-derived+cell+lines+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26atitle%3DThe%2520effects%2520of%2520the%2520novel%252C%2520reversible%2520epidermal%2520growth%2520factor%2520receptor%252FerbB-2%2520tyrosine%2520kinase%2520inhibitor%252C%2520GW572016%252C%2520on%2520the%2520growth%2520of%2520human%2520normal%2520and%2520tumor-derived%2520cell%2520lines%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2001%26volume%3D1%26spage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00019"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00019'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="jm050936ob00019_1"><span><span class="NLM_string-ref">Wood, E. R.; Truesdale, A. T.; McDonald, O. B.; Yuan, D.; Hassell, A.; Dickerson, S. H.; Ellis, B.; Pennisi, C.; Horne, E.; Lackey, K.; Alligood, K. J.; Rusnak, D. W.; Gilmer, T. M.; Shewchuk, L. A unique structure for epidermal growth factor receptor bound to GW572016 (lapatinib):  Relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells. <i>  Cancer Res</i>. <b>2004</b>, <i>64</i>, 6652−6659.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=6659&author=E.+R.+Wood&author=A.+T.+Truesdale&author=O.+B.+McDonald&author=D.+Yuan&author=A.+Hassell&author=S.+H.+Dickerson&author=B.+Ellis&author=C.+Pennisi&author=E.+Horne&author=K.+Lackey&author=K.+J.+Alligood&author=D.+W.+Rusnak&author=T.+M.+Gilmer&author=L+Shewchuk&title=A+unique+structure+for+epidermal+growth+factor+receptor+bound+to+GW572016+%28lapatinib%29%3A%E2%80%89+Relationships+among+protein+conformation%2C+inhibitor+off-rate%2C+and+receptor+activity+in+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DE.%2BR.%26atitle%3DA%2520unique%2520structure%2520for%2520epidermal%2520growth%2520factor%2520receptor%2520bound%2520to%2520GW572016%2520%2528lapatinib%2529%253A%25E2%2580%2589%2520Relationships%2520among%2520protein%2520conformation%252C%2520inhibitor%2520off-rate%252C%2520and%2520receptor%2520activity%2520in%2520tumor%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D6659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00020"><div class="reference"><div class="NLM_citation" id="jm050936ob00020_1"><span><span class="NLM_string-ref">Vite, G. D.; Gavai, A. V.; Fink, B. E.; Mastalerz, H.; Kadow, J. F. Preparation of C-6 Modified Indazolyl Pyrrolotriazines as Antiproliferative Agents. PCT Int. Appl. WO 2004054514 A2, 2004; 81 pp.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=054514&publication_year=2004&pages=2004&author=G.+D.+Vite&author=A.+V.+Gavai&author=B.+E.+Fink&author=H.+Mastalerz&author=J.+F+Kadow&title=Preparation+of+C-6+Modified+Indazolyl+Pyrrolotriazines+as+Antiproliferative+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVite%26aufirst%3DG.%2BD.%26atitle%3DPreparation%2520of%2520C-6%2520Modified%2520Indazolyl%2520Pyrrolotriazines%2520as%2520Antiproliferative%2520Agents%26jtitle%3DPCT%2520Int.%2520Appl.%2520WO%26date%3D2004%26volume%3D054514%26spage%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00021"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00021'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="jm050936ob00021_1"><span><span class="NLM_string-ref">Borman, S. Hopes ride on drug candidates. Researchers reveal potential new medicines for thrombosis, anxiety, diabetes, and cancer. <i>  Chem. Eng. News</i><b>2005</b>, <i>83</i>, 40−44.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2005&pages=44&author=S+Borman&title=Hopes+ride+on+drug+candidates.+Researchers+reveal+potential+new+medicines+for+thrombosis%2C+anxiety%2C+diabetes%2C+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorman%26aufirst%3DS%26atitle%3DHopes%2520ride%2520on%2520drug%2520candidates.%2520Researchers%2520reveal%2520potential%2520new%2520medicines%2520for%2520thrombosis%252C%2520anxiety%252C%2520diabetes%252C%2520and%2520cancer%26jtitle%3DChem.%2520Eng.%2520News%26date%3D2005%26volume%3D83%26spage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00022"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00022'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="jm050936ob00022_1"><span><span class="NLM_string-ref">Mellinghoff, I. K.; Tran, C.; Sawyers, C. L. Growth Inhibitory effects of the dual ErbB1/ErbB2 Tyr kinase inhibitor PKI-166 on human prostate cancer xenografts. <i>  Cancer Res</i>. <b>2002</b>, <i>62</i>, 5254−5259.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=5259&author=I.+K.+Mellinghoff&author=C.+Tran&author=C.+L+Sawyers&title=Growth+Inhibitory+effects+of+the+dual+ErbB1%2FErbB2+Tyr+kinase+inhibitor+PKI-166+on+human+prostate+cancer+xenografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26atitle%3DGrowth%2520Inhibitory%2520effects%2520of%2520the%2520dual%2520ErbB1%252FErbB2%2520Tyr%2520kinase%2520inhibitor%2520PKI-166%2520on%2520human%2520prostate%2520cancer%2520xenografts%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D5259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00023"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00023'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="jm050936ob00023_1"><span><span class="NLM_string-ref">Traxler, P.; Allegrini, P. R.; Brandt, R.; Brueggen, J.; Cozens, R.; Fabbro, D.; Grosios, K.; Lane, H. A.; McSheehy, P.; Mestan, J.; Meyer, T.; Tang, C.; Wartmann, M.; Wood, J.; Caravatti, G. AEE788:  A dual family epidermal growth factor receptor/erbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity. <i>  Cancer Res</i>. <b>2004</b>, <i>64</i>, 4931−4941.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=4941&author=P.+Traxler&author=P.+R.+Allegrini&author=R.+Brandt&author=J.+Brueggen&author=R.+Cozens&author=D.+Fabbro&author=K.+Grosios&author=H.+A.+Lane&author=P.+McSheehy&author=J.+Mestan&author=T.+Meyer&author=C.+Tang&author=M.+Wartmann&author=J.+Wood&author=G.+Caravatti&title=dual+family+epidermal+growth+factor+receptor%2FerbB2+and+vascular+endothelial+growth+factor+receptor+tyrosine+kinase+inhibitor+with+antitumor+and+antiangiogenic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP.%26atitle%3Ddual%2520family%2520epidermal%2520growth%2520factor%2520receptor%252FerbB2%2520and%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%2520with%2520antitumor%2520and%2520antiangiogenic%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D4941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00024"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00024'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="jm050936ob00024_1"><span><span class="NLM_string-ref">Stamos, J.; Sliwkowski, M. X.; Eigenbrot, C. Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. <i>  J. Biol. Chem</i>. <b>2002</b>, <i>277</i>, 46265−46272.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=46272&author=J.+Stamos&author=M.+X.+Sliwkowski&author=C+Eigenbrot&title=Structure+of+the+epidermal+growth+factor+receptor+kinase+domain+alone+and+in+complex+with+a+4-anilinoquinazoline+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStamos%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520kinase%2520domain%2520alone%2520and%2520in%2520complex%2520with%2520a%25204-anilinoquinazoline%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D46272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00025"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00025'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="jm050936ob00025_1"><span><span class="NLM_string-ref">Shewchuk, L.; Hassell, A.; Wisely, B.; Rocque, W.; Holmes, W.; Veal, J.; Kuyper, L. F. Binding mode of the 4-anilinoquinazoline class of protein kinase inhibitor:  X-ray Crystallographic studies of 4-anilinoquinazolines bound to cyclin-dependent kinase 2 and p38 kinase. <i>  J. Med. Chem</i>. <b>2000</b>, <i>43</i>, 133−138.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=138&author=L.+Shewchuk&author=A.+Hassell&author=B.+Wisely&author=W.+Rocque&author=W.+Holmes&author=J.+Veal&author=L.+F+Kuyper&title=Binding+mode+of+the+4-anilinoquinazoline+class+of+protein+kinase+inhibitor%3A%E2%80%89+X-ray+Crystallographic+studies+of+4-anilinoquinazolines+bound+to+cyclin-dependent+kinase+2+and+p38+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShewchuk%26aufirst%3DL.%26atitle%3DBinding%2520mode%2520of%2520the%25204-anilinoquinazoline%2520class%2520of%2520protein%2520kinase%2520inhibitor%253A%25E2%2580%2589%2520X-ray%2520Crystallographic%2520studies%2520of%25204-anilinoquinazolines%2520bound%2520to%2520cyclin-dependent%2520kinase%25202%2520and%2520p38%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00026"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00026'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="jm050936ob00026_1"><span><span class="NLM_string-ref">Wissner, A.; Berger, D. M.; Boschelli, D. H.; Floyd, M. B.; Greenberger, L. M.; Gruber, B. C.; Johnson, B. D.; Mamuya, N.; Nilakantan, R.; Reich, M. F.; Shen, R.; Tsou, H. R.; Upeslacis, E.; Wang, Y. F.; Wu, B.; Ye, F.; Zhang, N. 4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitors. <i>  J. Med. Chem</i>. <b>2000</b>, <i>43</i>, 3244−3256.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3256&author=A.+Wissner&author=D.+M.+Berger&author=D.+H.+Boschelli&author=M.+B.+Floyd&author=L.+M.+Greenberger&author=B.+C.+Gruber&author=B.+D.+Johnson&author=N.+Mamuya&author=R.+Nilakantan&author=M.+F.+Reich&author=R.+Shen&author=H.+R.+Tsou&author=E.+Upeslacis&author=Y.+F.+Wang&author=B.+Wu&author=F.+Ye&author=N.+Zhang&author=+Anilino&title=inhibitors+of+epidermal+growth+factor+receptor+kinase+and+their+bioisosteric+relationship+to+the+4-anilino-6%2C7-dialkoxyquinazoline+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00026_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26atitle%3Dinhibitors%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520kinase%2520and%2520their%2520bioisosteric%2520relationship%2520to%2520the%25204-anilino-6%252C7-dialkoxyquinazoline%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00027"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00027'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="jm050936ob00027_1"><span><span class="NLM_string-ref">Singh, J.; Dobrusin, E. M.; Fry, D. W.; Haske, T.; Whitty, A.; McNamara, D. J. Structure-based design of a potent, selective, and irreversible inhibitor of the catalytic domain of the erbB receptor subfamily of protein tyrosine kinases. <i>  J. Med. Chem</i>. <b>1997</b>, <i>40</i>, 1130−1135.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1135&author=J.+Singh&author=E.+M.+Dobrusin&author=D.+W.+Fry&author=T.+Haske&author=A.+Whitty&author=D.+J+McNamara&title=Structure-based+design+of+a+potent%2C+selective%2C+and+irreversible+inhibitor+of+the+catalytic+domain+of+the+erbB+receptor+subfamily+of+protein+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00027_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26atitle%3DStructure-based%2520design%2520of%2520a%2520potent%252C%2520selective%252C%2520and%2520irreversible%2520inhibitor%2520of%2520the%2520catalytic%2520domain%2520of%2520the%2520erbB%2520receptor%2520subfamily%2520of%2520protein%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00028"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00028'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="jm050936ob00028_1"><span><span class="NLM_string-ref">Fry, D. W.; Bridges, A. J.; Denny, W. A.; Doherty, A.; Greis, K. D.; Hicks, J. L.; Hook, K. E.; Keller, P. R.; Leopold, W. R.; Loo, J. A.; McNamara, D. J.; Nelson, J. M.; Sherwood, V.; Smaill, J. B.; Trumpp-Kallmeyer, S.; Dobrusin, E. M. Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor. <i>  Proc. </i><i>Natl. Acad. Sci. U.S.A.</i><b>1998</b>, <i>95</i>, 12022−12027.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=12027&author=D.+W.+Fry&author=A.+J.+Bridges&author=W.+A.+Denny&author=A.+Doherty&author=K.+D.+Greis&author=J.+L.+Hicks&author=K.+E.+Hook&author=P.+R.+Keller&author=W.+R.+Leopold&author=J.+A.+Loo&author=D.+J.+McNamara&author=J.+M.+Nelson&author=V.+Sherwood&author=J.+B.+Smaill&author=S.+Trumpp-Kallmeyer&author=E.+M+Dobrusin&title=Specific%2C+irreversible+inactivation+of+the+epidermal+growth+factor+receptor+and+erbB2%2C+by+a+new+class+of+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00028_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DSpecific%252C%2520irreversible%2520inactivation%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520and%2520erbB2%252C%2520by%2520a%2520new%2520class%2520of%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D12027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00029"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00029'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="jm050936ob00029_1"><span><span class="NLM_string-ref">Smaill, J. B.; Palmer, B. D.; Rewcastle, G. W.; Denny, W. A.; McNamara, D. J.; Dobrusin, E. M.; Bridges, A. J.; Zhou, H.; Showalter, H. D. H.; Winters, R. T.; Leopold, W. R.; Fry, D. W.; Nelson, J. M.; Slintak, V.; Elliot, W. L.; Roberts, B. J.; Vincent, P. W.; Patmore, S. J. Tyrosine kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[<i>d</i>]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor. <i>  J. Med. Chem.</i><b>1999</b>, <i>42</i>, 1803−1815.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1815&author=J.+B.+Smaill&author=B.+D.+Palmer&author=G.+W.+Rewcastle&author=W.+A.+Denny&author=D.+J.+McNamara&author=E.+M.+Dobrusin&author=A.+J.+Bridges&author=H.+Zhou&author=H.+D.+H.+Showalter&author=R.+T.+Winters&author=W.+R.+Leopold&author=D.+W.+Fry&author=J.+M.+Nelson&author=V.+Slintak&author=W.+L.+Elliot&author=B.+J.+Roberts&author=P.+W.+Vincent&author=S.+J+Patmore&title=Tyrosine+kinase+inhibitors.+15.+4-%28Phenylamino%29quinazoline+and+4-%28phenylamino%29pyrido%5Bd%5Dpyrimidine+acrylamides+as+irreversible+inhibitors+of+the+ATP+binding+site+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00029_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252015.%25204-%2528Phenylamino%2529quinazoline%2520and%25204-%2528phenylamino%2529pyrido%255Bd%255Dpyrimidine%2520acrylamides%2520as%2520irreversible%2520inhibitors%2520of%2520the%2520ATP%2520binding%2520site%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00030"><div class="reference"><div class="NLM_citation" id="jm050936ob00030_1"><span><span class="NLM_string-ref">Smaill, J. B.; Rewcastle, G. W.; Bridges, A. J.; Zhou, H.; Showalter, H. D. H.; Fry, D. W.; Nelson, J. M.; Sherwood, V.; Elliott, W. L.; Vincent, P. W.; DeJohn, D.; Loo, J. A.; Gries, K. D.; Chan, O. H.; Reyner, E. L.; Lipka, E.; Denny, W. A. Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor:  4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-<i>d</i>]pyrimidine-6-acrylamides bearing additional solubilizing functions. <i>  J. Med. Chem.</i><b>2000</b>, <i>43</i>, 1380−1397.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1397&author=J.+B.+Smaill&author=G.+W.+Rewcastle&author=A.+J.+Bridges&author=H.+Zhou&author=H.+D.+H.+Showalter&author=D.+W.+Fry&author=J.+M.+Nelson&author=V.+Sherwood&author=W.+L.+Elliott&author=P.+W.+Vincent&author=D.+DeJohn&author=J.+A.+Loo&author=K.+D.+Gries&author=O.+H.+Chan&author=E.+L.+Reyner&author=E.+Lipka&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+17.+Irreversible+inhibitors+of+the+epidermal+growth+factor+receptor%3A%E2%80%89+4-%28phenylamino%29quinazoline-+and+4-%28phenylamino%29pyrido%5B3%2C2-d%5Dpyrimidine-6-acrylamides+bearing+additional+solubilizing+functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00030_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252017.%2520Irreversible%2520inhibitors%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%253A%25E2%2580%2589%25204-%2528phenylamino%2529quinazoline-%2520and%25204-%2528phenylamino%2529pyrido%255B3%252C2-d%255Dpyrimidine-6-acrylamides%2520bearing%2520additional%2520solubilizing%2520functions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D1397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00031"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00031'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="jm050936ob00031_1"><span><span class="NLM_string-ref">Allen, L. F.; Eiseman, I. A.; Fry, D. W.; Lenehan, P. F. CI-1033, an irreversible pan-erbB receptor inhibitor and its potential application for the treatment of breast cancer. <i>  Semin. Oncol</i>. <b>2003</b>, <i>30 </i>(Suppl. 16), 65−78.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30+%28Suppl.+16&publication_year=2003&pages=78&author=L.+F.+Allen&author=I.+A.+Eiseman&author=D.+W.+Fry&author=P.+F.+Lenehan&title=an+irreversible+pan-erbB+receptor+inhibitor+and+its+potential+application+for+the+treatment+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00031_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DL.%2BF.%26atitle%3Dan%2520irreversible%2520pan-erbB%2520receptor%2520inhibitor%2520and%2520its%2520potential%2520application%2520for%2520the%2520treatment%2520of%2520breast%2520cancer%26jtitle%3DSemin.%2520Oncol.%26date%3D2003%26volume%3D30%2520%2528Suppl.%252016%26spage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00032"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00032'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="jm050936ob00032_1"><span><span class="NLM_string-ref">Calvo, E.; Tolcher, A. W.; Hammond, L. A.; Patnaik, A.; de Bono, J. S.; Eiseman, I. A.; Olson, S. C.; Lenehan, P. F.; McCreery, H.; LoRusso, P.; Rowinsky, E. K. Administration of CI-1033, an irreversible pan-erbB tyrosine kinase inhibitor, is feasible on a 7-day on, 7-day off schedule:  a phase I pharmacokinetic and food effect study. <i>  Clin. Cancer Res</i>. <b>2004</b>, <i>10</i>, 7112−7120.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=7120&author=E.+Calvo&author=A.+W.+Tolcher&author=L.+A.+Hammond&author=A.+Patnaik&author=J.+S.+de+Bono&author=I.+A.+Eiseman&author=S.+C.+Olson&author=P.+F.+Lenehan&author=H.+McCreery&author=P.+LoRusso&author=E.+K+Rowinsky&title=Administration+of+CI-1033%2C+an+irreversible+pan-erbB+tyrosine+kinase+inhibitor%2C+is+feasible+on+a+7-day+on%2C+7-day+off+schedule%3A%E2%80%89+a+phase+I+pharmacokinetic+and+food+effect+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00032_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCalvo%26aufirst%3DE.%26atitle%3DAdministration%2520of%2520CI-1033%252C%2520an%2520irreversible%2520pan-erbB%2520tyrosine%2520kinase%2520inhibitor%252C%2520is%2520feasible%2520on%2520a%25207-day%2520on%252C%25207-day%2520off%2520schedule%253A%25E2%2580%2589%2520a%2520phase%2520I%2520pharmacokinetic%2520and%2520food%2520effect%2520study%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D7120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00033"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00033'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="jm050936ob00033_1"><span><span class="NLM_string-ref">Smaill, J. B.; Showalter, H. D. H.; Zhou, H.; Bridges, A. J.; McNamara, D. J.; Fry, D. W.; Nelson, J. M.; Sherwood, V.; Vincent, P. W.; Roberts, B. J.; Elliott, W. L.; Denny, W. A. Tyrosine kinase inhibitors. 18. 6-Substituted 4-anilinoquinazolines and 4-anilinopyrido[3,4-<i>d</i>]pyrimidines as soluble, irreversible inhibitors of the epidermal growth factor receptor. <i>  J. Med. </i><i>Chem</i>. <b>2001</b>,<i> 44</i>, 429−440.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=440&author=J.+B.+Smaill&author=H.+D.+H.+Showalter&author=H.+Zhou&author=A.+J.+Bridges&author=D.+J.+McNamara&author=D.+W.+Fry&author=J.+M.+Nelson&author=V.+Sherwood&author=P.+W.+Vincent&author=B.+J.+Roberts&author=W.+L.+Elliott&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+18.+6-Substituted+4-anilinoquinazolines+and+4-anilinopyrido%5B3%2C4-d%5Dpyrimidines+as+soluble%2C+irreversible+inhibitors+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00033_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252018.%25206-Substituted%25204-anilinoquinazolines%2520and%25204-anilinopyrido%255B3%252C4-d%255Dpyrimidines%2520as%2520soluble%252C%2520irreversible%2520inhibitors%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00034"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00034'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="jm050936ob00034_1"><span><span class="NLM_string-ref">Tsou, H. R.; Mamuya, N.; Johnson, B. D.; Reich, M. F.; Gruber, B. C.; Ye, F.; Nilakantan, R.; Shen, R.; Discafani, C.; DeBlanc, R.; Davis, R.; Koehn, F. E.; Greenberger, L. M.; Wang, Y. F.; Wissner, A. 6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activity. <i>  J. Med. Chem. </i><b>2001</b>,<i> 44</i>, 2719−2734.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2734&author=H.+R.+Tsou&author=N.+Mamuya&author=B.+D.+Johnson&author=M.+F.+Reich&author=B.+C.+Gruber&author=F.+Ye&author=R.+Nilakantan&author=R.+Shen&author=C.+Discafani&author=R.+DeBlanc&author=R.+Davis&author=F.+E.+Koehn&author=L.+M.+Greenberger&author=Y.+F.+Wang&author=A.+Wissner&author=+Substituted&title=as+putative+irreversible+inhibitors+of+the+epidermal+growth+factor+receptor+%28EGFR%29+and+human+epidermal+growth+factor+receptor+%28HER-2%29+tyrosine+kinases+with+enhanced+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00034_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DH.%2BR.%26atitle%3Das%2520putative%2520irreversible%2520inhibitors%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520and%2520human%2520epidermal%2520growth%2520factor%2520receptor%2520%2528HER-2%2529%2520tyrosine%2520kinases%2520with%2520enhanced%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00035"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00035'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="jm050936ob00035_1"><span><span class="NLM_string-ref">Discafani, C. M.; Carroll, M. L.; Floyd, M. B.; Hollander, I. J.; Husain, Z.; Johnson, B. D.; Kitchen, D.; May, M. K.; Malo, M. S.; Minnick, A. A.; Nilakantan, R.; Shen, R.; Wang, Y.-F.; Wissner, A.; Greenburger, L. M. irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387, 785). <i>  Biochem. Pharmacol.</i><b>1999</b>, <i>57</i>, 917−925.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1999&pages=925&author=C.+M.+Discafani&author=M.+L.+Carroll&author=M.+B.+Floyd&author=I.+J.+Hollander&author=Z.+Husain&author=B.+D.+Johnson&author=D.+Kitchen&author=M.+K.+May&author=M.+S.+Malo&author=A.+A.+Minnick&author=R.+Nilakantan&author=R.+Shen&author=Y.-F.+Wang&author=A.+Wissner&author=L.+M+Greenburger&title=irreversible+inhibition+of+epidermal+growth+factor+receptor+tyrosine+kinase+with+in+vivo+activity+by+N-%5B4-%283-bromophenyl%29amino%5D-6-quinazolinyl%5D-2-butynamide+%28CL-387%2C+785%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00035_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiscafani%26aufirst%3DC.%2BM.%26atitle%3Dirreversible%2520inhibition%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520with%2520in%2520vivo%2520activity%2520by%2520N-%255B4-%25283-bromophenyl%2529amino%255D-6-quinazolinyl%255D-2-butynamide%2520%2528CL-387%252C%2520785%2529%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1999%26volume%3D57%26spage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00036"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00036'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="jm050936ob00036_1"><span><span class="NLM_string-ref">Wissner, A.; Overbeek, E.; Reich, M. F.; Brawner Floyd, M.; Johnson, B. D.; Mamuya, N.; Rosfjord, E. C.; Discafani, C.; Davis, R.; Shi, X.; Rabindran, S. K.; Gruber, B. C.; Ye, F.; Hallett, W. A.; Nilakantan, R.; Shen, R.; Wang, Y.-F.; Greenberger, L. M.; Tsou, H.-R. Synthesis and structure−activity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor-2 (HER-2).<i> J. Med. Chem. </i><b>2003</b>,<i> 46</i>, 49−63.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=63&author=A.+Wissner&author=E.+Overbeek&author=M.+F.+Reich&author=M.+Brawner+Floyd&author=B.+D.+Johnson&author=N.+Mamuya&author=E.+C.+Rosfjord&author=C.+Discafani&author=R.+Davis&author=X.+Shi&author=S.+K.+Rabindran&author=B.+C.+Gruber&author=F.+Ye&author=W.+A.+Hallett&author=R.+Nilakantan&author=R.+Shen&author=Y.-F.+Wang&author=L.+M.+Greenberger&author=H.-R+Tsou&title=Synthesis+and+structure%E2%88%92activity+relationships+of+6%2C7-disubstituted+4-anilinoquinoline-3-carbonitriles.+The+design+of+an+orally+active%2C+irreversible+inhibitor+of+the+tyrosine+kinase+activity+of+the+epidermal+growth+factor+receptor+%28EGFR%29+and+the+human+epidermal+growth+factor+receptor-2+%28HER-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00036_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%25206%252C7-disubstituted%25204-anilinoquinoline-3-carbonitriles.%2520The%2520design%2520of%2520an%2520orally%2520active%252C%2520irreversible%2520inhibitor%2520of%2520the%2520tyrosine%2520kinase%2520activity%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520and%2520the%2520human%2520epidermal%2520growth%2520factor%2520receptor-2%2520%2528HER-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00037"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00037'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="jm050936ob00037_1"><span><span class="NLM_string-ref">Nunes, M.; Shi, C.; Greenberger, L. M. Phosphorylation of extracellular signal-regulated kinase 1 and 2, protein kinase B, and signal transducer and activator of transcription 3 are differently inhibited by an epidermal growth factor receptor inhibitor, EKB-569, in tumor cells and normal human keratinocytes. <i>  Mol. Cancer Ther</i>. <b>2004</b>, <i>3</i>, 21−27.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=27&author=M.+Nunes&author=C.+Shi&author=L.+M+Greenberger&title=Phosphorylation+of+extracellular+signal-regulated+kinase+1+and+2%2C+protein+kinase+B%2C+and+signal+transducer+and+activator+of+transcription+3+are+differently+inhibited+by+an+epidermal+growth+factor+receptor+inhibitor%2C+EKB-569%2C+in+tumor+cells+and+normal+human+keratinocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00037_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNunes%26aufirst%3DM.%26atitle%3DPhosphorylation%2520of%2520extracellular%2520signal-regulated%2520kinase%25201%2520and%25202%252C%2520protein%2520kinase%2520B%252C%2520and%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25203%2520are%2520differently%2520inhibited%2520by%2520an%2520epidermal%2520growth%2520factor%2520receptor%2520inhibitor%252C%2520EKB-569%252C%2520in%2520tumor%2520cells%2520and%2520normal%2520human%2520keratinocytes%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26spage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00038"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00038'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="jm050936ob00038_1"><span><span class="NLM_string-ref">Wissner, A.; Hamann, P. R.; Nilakantan, R.; Greenberger, L. M.; Ye, F.; Rapuano, T. A.; Loganzo, F. Syntheses and EGFR kinase inhibitory activity of 6-substituted-4-anilino [1,7] and [1,8] naphthyridine-3-carbonitriles. <i>  Bioorg. Med. Chem. Lett.</i><b>2004</b>, <i>14</i>, 1411−1416.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1416&author=A.+Wissner&author=P.+R.+Hamann&author=R.+Nilakantan&author=L.+M.+Greenberger&author=F.+Ye&author=T.+A.+Rapuano&author=F+Loganzo&title=Syntheses+and+EGFR+kinase+inhibitory+activity+of+6-substituted-4-anilino+%5B1%2C7%5D+and+%5B1%2C8%5D+naphthyridine-3-carbonitriles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00038_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DSyntheses%2520and%2520EGFR%2520kinase%2520inhibitory%2520activity%2520of%25206-substituted-4-anilino%2520%255B1%252C7%255D%2520and%2520%255B1%252C8%255D%2520naphthyridine-3-carbonitriles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D1416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00039"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00039'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="jm050936ob00039_1"><span><span class="NLM_string-ref">Tsou, H.-R.; Overbeek-Klumpers, E. G.; Hallett, W. A.; Reich, M. F.; Brawner Floyd, M.; Johnson, B. D.; Michalak, R. S.; Nilakantan, R.; Discafani, C.; Golas, J.; Rabindran, S. K.; Shen, R.; Shi, X.; Wang, Y.-F.; Upeslacis, J.; Wissner, A. Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity. <i>  J. Med. Chem</i>. <b>2005</b>, <i>48</i>, 1107−1131.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1131&author=H.-R.+Tsou&author=E.+G.+Overbeek-Klumpers&author=W.+A.+Hallett&author=M.+F.+Reich&author=M.+Brawner+Floyd&author=B.+D.+Johnson&author=R.+S.+Michalak&author=R.+Nilakantan&author=C.+Discafani&author=J.+Golas&author=S.+K.+Rabindran&author=R.+Shen&author=X.+Shi&author=Y.-F.+Wang&author=J.+Upeslacis&author=A+Wissner&title=Optimization+of+6%2C7-disubstituted-4-%28arylamino%29quinoline-3-carbonitriles+as+orally+active%2C+irreversible+inhibitors+of+human+epidermal+growth+factor+receptor-2+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00039_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DH.-R.%26atitle%3DOptimization%2520of%25206%252C7-disubstituted-4-%2528arylamino%2529quinoline-3-carbonitriles%2520as%2520orally%2520active%252C%2520irreversible%2520inhibitors%2520of%2520human%2520epidermal%2520growth%2520factor%2520receptor-2%2520kinase%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00040"><div class="reference"><div class="NLM_citation" id="jm050936ob00040_1"><span><span class="NLM_string-ref">Kwak, E. L.; Sordella, R.; Bell, D. W.; Godin-Heymann, N.; Okimoto, R. A.; Brannigan, B. W.; Harris, P. L.; Driscoll, D. R.; Fidias, P.; Lynch, T. J.; Rabindran, S. K.; McGinnis, J. P.; Wissner, A.; Sharma, S. V.; Isselbacher, K. J.; Settleman, J.; Haber, D. A. Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib. <i>  Proc. Natl. Acad. Sci. </i><i>U.S.A.</i><b>2005</b>, <i>102</i>, 7665−7670.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=7670&author=E.+L.+Kwak&author=R.+Sordella&author=D.+W.+Bell&author=N.+Godin-Heymann&author=R.+A.+Okimoto&author=B.+W.+Brannigan&author=P.+L.+Harris&author=D.+R.+Driscoll&author=P.+Fidias&author=T.+J.+Lynch&author=S.+K.+Rabindran&author=J.+P.+McGinnis&author=A.+Wissner&author=S.+V.+Sharma&author=K.+J.+Isselbacher&author=J.+Settleman&author=D.+A+Haber&title=Irreversible+inhibitors+of+the+EGF+receptor+may+circumvent+acquired+resistance+to+gefitinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00040_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKwak%26aufirst%3DE.%2BL.%26atitle%3DIrreversible%2520inhibitors%2520of%2520the%2520EGF%2520receptor%2520may%2520circumvent%2520acquired%2520resistance%2520to%2520gefitinib%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D7670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00041"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00041'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="jm050936ob00041_1"><span><span class="NLM_string-ref">Rewcastle, G. W.; Denny, W. A.; Bridges, A. J.; Zhou, H.; Cody, D. R.; McMichael, A.; Fry, D. W. Tyrosine kinase inhibitors. 5. Synthesis and structure−activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5‘-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth factor receptor. <i>  J. Med. Chem.</i><b>1995</b>, <i>38</i>, 3482−3487.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=3487&author=G.+W.+Rewcastle&author=W.+A.+Denny&author=A.+J.+Bridges&author=H.+Zhou&author=D.+R.+Cody&author=A.+McMichael&author=D.+W+Fry&title=Tyrosine+kinase+inhibitors.+5.+Synthesis+and+structure%E2%88%92activity+relationships+for+4-%5B%28phenylmethyl%29amino%5D-+and+4-%28phenylamino%29quinazolines+as+potent+adenosine+5%E2%80%98-triphosphate+binding+site+inhibitors+of+the+tyrosine+kinase+domain+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00041_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%25205.%2520Synthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520for%25204-%255B%2528phenylmethyl%2529amino%255D-%2520and%25204-%2528phenylamino%2529quinazolines%2520as%2520potent%2520adenosine%25205%25E2%2580%2598-triphosphate%2520binding%2520site%2520inhibitors%2520of%2520the%2520tyrosine%2520kinase%2520domain%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D3487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00042"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00042'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="jm050936ob00042_1"><span><span class="NLM_string-ref">Rewcastle, G. W.; Palmer, B. D.; Thompson, A. M.; Bridges, A. J.; Cody, D. R.; Zhou, H.; Fry, D. W.; McMichael, A.; Kraker, A. J.; Denny, W. A. Tyrosine kinase inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]pyrido[d]pyrimidines are potent ATP Binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptor. <i>  J. Med. Chem</i>. <b>1996</b>, <i>39</i>, 1823−1835.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1835&author=G.+W.+Rewcastle&author=B.+D.+Palmer&author=A.+M.+Thompson&author=A.+J.+Bridges&author=D.+R.+Cody&author=H.+Zhou&author=D.+W.+Fry&author=A.+McMichael&author=A.+J.+Kraker&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+10.+Isomeric+4-%5B%283-bromophenyl%29amino%5Dpyrido%5Bd%5Dpyrimidines+are+potent+ATP+Binding+site+inhibitors+of+the+tyrosine+kinase+function+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00042_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252010.%2520Isomeric%25204-%255B%25283-bromophenyl%2529amino%255Dpyrido%255Bd%255Dpyrimidines%2520are%2520potent%2520ATP%2520Binding%2520site%2520inhibitors%2520of%2520the%2520tyrosine%2520kinase%2520function%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00043"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00043'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="jm050936ob00043_1"><span><span class="NLM_string-ref">Olomucki, M.; Marszak, I. The unsaturated amino acids. Synthesis of 4-dimethylamino-2-butynoic acid and 5-dimethylamino-2-pentynoic acid as well as their corresponding esters. <i>  C. R.</i><i>Hebd. Seances Acad. Sci.</i><b>1956</b>, <i>242</i>, 1338−1340.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=242&publication_year=1956&pages=1340&author=M.+Olomucki&author=I+Marszak&title=The+unsaturated+amino+acids.+Synthesis+of+4-dimethylamino-2-butynoic+acid+and+5-dimethylamino-2-pentynoic+acid+as+well+as+their+corresponding+esters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00043_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlomucki%26aufirst%3DM.%26atitle%3DThe%2520unsaturated%2520amino%2520acids.%2520Synthesis%2520of%25204-dimethylamino-2-butynoic%2520acid%2520and%25205-dimethylamino-2-pentynoic%2520acid%2520as%2520well%2520as%2520their%2520corresponding%2520esters%26jtitle%3DC.%2520R.%2520Hebd.%2520Seances%2520Acad.%2520Sci.%26date%3D1956%26volume%3D242%26spage%3D1340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00044"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00044'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="jm050936ob00044_1"><span><span class="NLM_string-ref">Johnson, C. D.; Lane, S.; Edwards, P. N.; Taylor, P. J. Prodrugs based on masked lactones. Cyclization of γ-hydroxy amides. <i>  J. Org. Chem</i>. <b>1988</b>, <i>53</i>, 5130−5139.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1988&pages=5139&author=C.+D.+Johnson&author=S.+Lane&author=P.+N.+Edwards&author=P.+J+Taylor&title=Prodrugs+based+on+masked+lactones.+Cyclization+of+%CE%B3-hydroxy+amides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00044_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BD.%26atitle%3DProdrugs%2520based%2520on%2520masked%2520lactones.%2520Cyclization%2520of%2520%25CE%25B3-hydroxy%2520amides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1988%26volume%3D53%26spage%3D5139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00045"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00045'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="jm050936ob00045_1"><span><span class="NLM_string-ref">Apodaca, R.; Xiao, W.; Jablonoski, J. A. Preparation of substituted phenylalkynes for use in histamine-mediated disorders. PCT Int. Appl. WO 2003050099 A1, 2003.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=050099&publication_year=2003&pages=2003&author=R.+Apodaca&author=W.+Xiao&author=J.+A+Jablonoski&title=Preparation+of+substituted+phenylalkynes+for+use+in+histamine-mediated+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00045_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DApodaca%26aufirst%3DR.%26atitle%3DPreparation%2520of%2520substituted%2520phenylalkynes%2520for%2520use%2520in%2520histamine-mediated%2520disorders%26jtitle%3DPCT%2520Int.%2520Appl.%2520WO%26date%3D2003%26volume%3D050099%26spage%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00046"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00046'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="jm050936ob00046_1"><span><span class="NLM_string-ref">Turner, S. C.; Esbenshade, T. A.; Bennani, Y. L.; Hancock, A. A. A new class of histamine H3-receptor antagonists:  synthesis and structure−activity relationships of 7,8,9,10-tetrahydro-6<i>H</i>-cyclohepta[<i>b</i>]quinolines. <i>  Bioorg. </i><i>Med. Chem. Lett</i>. <b>2003</b>, <i>13</i>, 2131−2135.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2135&author=S.+C.+Turner&author=T.+A.+Esbenshade&author=Y.+L.+Bennani&author=A.+A+Hancock&title=A+new+class+of+histamine+H3-receptor+antagonists%3A%E2%80%89+synthesis+and+structure%E2%88%92activity+relationships+of+7%2C8%2C9%2C10-tetrahydro-6H-cyclohepta%5Bb%5Dquinolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00046_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DS.%2BC.%26atitle%3DA%2520new%2520class%2520of%2520histamine%2520H3-receptor%2520antagonists%253A%25E2%2580%2589%2520synthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%25207%252C8%252C9%252C10-tetrahydro-6H-cyclohepta%255Bb%255Dquinolines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00047"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00047'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="jm050936ob00047_1"><span><span class="NLM_string-ref">Comess, K. M.; Erickson, S. A.; Henkin, J.; Kalvin, D. M.; Kawai, M.; Kim, K. H.; Bamaung, N. Y.; Park, C. H.; Sheppard, G. S.; Vasudevan, A.; Wang, J.; Barnes, D. M.; Fidanze, S. D.; Kolaczkowsi, L.; Mantei, R. A.; Park, D. C.; Sanders, W. J.; Tedrow, J. S.; Wang, G. T. Preparation of sulfonamides having antiangiogenic and anticancer activity. PCT Int. Appl. WO 2004033419 A1, 2004.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=033419&publication_year=2004&pages=2004&author=K.+M.+Comess&author=S.+A.+Erickson&author=J.+Henkin&author=D.+M.+Kalvin&author=M.+Kawai&author=K.+H.+Kim&author=N.+Y.+Bamaung&author=C.+H.+Park&author=G.+S.+Sheppard&author=A.+Vasudevan&author=J.+Wang&author=D.+M.+Barnes&author=S.+D.+Fidanze&author=L.+Kolaczkowsi&author=R.+A.+Mantei&author=D.+C.+Park&author=W.+J.+Sanders&author=J.+S.+Tedrow&author=G.+T+Wang&title=Preparation+of+sulfonamides+having+antiangiogenic+and+anticancer+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00047_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DComess%26aufirst%3DK.%2BM.%26atitle%3DPreparation%2520of%2520sulfonamides%2520having%2520antiangiogenic%2520and%2520anticancer%2520activity%26jtitle%3DPCT%2520Int.%2520Appl.%2520WO%26date%3D2004%26volume%3D033419%26spage%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00048"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00048'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="jm050936ob00048_1"><span><span class="NLM_string-ref">Chou, T. C.; Talalay, P. Applications of the Median-Effect Principle for the Assessment of Low-Dose Risk of Carcinogens and for the Quantitation of Synergism and Antagonism of ChemotherapeuticAgents. <i>  Bristol-Myers </i><i>Cancer Symp., New Ave. Dev. Cancer Chemother.</i><b>1987</b>, <i>8</i>, 37−64.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1987&pages=64&author=T.+C.+Chou&author=P+Talalay&title=Applications+of+the+Median-Effect+Principle+for+the+Assessment+of+Low-Dose+Risk+of+Carcinogens+and+for+the+Quantitation+of+Synergism+and+Antagonism+of+ChemotherapeuticAgents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00048_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DT.%2BC.%26atitle%3DApplications%2520of%2520the%2520Median-Effect%2520Principle%2520for%2520the%2520Assessment%2520of%2520Low-Dose%2520Risk%2520of%2520Carcinogens%2520and%2520for%2520the%2520Quantitation%2520of%2520Synergism%2520and%2520Antagonism%2520of%2520ChemotherapeuticAgents%26jtitle%3DBristol-Myers%2520Cancer%2520Symp.%252C%2520New%2520Ave.%2520Dev.%2520Cancer%2520Chemother.%26date%3D1987%26volume%3D8%26spage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00049"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00049'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="jm050936ob00049_1"><span><span class="NLM_string-ref">Cohen, B. D.; Goldstein, D. J.; Rutledge, L.; Vass, W. C.; Lowy, D. R.; Schlegel, R.; Schiller, J. T. Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain. <i>  J. Virol.</i><b>1993</b>, <i>67</i>, 5303−5511.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1993&pages=5511&author=B.+D.+Cohen&author=D.+J.+Goldstein&author=L.+Rutledge&author=W.+C.+Vass&author=D.+R.+Lowy&author=R.+Schlegel&author=J.+T+Schiller&title=Transformation-specific+interaction+of+the+bovine+papillomavirus+E5+oncoprotein+with+the+platelet-derived+growth+factor+receptor+transmembrane+domain+and+the+epidermal+growth+factor+receptor+cytoplasmic+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00049_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DB.%2BD.%26atitle%3DTransformation-specific%2520interaction%2520of%2520the%2520bovine%2520papillomavirus%2520E5%2520oncoprotein%2520with%2520the%2520platelet-derived%2520growth%2520factor%2520receptor%2520transmembrane%2520domain%2520and%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520cytoplasmic%2520domain%26jtitle%3DJ.%2520Virol.%26date%3D1993%26volume%3D67%26spage%3D5511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00050"><div class="reference"><div class="NLM_citation" id="jm050936ob00050_1"><span><span class="NLM_string-ref">Fry, D. W.; Nelson, J. M.; Slintak, V.; Keller, P. R.; Rewcastle, G. W.; Denny, W. A.; Zhou, H.; Bridges, A. J. Biochemical and antiproliferative properties of 4-[ar(alk)ylamino]pyridopyrimidines, a new chemical class of potent and specific epidermal growth factor receptor tyrosine kinase inhibitor. <i>  Biochem. Pharmacol</i>. <b>1997</b>, <i>54</i>, 877−887.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1997&pages=887&author=D.+W.+Fry&author=J.+M.+Nelson&author=V.+Slintak&author=P.+R.+Keller&author=G.+W.+Rewcastle&author=W.+A.+Denny&author=H.+Zhou&author=A.+J+Bridges&title=Biochemical+and+antiproliferative+properties+of+4-%5Bar%28alk%29ylamino%5Dpyridopyrimidines%2C+a+new+chemical+class+of+potent+and+specific+epidermal+growth+factor+receptor+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00050_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DBiochemical%2520and%2520antiproliferative%2520properties%2520of%25204-%255Bar%2528alk%2529ylamino%255Dpyridopyrimidines%252C%2520a%2520new%2520chemical%2520class%2520of%2520potent%2520and%2520specific%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1997%26volume%3D54%26spage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00051"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00051'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="jm050936ob00051_1"><span><span class="NLM_string-ref">Schabel, F. M., Jr.; Griswold, D. P., Jr.; Laster, W. R., Jr.; Corbett, T. H.; Lloyd, H. H. Quantitative evaluation of anticancer agent activity in experimental animals. <i>  Pharmacol. Ther</i>. <b>1977</b>, <i>1</i>, 411−435.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1977&pages=435&author=F.+M.+Schabel&author=+Jr&author=+Jr&author=+Jr&author=H.+H+Lloyd&title=Quantitative+evaluation+of+anticancer+agent+activity+in+experimental+animals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00051_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchabel%26aufirst%3DF.%2BM.%26atitle%3DQuantitative%2520evaluation%2520of%2520anticancer%2520agent%2520activity%2520in%2520experimental%2520animals%26jtitle%3DPharmacol.%2520Ther.%26date%3D1977%26volume%3D1%26spage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00052"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00052'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="jm050936ob00052_1"><span><span class="NLM_string-ref">Leopold, W. R.; Nelson, J. M.; Plowman, J.; Jackson, R. C. Anthrapyrazoles, a new class of intercalating agents with high-level, broad spectrum activity against murine tumors. <i>  Cancer Res</i>. <b>1985</b>, <i>45</i>, 5532−5539.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1985&pages=5539&author=W.+R.+Leopold&author=J.+M.+Nelson&author=J.+Plowman&author=R.+C+Jackson&title=Anthrapyrazoles%2C+a+new+class+of+intercalating+agents+with+high-level%2C+broad+spectrum+activity+against+murine+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00052_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeopold%26aufirst%3DW.%2BR.%26atitle%3DAnthrapyrazoles%252C%2520a%2520new%2520class%2520of%2520intercalating%2520agents%2520with%2520high-level%252C%2520broad%2520spectrum%2520activity%2520against%2520murine%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D1985%26volume%3D45%26spage%3D5539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00053"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00053'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="jm050936ob00053_1"><span><span class="NLM_string-ref">Elliott, W. L.; Howard, C. T.; Dykes, D. J.; Leopold, W. R. Sequence and schedule-dependent synergy of trimetrexate in combination with 5-fluorouracil in vitro and in mice. <i>  Cancer Res</i>. <b>1989</b>, <i>49</i>, 5586−5590.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1989&pages=5590&author=W.+L.+Elliott&author=C.+T.+Howard&author=D.+J.+Dykes&author=W.+R+Leopold&title=Sequence+and+schedule-dependent+synergy+of+trimetrexate+in+combination+with+5-fluorouracil+in+vitro+and+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00053_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElliott%26aufirst%3DW.%2BL.%26atitle%3DSequence%2520and%2520schedule-dependent%2520synergy%2520of%2520trimetrexate%2520in%2520combination%2520with%25205-fluorouracil%2520in%2520vitro%2520and%2520in%2520mice%26jtitle%3DCancer%2520Res.%26date%3D1989%26volume%3D49%26spage%3D5590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00054"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00054'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="jm050936ob00054_1"><span><span class="NLM_string-ref">Elliott, W. L.; Roberts, B. J.; Howard, C. T.; Leopold, W. R. Chemotherapy with [SP-4-3-(<i>R</i>)]-[1,1-cyclobutanedicarboxylato (2-)] (2-methyl-1,4-butanediamine-N,N‘) platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo. <i>  Cancer </i><i>Res</i>. <b>1994</b>, <i>54</i>, 4412−4418.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1994&pages=4418&author=W.+L.+Elliott&author=B.+J.+Roberts&author=C.+T.+Howard&author=W.+R.+Leopold&author=+Chemotherapy&author=+N%E2%80%98&title=in+combination+with+standard+agents+against+murine+tumors+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00054_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElliott%26aufirst%3DW.%2BL.%26atitle%3Din%2520combination%2520with%2520standard%2520agents%2520against%2520murine%2520tumors%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D1994%26volume%3D54%26spage%3D4418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm050936ob00055"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm050936ob00055'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="jm050936ob00055_1"><span><span class="NLM_string-ref">Bridges, A. J.; Denny, W. A.; Dobrusin, E. M.; Doherty, A. M.; Fry, D. W.; McNamara, D. J.; Showalter, H. D. H.; Smaill, J. B.; Zhou, H. Preparation of N-quinazolinylacrylamides and analogues as tyrosine kinase inhibitors. PCT Int. Appln<i>.</i> WO 9738983 A1, 1997; 194 pp.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=A.+J.+Bridges&author=W.+A.+Denny&author=E.+M.+Dobrusin&author=A.+M.+Doherty&author=D.+W.+Fry&author=D.+J.+McNamara&author=H.+D.+H.+Showalter&author=J.+B.+Smaill&author=H.+Zhou&title=Preparation+of+N-quinazolinylacrylamides+and+analogues+as+tyrosine+kinase+inhibitors.+PCT+Int.+Appln.+WO+9738983+A1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00055_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26btitle%3DPreparation%2520of%2520N-quinazolinylacrylamides%2520and%2520analogues%2520as%2520tyrosine%2520kinase%2520inhibitors.%2520PCT%2520Int.%2520Appln.%2520WO%25209738983%2520A1%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'jm050936ob00001':['jm050936ob00001_1'],'jm050936ob00002':['jm050936ob00002_1'],'jm050936ob00003':['jm050936ob00003_1'],'jm050936ob00004':['jm050936ob00004_1'],'jm050936ob00005':['jm050936ob00005_1'],'jm050936ob00006':['jm050936ob00006_1'],'jm050936ob00007':['jm050936ob00007_1'],'jm050936ob00008':['jm050936ob00008_1'],'jm050936ob00009':['jm050936ob00009_1'],'jm050936ob00010':['jm050936ob00010_1'],'jm050936ob00011':['jm050936ob00011_1'],'jm050936ob00012':['jm050936ob00012_1'],'jm050936ob00013':['jm050936ob00013_1'],'jm050936ob00014':['jm050936ob00014_1'],'jm050936ob00015':['jm050936ob00015_1'],'jm050936ob00016':['jm050936ob00016_1'],'jm050936ob00017':['jm050936ob00017_1'],'jm050936ob00018':['jm050936ob00018_1'],'jm050936ob00019':['jm050936ob00019_1'],'jm050936ob00020':['jm050936ob00020_1'],'jm050936ob00021':['jm050936ob00021_1'],'jm050936ob00022':['jm050936ob00022_1'],'jm050936ob00023':['jm050936ob00023_1'],'jm050936ob00024':['jm050936ob00024_1'],'jm050936ob00025':['jm050936ob00025_1'],'jm050936ob00026':['jm050936ob00026_1'],'jm050936ob00027':['jm050936ob00027_1'],'jm050936ob00028':['jm050936ob00028_1'],'jm050936ob00029':['jm050936ob00029_1'],'jm050936ob00030':['jm050936ob00030_1'],'jm050936ob00031':['jm050936ob00031_1'],'jm050936ob00032':['jm050936ob00032_1'],'jm050936ob00033':['jm050936ob00033_1'],'jm050936ob00034':['jm050936ob00034_1'],'jm050936ob00035':['jm050936ob00035_1'],'jm050936ob00036':['jm050936ob00036_1'],'jm050936ob00037':['jm050936ob00037_1'],'jm050936ob00038':['jm050936ob00038_1'],'jm050936ob00039':['jm050936ob00039_1'],'jm050936ob00040':['jm050936ob00040_1'],'jm050936ob00041':['jm050936ob00041_1'],'jm050936ob00042':['jm050936ob00042_1'],'jm050936ob00043':['jm050936ob00043_1'],'jm050936ob00044':['jm050936ob00044_1'],'jm050936ob00045':['jm050936ob00045_1'],'jm050936ob00046':['jm050936ob00046_1'],'jm050936ob00047':['jm050936ob00047_1'],'jm050936ob00048':['jm050936ob00048_1'],'jm050936ob00049':['jm050936ob00049_1'],'jm050936ob00050':['jm050936ob00050_1'],'jm050936ob00051':['jm050936ob00051_1'],'jm050936ob00052':['jm050936ob00052_1'],'jm050936ob00053':['jm050936ob00053_1'],'jm050936ob00054':['jm050936ob00054_1'],'jm050936ob00055':['jm050936ob00055_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 56 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroyuki  Kimura</span>, <span class="hlFld-ContribAuthor ">Haruka  Okuda</span>, <span class="hlFld-ContribAuthor ">Masumi  Ishiguro</span>, <span class="hlFld-ContribAuthor ">Kenji  Arimitsu</span>, <span class="hlFld-ContribAuthor ">Akira  Makino</span>, <span class="hlFld-ContribAuthor ">Ryuichi  Nishii</span>, <span class="hlFld-ContribAuthor ">Anna  Miyazaki</span>, <span class="hlFld-ContribAuthor ">Yusuke  Yagi</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Watanabe</span>, <span class="hlFld-ContribAuthor ">Ikuo  Kawasaki</span>, <span class="hlFld-ContribAuthor ">Masahiro  Ono</span>, and <span class="hlFld-ContribAuthor ">Hideo  Saji</span>  . </span><span class="cited-content_cbyCitation_article-title">18F-Labeled Pyrido[3,4-d]pyrimidine as an Effective Probe for Imaging of L858R Mutant Epidermal Growth Factor Receptor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (4)
                                     , 418-422. <a href="https://doi.org/10.1021/acsmedchemlett.6b00520" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00520</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00520%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D18F-Labeled%252BPyrido%25255B3%25252C4-d%25255Dpyrimidine%252Bas%252Ban%252BEffective%252BProbe%252Bfor%252BImaging%252Bof%252BL858R%252BMutant%252BEpidermal%252BGrowth%252BFactor%252BReceptor%26aulast%3DKimura%26aufirst%3DHiroyuki%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D28122016%26date%3D20032017%26date%3D31032017%26date%3D13042017%26date%3D20032017%26volume%3D8%26issue%3D4%26spage%3D418%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeff B.  Smaill</span>, <span class="hlFld-ContribAuthor ">Andrea J.  Gonzales</span>, <span class="hlFld-ContribAuthor ">Julie A.  Spicer</span>, <span class="hlFld-ContribAuthor ">Helen  Lee</span>, <span class="hlFld-ContribAuthor ">Jessica E.  Reed</span>, <span class="hlFld-ContribAuthor ">Karen  Sexton</span>, <span class="hlFld-ContribAuthor ">Irene W.  Althaus</span>, <span class="hlFld-ContribAuthor ">Tong  Zhu</span>, <span class="hlFld-ContribAuthor ">Shannon L.  Black</span>, <span class="hlFld-ContribAuthor ">Adrian  Blaser</span>, <span class="hlFld-ContribAuthor ">William A.  Denny</span>, <span class="hlFld-ContribAuthor ">Paul A.  Ellis</span>, <span class="hlFld-ContribAuthor ">Stephen  Fakhoury</span>, <span class="hlFld-ContribAuthor ">Patricia J.  Harvey</span>, <span class="hlFld-ContribAuthor ">Ken  Hook</span>, <span class="hlFld-ContribAuthor ">Florence O. J.  McCarthy</span>, <span class="hlFld-ContribAuthor ">Brian D.  Palmer</span>, <span class="hlFld-ContribAuthor ">Freddy  Rivault</span>, <span class="hlFld-ContribAuthor ">Kevin  Schlosser</span>, <span class="hlFld-ContribAuthor ">Teresa  Ellis</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Thompson</span>, <span class="hlFld-ContribAuthor ">Erin  Trachet</span>, <span class="hlFld-ContribAuthor ">R. Thomas  Winters</span>, <span class="hlFld-ContribAuthor ">Haile  Tecle</span>, and <span class="hlFld-ContribAuthor ">Alexander  Bridges</span>  . </span><span class="cited-content_cbyCitation_article-title">Tyrosine Kinase Inhibitors. 20. Optimization of Substituted Quinazoline and Pyrido[3,4-d]pyrimidine Derivatives as Orally Active, Irreversible Inhibitors of the Epidermal Growth Factor Receptor Family. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (17)
                                     , 8103-8124. <a href="https://doi.org/10.1021/acs.jmedchem.6b00883" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00883</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00883%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTyrosine%252BKinase%252BInhibitors.%252B20.%252BOptimization%252Bof%252BSubstituted%252BQuinazoline%252Band%252BPyrido%25255B3%25252C4-d%25255Dpyrimidine%252BDerivatives%252Bas%252BOrally%252BActive%25252C%252BIrreversible%252BInhibitors%252Bof%252Bthe%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BFamily%26aulast%3DSmaill%26aufirst%3DJeff%2BB.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D15062016%26date%3D22082016%26date%3D08092016%26date%3D04082016%26volume%3D59%26issue%3D17%26spage%3D8103%26epage%3D8124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Jessica E.    Reed </span><span class="hlFld-ContribAuthor "> Jeff B.    Smaill </span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery of Dacomitinib, a Potent Irreversible EGFR Inhibitor. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 207-233. <a href="https://doi.org/10.1021/bk-2016-1239.ch008" title="DOI URL">https://doi.org/10.1021/bk-2016-1239.ch008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2016-1239.ch008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2016-1239.ch008%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDiscovery%252Bof%252BDacomitinib%25252C%252Ba%252BPotent%252BIrreversible%252BEGFR%252BInhibitor%26aulast%3DReed%26aufirst%3DJessica%2BE.%26date%3D2016%26date%3D2016%26spage%3D207%26epage%3D233%26atitle%3DComprehensive%252BAccounts%252Bof%252BPharmaceutical%252BResearch%252Band%252BDevelopment%25253A%252BFrom%252BDiscovery%252Bto%252BLate-Stage%252BProcess%252BDevelopment%252BVolume%252B1%26aulast%3DAbdel-Magid%26aufirst%3DAhmed%2BF.%26date%3D2016%26date%3D2016%26volume%3D1239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Zhang</span>, <span class="hlFld-ContribAuthor ">Dingyuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Yongjiu  Liang</span>, <span class="hlFld-ContribAuthor ">Guangyuan  Zhou</span>, and <span class="hlFld-ContribAuthor ">Dewen  Dong</span>  . </span><span class="cited-content_cbyCitation_article-title">Vilsmeier Reaction of 3-Aminopropenamides: One-Pot Synthesis of Pyrimidin-4(3H)-ones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2011,</strong> <em>76 </em>
                                    (8)
                                     , 2880-2883. <a href="https://doi.org/10.1021/jo101949y" title="DOI URL">https://doi.org/10.1021/jo101949y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo101949y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo101949y%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DVilsmeier%252BReaction%252Bof%252B3-Aminopropenamides%25253A%252BOne-Pot%252BSynthesis%252Bof%252BPyrimidin-4%2525283H%252529-ones%26aulast%3DZhang%26aufirst%3DRui%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D02102010%26date%3D18032011%26date%3D15042011%26date%3D10032011%26volume%3D76%26issue%3D8%26spage%3D2880%26epage%3D2883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Concettina  La Motta</span>, <span class="hlFld-ContribAuthor ">Stefania  Sartini</span>, <span class="hlFld-ContribAuthor ">Tiziano  Tuccinardi</span>, <span class="hlFld-ContribAuthor ">Erika  Nerini</span>, <span class="hlFld-ContribAuthor ">Federico  Da Settimo</span> and <span class="hlFld-ContribAuthor ">Adriano  Martinelli</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Studies of Epidermal Growth Factor Receptor: Docking Reliability, Three-Dimensional Quantitative Structure−Activity Relationship Analysis, and Virtual Screening Studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (4)
                                     , 964-975. <a href="https://doi.org/10.1021/jm800829v" title="DOI URL">https://doi.org/10.1021/jm800829v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm800829v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm800829v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DComputational%252BStudies%252Bof%252BEpidermal%252BGrowth%252BFactor%252BReceptor%25253A%252BDocking%252BReliability%25252C%252BThree-Dimensional%252BQuantitative%252BStructure%2525E2%252588%252592Activity%252BRelationship%252BAnalysis%25252C%252Band%252BVirtual%252BScreening%252BStudies%26aulast%3DLa%2BMotta%26aufirst%3DConcettina%26date%3D2009%26date%3D2009%26date%3D2008%26date%3D26%252002%25202009%26date%3D26%252001%25202009%26date%3D8%252007%25202008%26volume%3D52%26issue%3D4%26spage%3D964%26epage%3D975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nilantha  Sirisoma</span>, <span class="hlFld-ContribAuthor ">Shailaja  Kasibhatla</span>, <span class="hlFld-ContribAuthor ">Azra  Pervin</span>, <span class="hlFld-ContribAuthor ">Hong  Zhang</span>, <span class="hlFld-ContribAuthor ">Songchun  Jiang</span>, <span class="hlFld-ContribAuthor ">J. Adam  Willardsen</span>, <span class="hlFld-ContribAuthor ">Mark B.  Anderson</span>, <span class="hlFld-ContribAuthor ">Vijay  Baichwal</span>, <span class="hlFld-ContribAuthor ">Gary G.  Mather</span>, <span class="hlFld-ContribAuthor ">Kevin  Jessing</span>, <span class="hlFld-ContribAuthor ">Raouf  Hussain</span>, <span class="hlFld-ContribAuthor ">Khanh  Hoang</span>, <span class="hlFld-ContribAuthor ">Christopher M.  Pleiman</span>, <span class="hlFld-ContribAuthor ">Ben  Tseng</span>, <span class="hlFld-ContribAuthor ">John  Drewe</span> and <span class="hlFld-ContribAuthor ">Sui Xiong  Cai</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-Chloro-N-(4-methoxyphenyl)-N-methylquinazolin-4-amine (EP128265, MPI-0441138) as a Potent Inducer of Apoptosis with High In Vivo Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2008,</strong> <em>51 </em>
                                    (15)
                                     , 4771-4779. <a href="https://doi.org/10.1021/jm8003653" title="DOI URL">https://doi.org/10.1021/jm8003653</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm8003653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm8003653%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B2-Chloro-N-%2525284-methoxyphenyl%252529-N-methylquinazolin-4-amine%252B%252528EP128265%25252C%252BMPI-0441138%252529%252Bas%252Ba%252BPotent%252BInducer%252Bof%252BApoptosis%252Bwith%252BHigh%252BIn%252BVivo%252BActivity%26aulast%3DSirisoma%26aufirst%3DNilantha%26date%3D2008%26date%3D2008%26date%3D2008%26date%3D14%252008%25202008%26date%3D24%252007%25202008%26date%3D31%252003%25202008%26volume%3D51%26issue%3D15%26spage%3D4771%26epage%3D4779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Serena  Ferrini,,   Fabio  Ponticelli, and,   <span class="NLM_string-name hlFld-ContribAuthor">Maurizio  Taddei</span>. </span><span class="cited-content_cbyCitation_article-title">Convenient Synthetic Approach to 2,4-Disubstituted Quinazolines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2007,</strong> <em>9 </em>
                                    (1)
                                     , 69-72. <a href="https://doi.org/10.1021/ol062540s" title="DOI URL">https://doi.org/10.1021/ol062540s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol062540s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol062540s%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DConvenient%252BSynthetic%252BApproach%252Bto%252B2%25252C4-Disubstituted%252BQuinazolines%26aulast%3DFerrini%26aufirst%3DSerena%26date%3D2007%26date%3D2006%26date%3D2006%26date%3D16%252010%25202006%2520Received%2520October%252016%252C%25202006%26volume%3D9%26issue%3D1%26spage%3D69%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher J.  Matheson</span>, <span class="hlFld-ContribAuthor ">Christopher R.  Coxon</span>, <span class="hlFld-ContribAuthor ">Richard  Bayliss</span>, <span class="hlFld-ContribAuthor ">Kathy  Boxall</span>, <span class="hlFld-ContribAuthor ">Benoit  Carbain</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Fry</span>, <span class="hlFld-ContribAuthor ">Ian R.  Hardcastle</span>, <span class="hlFld-ContribAuthor ">Suzannah J.  Harnor</span>, <span class="hlFld-ContribAuthor ">Corine  Mas-Droux</span>, <span class="hlFld-ContribAuthor ">David R.  Newell</span>, <span class="hlFld-ContribAuthor ">Mark W.  Richards</span>, <span class="hlFld-ContribAuthor ">Mangaleswaran  Sivaprakasam</span>, <span class="hlFld-ContribAuthor ">David  Turner</span>, <span class="hlFld-ContribAuthor ">Roger J.  Griffin</span>, <span class="hlFld-ContribAuthor ">Bernard T.  Golding</span>, <span class="hlFld-ContribAuthor ">Céline  Cano</span>. </span><span class="cited-content_cbyCitation_article-title">2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (6)
                                     , 707-731. <a href="https://doi.org/10.1039/D0MD00074D" title="DOI URL">https://doi.org/10.1039/D0MD00074D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00074D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00074D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3D2-Arylamino-6-ethynylpurines%252Bare%252Bcysteine-targeting%252Birreversible%252Binhibitors%252Bof%252BNek2%252Bkinase%26aulast%3DMatheson%26aufirst%3DChristopher%2BJ.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D6%26spage%3D707%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed  Monier</span>, <span class="hlFld-ContribAuthor ">Doaa  Abdel-Latif</span>, <span class="hlFld-ContribAuthor ">Ahmed  El-Mekabaty</span>, <span class="hlFld-ContribAuthor ">Başak D.  Mert</span>, <span class="hlFld-ContribAuthor ">Khaled M.  Elattar</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the Chemistry of 6-6 Bicyclic Systems: Chemistry of Pyrido[3,4- d]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Current Organic Synthesis</span><span> <strong>2019,</strong> <em>16 </em>
                                    (6)
                                     , 812-854. <a href="https://doi.org/10.2174/1570179416666190704113647" title="DOI URL">https://doi.org/10.2174/1570179416666190704113647</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570179416666190704113647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570179416666190704113647%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Organic%2520Synthesis%26atitle%3DAdvances%252Bin%252Bthe%252BChemistry%252Bof%252B6-6%252BBicyclic%252BSystems%25253A%252BChemistry%252Bof%252BPyrido%25255B3%25252C4-%252Bd%25255Dpyrimidines%26aulast%3DMonier%26aufirst%3DMohamed%26date%3D2019%26volume%3D16%26issue%3D6%26spage%3D812%26epage%3D854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abida  Ashraf</span>, <span class="hlFld-ContribAuthor ">Muhammad  Khalid</span>, <span class="hlFld-ContribAuthor ">Muhammad Nawaz  Tahir</span>, <span class="hlFld-ContribAuthor ">Muhammad  Yaqub</span>, <span class="hlFld-ContribAuthor ">Muhammad Moazzam  Naseer</span>, <span class="hlFld-ContribAuthor ">Ghulam Mustafa  Kamal</span>, <span class="hlFld-ContribAuthor ">Bullo  Saifullah</span>, <span class="hlFld-ContribAuthor ">Ataualpa Albert Carmo  Braga</span>, <span class="hlFld-ContribAuthor ">Zahid  Shafiq</span>, <span class="hlFld-ContribAuthor ">Waqar  Rauf</span>. </span><span class="cited-content_cbyCitation_article-title">A facile and concise route to (hydroxybenzoyl)pyrido[2,3-
              d
              ]pyrimidine heterocycle derivatives: synthesis, and structural, spectral and computational exploration. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2019,</strong> <em>9 </em>
                                    (59)
                                     , 34567-34580. <a href="https://doi.org/10.1039/C9RA05415D" title="DOI URL">https://doi.org/10.1039/C9RA05415D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9RA05415D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9RA05415D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DA%252Bfacile%252Band%252Bconcise%252Broute%252Bto%252B%252528hydroxybenzoyl%252529pyrido%25255B2%25252C3-%252Bd%252B%25255Dpyrimidine%252Bheterocycle%252Bderivatives%25253A%252Bsynthesis%25252C%252Band%252Bstructural%25252C%252Bspectral%252Band%252Bcomputational%252Bexploration%26aulast%3DAshraf%26aufirst%3DAbida%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D59%26spage%3D34567%26epage%3D34580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wendy A.  Loughlin</span>, <span class="hlFld-ContribAuthor ">Asmaa  Boufridi</span>. </span><span class="cited-content_cbyCitation_article-title">6-6 Bicyclic Systems: Three Heteroatoms 1:2. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.14794-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.14794-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.14794-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.14794-8%26sid%3Dliteratum%253Aachs%26atitle%3D6-6%252BBicyclic%252BSystems%25253A%252BThree%252BHeteroatoms%252B1%25253A2%26aulast%3DLoughlin%26aufirst%3DWendy%2BA.%26date%3D2019%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wensheng  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaofeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Ma</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">One-pot synthesis of dihydroquinazolinethione-based polycyclic system. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2018,</strong> <em>59 </em>
                                    (43)
                                     , 3845-3847. <a href="https://doi.org/10.1016/j.tetlet.2018.09.023" title="DOI URL">https://doi.org/10.1016/j.tetlet.2018.09.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2018.09.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2018.09.023%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DOne-pot%252Bsynthesis%252Bof%252Bdihydroquinazolinethione-based%252Bpolycyclic%252Bsystem%26aulast%3DZhang%26aufirst%3DWensheng%26date%3D2018%26volume%3D59%26issue%3D43%26spage%3D3845%26epage%3D3847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Xu</span>, <span class="hlFld-ContribAuthor ">Jon  Cuccui</span>, <span class="hlFld-ContribAuthor ">Carmen  Denman</span>, <span class="hlFld-ContribAuthor ">Tripty  Maharjan</span>, <span class="hlFld-ContribAuthor ">Brendan W.  Wren</span>, <span class="hlFld-ContribAuthor ">Gerd K.  Wagner</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationships in a new class of non-substrate-like covalent inhibitors of the bacterial glycosyltransferase LgtC. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (11)
                                     , 2973-2983. <a href="https://doi.org/10.1016/j.bmc.2018.03.006" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.03.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.03.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStructure-activity%252Brelationships%252Bin%252Ba%252Bnew%252Bclass%252Bof%252Bnon-substrate-like%252Bcovalent%252Binhibitors%252Bof%252Bthe%252Bbacterial%252Bglycosyltransferase%252BLgtC%26aulast%3DXu%26aufirst%3DYong%26date%3D2018%26volume%3D26%26issue%3D11%26spage%3D2973%26epage%3D2983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Jin</span>, <span class="hlFld-ContribAuthor ">Hu-Guang  Dan</span>, <span class="hlFld-ContribAuthor ">Guo-Wu  Rao</span>. </span><span class="cited-content_cbyCitation_article-title">Research progress in quinazoline derivatives as multi-target tyrosine kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Heterocyclic Communications</span><span> <strong>2018,</strong> <em>24 </em>
                                    (1)
                                     , 1-10. <a href="https://doi.org/10.1515/hc-2017-0066" title="DOI URL">https://doi.org/10.1515/hc-2017-0066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/hc-2017-0066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fhc-2017-0066%26sid%3Dliteratum%253Aachs%26jtitle%3DHeterocyclic%2520Communications%26atitle%3DResearch%252Bprogress%252Bin%252Bquinazoline%252Bderivatives%252Bas%252Bmulti-target%252Btyrosine%252Bkinase%252Binhibitors%26aulast%3DJin%26aufirst%3DHao%26date%3D2018%26volume%3D24%26issue%3D1%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matam  Sivakumar</span>, <span class="hlFld-ContribAuthor ">Kaliyan  Prabakaran</span>, <span class="hlFld-ContribAuthor ">Muthu  Seenivasa Perumal</span>. </span><span class="cited-content_cbyCitation_article-title">Base-mediated one-pot synthesis of 3,4,5,6-tetrahydro-4-substituted benzo[
              h
              ]quinazoline-2(1
              H
              )-thione derivatives and evaluation of their antioxidant activity. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2018,</strong> <em>48 </em>
                                    (2)
                                     , 197-207. <a href="https://doi.org/10.1080/00397911.2017.1393688" title="DOI URL">https://doi.org/10.1080/00397911.2017.1393688</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2017.1393688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2017.1393688%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DBase-mediated%252Bone-pot%252Bsynthesis%252Bof%252B3%25252C4%25252C5%25252C6-tetrahydro-4-substituted%252Bbenzo%25255B%252Bh%252B%25255Dquinazoline-2%2525281%252BH%252B%252529-thione%252Bderivatives%252Band%252Bevaluation%252Bof%252Btheir%252Bantioxidant%252Bactivity%26aulast%3DSivakumar%26aufirst%3DMatam%26date%3D2018%26date%3D2017%26volume%3D48%26issue%3D2%26spage%3D197%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D.  Qu</span>, <span class="hlFld-ContribAuthor ">A.  Yan</span>, <span class="hlFld-ContribAuthor ">J. S.  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">SAR and QSAR study on the bioactivities of human epidermal growth factor receptor-2 (HER2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2017,</strong> <em>28 </em>
                                    (2)
                                     , 111-132. <a href="https://doi.org/10.1080/1062936X.2017.1284898" title="DOI URL">https://doi.org/10.1080/1062936X.2017.1284898</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2017.1284898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2017.1284898%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DSAR%252Band%252BQSAR%252Bstudy%252Bon%252Bthe%252Bbioactivities%252Bof%252Bhuman%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor-2%252B%252528HER2%252529%252Binhibitors%26aulast%3DQu%26aufirst%3DD.%26date%3D2017%26date%3D2017%26volume%3D28%26issue%3D2%26spage%3D111%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kovuru  Gopalaiah</span>, <span class="hlFld-ContribAuthor ">Anupama  Saini</span>, <span class="hlFld-ContribAuthor ">Alka  Devi</span>. </span><span class="cited-content_cbyCitation_article-title">Iron-catalyzed cascade reaction of 2-aminobenzyl alcohols with benzylamines: synthesis of quinazolines by trapping of ammonia. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2017,</strong> <em>15 </em>
                                    (27)
                                     , 5781-5789. <a href="https://doi.org/10.1039/C7OB01159H" title="DOI URL">https://doi.org/10.1039/C7OB01159H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB01159H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB01159H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DIron-catalyzed%252Bcascade%252Breaction%252Bof%252B2-aminobenzyl%252Balcohols%252Bwith%252Bbenzylamines%25253A%252Bsynthesis%252Bof%252Bquinazolines%252Bby%252Btrapping%252Bof%252Bammonia%26aulast%3DGopalaiah%26aufirst%3DKovuru%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D27%26spage%3D5781%26epage%3D5789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dhrubajyoti  Gogoi</span>, <span class="hlFld-ContribAuthor ">Vishwa Jyoti  Baruah</span>, <span class="hlFld-ContribAuthor ">Amrita Kashyap  Chaliha</span>, <span class="hlFld-ContribAuthor ">Bibhuti Bhushan  Kakoti</span>, <span class="hlFld-ContribAuthor ">Diganta  Sarma</span>, <span class="hlFld-ContribAuthor ">Alak Kumar  Buragohain</span>. </span><span class="cited-content_cbyCitation_article-title">3D pharmacophore-based virtual screening, docking and density functional theory approach towards the discovery of novel human epidermal growth factor receptor-2 (HER2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Theoretical Biology</span><span> <strong>2016,</strong> <em>411 </em>, 68-80. <a href="https://doi.org/10.1016/j.jtbi.2016.09.016" title="DOI URL">https://doi.org/10.1016/j.jtbi.2016.09.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jtbi.2016.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jtbi.2016.09.016%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Theoretical%2520Biology%26atitle%3D3D%252Bpharmacophore-based%252Bvirtual%252Bscreening%25252C%252Bdocking%252Band%252Bdensity%252Bfunctional%252Btheory%252Bapproach%252Btowards%252Bthe%252Bdiscovery%252Bof%252Bnovel%252Bhuman%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor-2%252B%252528HER2%252529%252Binhibitors%26aulast%3DGogoi%26aufirst%3DDhrubajyoti%26date%3D2016%26volume%3D411%26spage%3D68%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monia  Hossam</span>, <span class="hlFld-ContribAuthor ">Deena S.  Lasheen</span>, <span class="hlFld-ContribAuthor ">Khaled A. M.  Abouzid</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent EGFR Inhibitors: Binding Mechanisms, Synthetic Approaches, and Clinical Profiles. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2016,</strong> <em>349 </em>
                                    (8)
                                     , 573-593. <a href="https://doi.org/10.1002/ardp.201600063" title="DOI URL">https://doi.org/10.1002/ardp.201600063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201600063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201600063%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DCovalent%252BEGFR%252BInhibitors%25253A%252BBinding%252BMechanisms%25252C%252BSynthetic%252BApproaches%25252C%252Band%252BClinical%252BProfiles%26aulast%3DHossam%26aufirst%3DMonia%26date%3D2016%26date%3D2016%26volume%3D349%26issue%3D8%26spage%3D573%26epage%3D593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Krisna C.  Duong-Ly</span>, <span class="hlFld-ContribAuthor ">Karthik  Devarajan</span>, <span class="hlFld-ContribAuthor ">Shuguang  Liang</span>, <span class="hlFld-ContribAuthor ">Kurumi Y.  Horiuchi</span>, <span class="hlFld-ContribAuthor ">Yuren  Wang</span>, <span class="hlFld-ContribAuthor ">Haiching  Ma</span>, <span class="hlFld-ContribAuthor ">Jeffrey R.  Peterson</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitor Profiling Reveals Unexpected Opportunities to Inhibit Disease-Associated Mutant Kinases. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2016,</strong> <em>14 </em>
                                    (4)
                                     , 772-781. <a href="https://doi.org/10.1016/j.celrep.2015.12.080" title="DOI URL">https://doi.org/10.1016/j.celrep.2015.12.080</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2015.12.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2015.12.080%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DKinase%252BInhibitor%252BProfiling%252BReveals%252BUnexpected%252BOpportunities%252Bto%252BInhibit%252BDisease-Associated%252BMutant%252BKinases%26aulast%3DDuong-Ly%26aufirst%3DKrisna%2BC.%26date%3D2016%26volume%3D14%26issue%3D4%26spage%3D772%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yonghai  Song</span>, <span class="hlFld-ContribAuthor ">Dandan  Zhong</span>, <span class="hlFld-ContribAuthor ">Jinhui  Luo</span>, <span class="hlFld-ContribAuthor ">Hongliang  Tan</span>, <span class="hlFld-ContribAuthor ">Shouhui  Chen</span>, <span class="hlFld-ContribAuthor ">Ping  Li</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Tao  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Binding characteristics and interactive region of 2-phenylpyrazolo[1,5-
              c
              ]quinazoline with DNA. </span><span class="cited-content_cbyCitation_journal-name">Luminescence</span><span> <strong>2014,</strong> <em>29 </em>
                                    (8)
                                     , 1141-1147. <a href="https://doi.org/10.1002/bio.2674" title="DOI URL">https://doi.org/10.1002/bio.2674</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bio.2674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbio.2674%26sid%3Dliteratum%253Aachs%26jtitle%3DLuminescence%26atitle%3DBinding%252Bcharacteristics%252Band%252Binteractive%252Bregion%252Bof%252B2-phenylpyrazolo%25255B1%25252C5-%252Bc%252B%25255Dquinazoline%252Bwith%252BDNA%26aulast%3DSong%26aufirst%3DYonghai%26date%3D2014%26date%3D2014%26volume%3D29%26issue%3D8%26spage%3D1141%26epage%3D1147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiu L.  Yang</span>, <span class="hlFld-ContribAuthor ">Tian C.  Wang</span>, <span class="hlFld-ContribAuthor ">Sen  Lin</span>, <span class="hlFld-ContribAuthor ">Hou X.  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Irreversible Inhibitors of the Epidermal Growth Factor Receptor: Thienopyrimidine Core with α,β-Unsaturated Amide Side Chain. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2014,</strong> <em>347 </em>
                                    (8)
                                     , 552-558. <a href="https://doi.org/10.1002/ardp.201400098" title="DOI URL">https://doi.org/10.1002/ardp.201400098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201400098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201400098%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DIrreversible%252BInhibitors%252Bof%252Bthe%252BEpidermal%252BGrowth%252BFactor%252BReceptor%25253A%252BThienopyrimidine%252BCore%252Bwith%252B%2525CE%2525B1%25252C%2525CE%2525B2-Unsaturated%252BAmide%252BSide%252BChain%26aulast%3DYang%26aufirst%3DXiu%2BL.%26date%3D2014%26date%3D2014%26volume%3D347%26issue%3D8%26spage%3D552%26epage%3D558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anshu  Rajawat</span>, <span class="hlFld-ContribAuthor ">Sarita  Khandelwal</span>, <span class="hlFld-ContribAuthor ">Mahendra  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient and environmentally benign synthetic protocol for the synthesis of structurally diverse annulated pyridopyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry Letters and Reviews</span><span> <strong>2014,</strong> <em>7 </em>
                                    (1)
                                     , 37-45. <a href="https://doi.org/10.1080/17518253.2014.895057" title="DOI URL">https://doi.org/10.1080/17518253.2014.895057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17518253.2014.895057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17518253.2014.895057%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%2520Letters%2520and%2520Reviews%26atitle%3DEfficient%252Band%252Benvironmentally%252Bbenign%252Bsynthetic%252Bprotocol%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bstructurally%252Bdiverse%252Bannulated%252Bpyridopyrimidines%26aulast%3DRajawat%26aufirst%3DAnshu%26date%3D2014%26date%3D2014%26volume%3D7%26issue%3D1%26spage%3D37%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicole  Forster</span>, <span class="hlFld-ContribAuthor ">Srinivas Vinod  Saladi</span>, <span class="hlFld-ContribAuthor ">Maaike  van Bragt</span>, <span class="hlFld-ContribAuthor ">Mary E.  Sfondouris</span>, <span class="hlFld-ContribAuthor ">Frank E.  Jones</span>, <span class="hlFld-ContribAuthor ">Zhe  Li</span>, <span class="hlFld-ContribAuthor ">Leif W.  Ellisen</span>. </span><span class="cited-content_cbyCitation_article-title">Basal Cell Signaling by p63 Controls Luminal Progenitor Function and Lactation via NRG1. </span><span class="cited-content_cbyCitation_journal-name">Developmental Cell</span><span> <strong>2014,</strong> <em>28 </em>
                                    (2)
                                     , 147-160. <a href="https://doi.org/10.1016/j.devcel.2013.11.019" title="DOI URL">https://doi.org/10.1016/j.devcel.2013.11.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.devcel.2013.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.devcel.2013.11.019%26sid%3Dliteratum%253Aachs%26jtitle%3DDevelopmental%2520Cell%26atitle%3DBasal%252BCell%252BSignaling%252Bby%252Bp63%252BControls%252BLuminal%252BProgenitor%252BFunction%252Band%252BLactation%252Bvia%252BNRG1%26aulast%3DForster%26aufirst%3DNicole%26date%3D2014%26volume%3D28%26issue%3D2%26spage%3D147%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dan  Wang</span>, <span class="hlFld-ContribAuthor ">Feng  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Quinazoline derivatives: synthesis and bioactivities. </span><span class="cited-content_cbyCitation_journal-name">Chemistry Central Journal</span><span> <strong>2013,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/1752-153X-7-95" title="DOI URL">https://doi.org/10.1186/1752-153X-7-95</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/1752-153X-7-95&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2F1752-153X-7-95%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520Central%2520Journal%26atitle%3DQuinazoline%252Bderivatives%25253A%252Bsynthesis%252Band%252Bbioactivities%26aulast%3DWang%26aufirst%3DDan%26date%3D2013%26date%3D2013%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S  Nijmeijer</span>, <span class="hlFld-ContribAuthor ">H  Engelhardt</span>, <span class="hlFld-ContribAuthor ">S  Schultes</span>, <span class="hlFld-ContribAuthor ">A C  van de Stolpe</span>, <span class="hlFld-ContribAuthor ">V  Lusink</span>, <span class="hlFld-ContribAuthor ">C  de Graaf</span>, <span class="hlFld-ContribAuthor ">M  Wijtmans</span>, <span class="hlFld-ContribAuthor ">E E J  Haaksma</span>, <span class="hlFld-ContribAuthor ">I J P  de Esch</span>, <span class="hlFld-ContribAuthor ">K  Stachurski</span>, <span class="hlFld-ContribAuthor ">H F  Vischer</span>, <span class="hlFld-ContribAuthor ">R  Leurs</span>. </span><span class="cited-content_cbyCitation_article-title">Design and pharmacological characterization of VUF14480, a covalent partial agonist that interacts with cysteine 98
              3.36
              of the human histamine H
              4
              receptor. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2013,</strong> <em>170 </em>
                                    (1)
                                     , 89-100. <a href="https://doi.org/10.1111/bph.12113" title="DOI URL">https://doi.org/10.1111/bph.12113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.12113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.12113%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DDesign%252Band%252Bpharmacological%252Bcharacterization%252Bof%252BVUF14480%25252C%252Ba%252Bcovalent%252Bpartial%252Bagonist%252Bthat%252Binteracts%252Bwith%252Bcysteine%252B98%252B3.36%252Bof%252Bthe%252Bhuman%252Bhistamine%252BH%252B4%252Breceptor%26aulast%3DNijmeijer%26aufirst%3DS%26date%3D2013%26date%3D2013%26volume%3D170%26issue%3D1%26spage%3D89%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jemin R.  Avalani</span>, <span class="hlFld-ContribAuthor ">Devji S.  Patel</span>, <span class="hlFld-ContribAuthor ">Dipak K.  Raval</span>. </span><span class="cited-content_cbyCitation_article-title">Saccharomyces cerevisiae catalyzed one pot synthesis of isoindolo[2,1-a]quinazoline performed under ultrasonication. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Catalysis B: Enzymatic</span><span> <strong>2013,</strong> <em>90 </em>, 70-75. <a href="https://doi.org/10.1016/j.molcatb.2013.01.024" title="DOI URL">https://doi.org/10.1016/j.molcatb.2013.01.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molcatb.2013.01.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molcatb.2013.01.024%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Catalysis%2520B%253A%2520Enzymatic%26atitle%3DSaccharomyces%252Bcerevisiae%252Bcatalyzed%252Bone%252Bpot%252Bsynthesis%252Bof%252Bisoindolo%25255B2%25252C1-a%25255Dquinazoline%252Bperformed%252Bunder%252Bultrasonication%26aulast%3DAvalani%26aufirst%3DJemin%2BR.%26date%3D2013%26volume%3D90%26spage%3D70%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinsheng  Lin</span>, <span class="hlFld-ContribAuthor ">Wei  Shen</span>, <span class="hlFld-ContribAuthor ">Jingwei  Xue</span>, <span class="hlFld-ContribAuthor ">Juan  Sun</span>, <span class="hlFld-ContribAuthor ">Xue  Zhang</span>, <span class="hlFld-ContribAuthor ">Can  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Novel oxazolo[4,5-g]quinazolin-2(1H)-ones: Dual inhibitors of EGFR and Src protein tyrosine kinases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>, 39-48. <a href="https://doi.org/10.1016/j.ejmech.2012.06.055" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.06.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.06.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.06.055%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Boxazolo%25255B4%25252C5-g%25255Dquinazolin-2%2525281H%252529-ones%25253A%252BDual%252Binhibitors%252Bof%252BEGFR%252Band%252BSrc%252Bprotein%252Btyrosine%252Bkinases%26aulast%3DLin%26aufirst%3DJinsheng%26date%3D2012%26volume%3D55%26spage%3D39%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Madhav  Bandaru</span>, <span class="hlFld-ContribAuthor ">Narayana Murthy  Sabbavarapu</span>, <span class="hlFld-ContribAuthor ">Anil Kumar Bandam Santosh  Pavan</span>, <span class="hlFld-ContribAuthor ">Ashwan Kumar  Akula</span>, <span class="hlFld-ContribAuthor ">Nageswar Yadavalli Venkata  Durga</span>. </span><span class="cited-content_cbyCitation_article-title">Simple and straight forward synthesis of 2,4-disubstituted quinazolines in aqueous medium. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Chemistry</span><span> <strong>2012,</strong> <em>3 </em>
                                    (2)
                                     , 252-257. <a href="https://doi.org/10.5155/eurjchem.3.2.252-257.527" title="DOI URL">https://doi.org/10.5155/eurjchem.3.2.252-257.527</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5155/eurjchem.3.2.252-257.527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5155%2Feurjchem.3.2.252-257.527%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Chemistry%26atitle%3DSimple%252Band%252Bstraight%252Bforward%252Bsynthesis%252Bof%252B2%25252C4-disubstituted%252Bquinazolines%252Bin%252Baqueous%252Bmedium%26aulast%3DBandaru%26aufirst%3DMadhav%26date%3D2012%26date%3D2012%26volume%3D3%26issue%3D2%26spage%3D252%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yassine  Riadi</span>, <span class="hlFld-ContribAuthor ">Stephane  Massip</span>, <span class="hlFld-ContribAuthor ">Jean-Michel  Leger</span>, <span class="hlFld-ContribAuthor ">Christian  Jarry</span>, <span class="hlFld-ContribAuthor ">Saïd  Lazar</span>, <span class="hlFld-ContribAuthor ">Gérald  Guillaumet</span>. </span><span class="cited-content_cbyCitation_article-title">Convenient synthesis of 2,4-disubstituted pyrido[2,3-d]pyrimidines via regioselective palladium-catalyzed reactions. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2012,</strong> <em>68 </em>
                                    (25)
                                     , 5018-5024. <a href="https://doi.org/10.1016/j.tet.2012.04.051" title="DOI URL">https://doi.org/10.1016/j.tet.2012.04.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2012.04.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2012.04.051%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DConvenient%252Bsynthesis%252Bof%252B2%25252C4-disubstituted%252Bpyrido%25255B2%25252C3-d%25255Dpyrimidines%252Bvia%252Bregioselective%252Bpalladium-catalyzed%252Breactions%26aulast%3DRiadi%26aufirst%3DYassine%26date%3D2012%26volume%3D68%26issue%3D25%26spage%3D5018%26epage%3D5024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siyuan  Li</span>, <span class="hlFld-ContribAuthor ">Chunying  Guo</span>, <span class="hlFld-ContribAuthor ">Xianqiang  Sun</span>, <span class="hlFld-ContribAuthor ">Yaozong  Li</span>, <span class="hlFld-ContribAuthor ">Hongli  Zhao</span>, <span class="hlFld-ContribAuthor ">Dongmei  Zhan</span>, <span class="hlFld-ContribAuthor ">Minbo  Lan</span>, <span class="hlFld-ContribAuthor ">Yun  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of quinazoline and quinoline bearing 2,2,6,6-tetramethylpiperidine-N-oxyl as potential epidermal growth factor receptor(EGFR) tyrosine kinase inhibitors and EPR bio-probe agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>49 </em>, 271-278. <a href="https://doi.org/10.1016/j.ejmech.2012.01.021" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.01.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.01.021%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bquinazoline%252Band%252Bquinoline%252Bbearing%252B2%25252C2%25252C6%25252C6-tetramethylpiperidine-N-oxyl%252Bas%252Bpotential%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%252528EGFR%252529%252Btyrosine%252Bkinase%252Binhibitors%252Band%252BEPR%252Bbio-probe%252Bagents%26aulast%3DLi%26aufirst%3DSiyuan%26date%3D2012%26volume%3D49%26spage%3D271%26epage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephan  Heermann</span>, <span class="hlFld-ContribAuthor ">Julia  Schmücker</span>, <span class="hlFld-ContribAuthor ">Ursula  Hinz</span>, <span class="hlFld-ContribAuthor ">Michael  Rickmann</span>, <span class="hlFld-ContribAuthor ">Tilmann  Unterbarnscheidt</span>, <span class="hlFld-ContribAuthor ">Markus H.  Schwab</span>, <span class="hlFld-ContribAuthor ">Kerstin  Krieglstein</span>, . </span><span class="cited-content_cbyCitation_article-title">Neuregulin 1 Type III/ErbB Signaling Is Crucial for Schwann Cell Colonization of Sympathetic Axons. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2011,</strong> <em>6 </em>
                                    (12)
                                     , e28692. <a href="https://doi.org/10.1371/journal.pone.0028692" title="DOI URL">https://doi.org/10.1371/journal.pone.0028692</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0028692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0028692%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DNeuregulin%252B1%252BType%252BIII%25252FErbB%252BSignaling%252BIs%252BCrucial%252Bfor%252BSchwann%252BCell%252BColonization%252Bof%252BSympathetic%252BAxons%26aulast%3DHeermann%26aufirst%3DStephan%26date%3D2011%26date%3D2011%26volume%3D6%26issue%3D12%26spage%3De28692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Galyna G.  Berest</span>, <span class="hlFld-ContribAuthor ">Olexii Yu.  Voskoboynik</span>, <span class="hlFld-ContribAuthor ">Sergiy I.  Kovalenko</span>, <span class="hlFld-ContribAuthor ">Olexii M.  Antypenko</span>, <span class="hlFld-ContribAuthor ">Inna S.  Nosulenko</span>, <span class="hlFld-ContribAuthor ">Andrii M.  Katsev</span>, <span class="hlFld-ContribAuthor ">Olena S.  Shandrovskaya</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological activity of novel N-cycloalkyl-(cycloalkylaryl)-2-[(3-R-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamides. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>46 </em>
                                    (12)
                                     , 6066-6074. <a href="https://doi.org/10.1016/j.ejmech.2011.10.022" title="DOI URL">https://doi.org/10.1016/j.ejmech.2011.10.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2011.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2011.10.022%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bactivity%252Bof%252Bnovel%252BN-cycloalkyl-%252528cycloalkylaryl%252529-2-%25255B%2525283-R-2-oxo-2H-%25255B1%25252C2%25252C4%25255Dtriazino%25255B2%25252C3-c%25255Dquinazoline-6-yl%252529thio%25255Dacetamides%26aulast%3DBerest%26aufirst%3DGalyna%2BG.%26date%3D2011%26volume%3D46%26issue%3D12%26spage%3D6066%26epage%3D6074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed Mahmoud  Alafeefy</span>. </span><span class="cited-content_cbyCitation_article-title">Some new quinazolin-4(3H)-one derivatives, synthesis and antitumor activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Saudi Chemical Society</span><span> <strong>2011,</strong> <em>15 </em>
                                    (4)
                                     , 337-343. <a href="https://doi.org/10.1016/j.jscs.2011.06.019" title="DOI URL">https://doi.org/10.1016/j.jscs.2011.06.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jscs.2011.06.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jscs.2011.06.019%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Saudi%2520Chemical%2520Society%26atitle%3DSome%252Bnew%252Bquinazolin-4%2525283H%252529-one%252Bderivatives%25252C%252Bsynthesis%252Band%252Bantitumor%252Bactivity%26aulast%3DAlafeefy%26aufirst%3DAhmed%2BMahmoud%26date%3D2011%26volume%3D15%26issue%3D4%26spage%3D337%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Malleshappa N.  Noolvi</span>, <span class="hlFld-ContribAuthor ">Harun M.  Patel</span>, <span class="hlFld-ContribAuthor ">Varun  Bhardwaj</span>, <span class="hlFld-ContribAuthor ">Ankit  Chauhan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: Search for anticancer agent. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>46 </em>
                                    (6)
                                     , 2327-2346. <a href="https://doi.org/10.1016/j.ejmech.2011.03.015" title="DOI URL">https://doi.org/10.1016/j.ejmech.2011.03.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2011.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2011.03.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bin%252Bvitro%252Bantitumor%252Bactivity%252Bof%252Bsubstituted%252Bquinazoline%252Band%252Bquinoxaline%252Bderivatives%25253A%252BSearch%252Bfor%252Banticancer%252Bagent%26aulast%3DNoolvi%26aufirst%3DMalleshappa%2BN.%26date%3D2011%26volume%3D46%26issue%3D6%26spage%3D2327%26epage%3D2346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Watanabe</span>, <span class="hlFld-ContribAuthor ">M.  Misawa</span>, <span class="hlFld-ContribAuthor ">T.  Matsuzaki</span>, <span class="hlFld-ContribAuthor ">T.  Sakurai</span>, <span class="hlFld-ContribAuthor ">T.  Muramatsu</span>, <span class="hlFld-ContribAuthor ">M.  Sato</span>. </span><span class="cited-content_cbyCitation_article-title">A novel glycosylation signal regulates transforming growth factor   receptors as evidenced by endo- -galactosidase C expression in rodent cells. </span><span class="cited-content_cbyCitation_journal-name">Glycobiology</span><span> <strong>2011,</strong> <em>21 </em>
                                    (4)
                                     , 482-492. <a href="https://doi.org/10.1093/glycob/cwq186" title="DOI URL">https://doi.org/10.1093/glycob/cwq186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/glycob/cwq186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fglycob%2Fcwq186%26sid%3Dliteratum%253Aachs%26jtitle%3DGlycobiology%26atitle%3DA%252Bnovel%252Bglycosylation%252Bsignal%252Bregulates%252Btransforming%252Bgrowth%252Bfactor%252B%2525C2%2525A0%252Breceptors%252Bas%252Bevidenced%252Bby%252Bendo-%2525C2%2525A0-galactosidase%252BC%252Bexpression%252Bin%252Brodent%252Bcells%26aulast%3DWatanabe%26aufirst%3DS.%26date%3D2011%26date%3D2010%26volume%3D21%26issue%3D4%26spage%3D482%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wonseon  Choi</span>, <span class="hlFld-ContribAuthor ">Rainer  Wolber</span>, <span class="hlFld-ContribAuthor ">Wolfram  Gerwat</span>, <span class="hlFld-ContribAuthor ">Tobias  Mann</span>, <span class="hlFld-ContribAuthor ">Jan  Batzer</span>, <span class="hlFld-ContribAuthor ">Christoph  Smuda</span>, <span class="hlFld-ContribAuthor ">Hongfang  Liu</span>, <span class="hlFld-ContribAuthor ">Ludger  Kolbe</span>, <span class="hlFld-ContribAuthor ">Vincent J.  Hearing</span>. </span><span class="cited-content_cbyCitation_article-title">The fibroblast-derived paracrine factor neuregulin-1 has a novel role in regulating the constitutive color and melanocyte function in human skin. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cell Science</span><span> <strong>2010,</strong> <em>123 </em>
                                    (18)
                                     , 3102-3111. <a href="https://doi.org/10.1242/jcs.064774" title="DOI URL">https://doi.org/10.1242/jcs.064774</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1242/jcs.064774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1242%2Fjcs.064774%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cell%2520Science%26atitle%3DThe%252Bfibroblast-derived%252Bparacrine%252Bfactor%252Bneuregulin-1%252Bhas%252Ba%252Bnovel%252Brole%252Bin%252Bregulating%252Bthe%252Bconstitutive%252Bcolor%252Band%252Bmelanocyte%252Bfunction%252Bin%252Bhuman%252Bskin%26aulast%3DChoi%26aufirst%3DWonseon%26date%3D2010%26volume%3D123%26issue%3D18%26spage%3D3102%26epage%3D3111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philip  Jessmon</span>, <span class="hlFld-ContribAuthor ">Brian A.  Kilburn</span>, <span class="hlFld-ContribAuthor ">Roberto  Romero</span>, <span class="hlFld-ContribAuthor ">Richard E.  Leach</span>, <span class="hlFld-ContribAuthor ">D. Randall  Armant</span>. </span><span class="cited-content_cbyCitation_article-title">Function-Specific Intracellular Signaling Pathways Downstream of Heparin-Binding EGF-Like Growth Factor Utilized by Human Trophoblasts1. </span><span class="cited-content_cbyCitation_journal-name">Biology of Reproduction</span><span> <strong>2010,</strong> <em>82 </em>
                                    (5)
                                     , 921-929. <a href="https://doi.org/10.1095/biolreprod.109.082305" title="DOI URL">https://doi.org/10.1095/biolreprod.109.082305</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1095/biolreprod.109.082305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1095%2Fbiolreprod.109.082305%26sid%3Dliteratum%253Aachs%26jtitle%3DBiology%2520of%2520Reproduction%26atitle%3DFunction-Specific%252BIntracellular%252BSignaling%252BPathways%252BDownstream%252Bof%252BHeparin-Binding%252BEGF-Like%252BGrowth%252BFactor%252BUtilized%252Bby%252BHuman%252BTrophoblasts1%26aulast%3DJessmon%26aufirst%3DPhilip%26date%3D2010%26volume%3D82%26issue%3D5%26spage%3D921%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sabine  Amslinger</span>. </span><span class="cited-content_cbyCitation_article-title">The Tunable Functionality of α,β-Unsaturated Carbonyl Compounds Enables Their Differential Application in Biological Systems. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2010,</strong> <em>5 </em>
                                    (3)
                                     , 351-356. <a href="https://doi.org/10.1002/cmdc.200900499" title="DOI URL">https://doi.org/10.1002/cmdc.200900499</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.200900499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.200900499%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DThe%252BTunable%252BFunctionality%252Bof%252B%2525CE%2525B1%25252C%2525CE%2525B2-Unsaturated%252BCarbonyl%252BCompounds%252BEnables%252BTheir%252BDifferential%252BApplication%252Bin%252BBiological%252BSystems%26aulast%3DAmslinger%26aufirst%3DSabine%26date%3D2010%26date%3D2010%26volume%3D5%26issue%3D3%26spage%3D351%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C. Uma  Maheswari</span>, <span class="hlFld-ContribAuthor ">G. Sathish  Kumar</span>, <span class="hlFld-ContribAuthor ">M.  Venkateshwar</span>, <span class="hlFld-ContribAuthor ">R. Arun  Kumar</span>, <span class="hlFld-ContribAuthor ">M. Lakshmi  Kantam</span>, <span class="hlFld-ContribAuthor ">K. Rajender  Reddy</span>. </span><span class="cited-content_cbyCitation_article-title">Highly Efficient One-Pot Synthesis of 2-Substituted Quinazolines and 4
              H
              -Benzo[
              d
              ][1,3]oxazines
              via
              Cross Dehydrogenative Coupling using Sodium Hypochlorite. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2010,</strong> <em>352 </em>
                                    (2-3)
                                     , 341-346. <a href="https://doi.org/10.1002/adsc.200900715" title="DOI URL">https://doi.org/10.1002/adsc.200900715</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.200900715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.200900715%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DHighly%252BEfficient%252BOne-Pot%252BSynthesis%252Bof%252B2-Substituted%252BQuinazolines%252Band%252B4%252BH%252B-Benzo%25255B%252Bd%252B%25255D%25255B1%25252C3%25255Doxazines%252Bvia%252BCross%252BDehydrogenative%252BCoupling%252Busing%252BSodium%252BHypochlorite%26aulast%3DMaheswari%26aufirst%3DC.%2BUma%26date%3D2010%26volume%3D352%26issue%3D2-3%26spage%3D341%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lijiu  Gao</span>, <span class="hlFld-ContribAuthor ">Honglou  Ji</span>, <span class="hlFld-ContribAuthor ">Liangce  Rong</span>, <span class="hlFld-ContribAuthor ">Hongxia  Han</span>, <span class="hlFld-ContribAuthor ">Yanhui  Shi</span>, <span class="hlFld-ContribAuthor ">Shujiang  Tu</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient synthesis of 5,6-dihydrobenzo[
              h
              ]quinazoline derivatives under solvent-free conditions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2010,</strong> <em>49 </em>, NA-NA. <a href="https://doi.org/10.1002/jhet.318" title="DOI URL">https://doi.org/10.1002/jhet.318</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.318%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DAn%252Befficient%252Bsynthesis%252Bof%252B5%25252C6-dihydrobenzo%25255B%252Bh%252B%25255Dquinazoline%252Bderivatives%252Bunder%252Bsolvent-free%252Bconditions%26aulast%3DGao%26aufirst%3DLijiu%26date%3D2010%26volume%3D49%26spage%3DNA%26epage%3DNA" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hamid Reza  Shaterian</span>, <span class="hlFld-ContribAuthor ">Ali Reza  Oveisi</span>. </span><span class="cited-content_cbyCitation_article-title">PPA-SiO
              2
              as a Heterogeneous Catalyst for Efficient Synthesis of 2-Substituted-1,2,3,4-tetrahydro-4-quinazolinones under Solvent-free Conditions. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2009,</strong> <em>27 </em>
                                    (12)
                                     , 2418-2422. <a href="https://doi.org/10.1002/cjoc.201090018" title="DOI URL">https://doi.org/10.1002/cjoc.201090018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.201090018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.201090018%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DPPA-SiO%252B2%252Bas%252Ba%252BHeterogeneous%252BCatalyst%252Bfor%252BEfficient%252BSynthesis%252Bof%252B2-Substituted-1%25252C2%25252C3%25252C4-tetrahydro-4-quinazolinones%252Bunder%252BSolvent-free%252BConditions%26aulast%3DShaterian%26aufirst%3DHamid%2BReza%26date%3D2009%26volume%3D27%26issue%3D12%26spage%3D2418%26epage%3D2422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aiming  Sun</span>, <span class="hlFld-ContribAuthor ">Yang J.  Lu</span>, <span class="hlFld-ContribAuthor ">Haipeng  Hu</span>, <span class="hlFld-ContribAuthor ">Mamoru  Shoji</span>, <span class="hlFld-ContribAuthor ">Dennis C.  Liotta</span>, <span class="hlFld-ContribAuthor ">James P.  Snyder</span>. </span><span class="cited-content_cbyCitation_article-title">Curcumin analog cytotoxicity against breast cancer cells: exploitation of a redox-dependent mechanism. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (23)
                                     , 6627-6631. <a href="https://doi.org/10.1016/j.bmcl.2009.10.023" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.10.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.10.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.10.023%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCurcumin%252Banalog%252Bcytotoxicity%252Bagainst%252Bbreast%252Bcancer%252Bcells%25253A%252Bexploitation%252Bof%252Ba%252Bredox-dependent%252Bmechanism%26aulast%3DSun%26aufirst%3DAiming%26date%3D2009%26volume%3D19%26issue%3D23%26spage%3D6627%26epage%3D6631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Lu</span>, <span class="hlFld-ContribAuthor ">Wangze  Song</span>, <span class="hlFld-ContribAuthor ">Deng  Hong</span>, <span class="hlFld-ContribAuthor ">Ping  Lu</span>, <span class="hlFld-ContribAuthor ">Yanguang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-Catalyzed One-Pot Synthesis of 2-Alkylidene-1,2,3,4- tetrahydropyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2009,</strong> <em>351 </em>
                                    (11-12)
                                     , 1768-1772. <a href="https://doi.org/10.1002/adsc.200900260" title="DOI URL">https://doi.org/10.1002/adsc.200900260</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.200900260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.200900260%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DCopper-Catalyzed%252BOne-Pot%252BSynthesis%252Bof%252B2-Alkylidene-1%25252C2%25252C3%25252C4-%252Btetrahydropyrimidines%26aulast%3DLu%26aufirst%3DWei%26date%3D2009%26volume%3D351%26issue%3D11-12%26spage%3D1768%26epage%3D1772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon J.  Mantell</span>, <span class="hlFld-ContribAuthor ">Karl R.  Gibson</span>, <span class="hlFld-ContribAuthor ">Simon A.  Osborne</span>, <span class="hlFld-ContribAuthor ">Graham N.  Maw</span>, <span class="hlFld-ContribAuthor ">Huw  Rees</span>, <span class="hlFld-ContribAuthor ">Peter G.  Dodd</span>, <span class="hlFld-ContribAuthor ">Ben  Greener</span>, <span class="hlFld-ContribAuthor ">Gareth W.  Harbottle</span>, <span class="hlFld-ContribAuthor ">William A.  Million</span>, <span class="hlFld-ContribAuthor ">Cedric  Poinsard</span>, <span class="hlFld-ContribAuthor ">Steven  England</span>, <span class="hlFld-ContribAuthor ">Pauline  Carnell</span>, <span class="hlFld-ContribAuthor ">Alison M.  Betts</span>, <span class="hlFld-ContribAuthor ">Russell  Monhemius</span>, <span class="hlFld-ContribAuthor ">Rebecca L.  Prime</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro and in vivo SAR of pyrido[3,4-d]pyramid-4-ylamine based mGluR1 antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (8)
                                     , 2190-2194. <a href="https://doi.org/10.1016/j.bmcl.2009.02.106" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.02.106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.02.106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.02.106%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIn%252Bvitro%252Band%252Bin%252Bvivo%252BSAR%252Bof%252Bpyrido%25255B3%25252C4-d%25255Dpyramid-4-ylamine%252Bbased%252BmGluR1%252Bantagonists%26aulast%3DMantell%26aufirst%3DSimon%2BJ.%26date%3D2009%26volume%3D19%26issue%3D8%26spage%3D2190%26epage%3D2194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liangce  Rong</span>, <span class="hlFld-ContribAuthor ">Hongxia  Han</span>, <span class="hlFld-ContribAuthor ">Haiying  Wang</span>, <span class="hlFld-ContribAuthor ">Hong  Jiang</span>, <span class="hlFld-ContribAuthor ">Shuajiang  Tu</span>, <span class="hlFld-ContribAuthor ">Daqing  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient and facile synthesis of pyrimidine and quinazoline derivatives via one-pot three-component reaction under solvent-free conditions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2009,</strong> <em>46 </em>
                                    (2)
                                     , 152-157. <a href="https://doi.org/10.1002/jhet.43" title="DOI URL">https://doi.org/10.1002/jhet.43</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.43&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.43%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DAn%252Befficient%252Band%252Bfacile%252Bsynthesis%252Bof%252Bpyrimidine%252Band%252Bquinazoline%252Bderivatives%252Bvia%252Bone-pot%252Bthree-component%252Breaction%252Bunder%252Bsolvent-free%252Bconditions%26aulast%3DRong%26aufirst%3DLiangce%26date%3D2009%26volume%3D46%26issue%3D2%26spage%3D152%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdellatif  Tikad</span>, <span class="hlFld-ContribAuthor ">Sylvain  Routier</span>, <span class="hlFld-ContribAuthor ">Mohamed  Akssira</span>, <span class="hlFld-ContribAuthor ">Gérald  Guillaumet</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient one-pot synthesis of 2,4-di(het)aryl and 2,4-diamino pyrido[3,2-d]pyrimidines involving regioselective SNAr and palladium-catalyzed reactions. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2009,</strong> <em>7 </em>
                                    (24)
                                     , 5113. <a href="https://doi.org/10.1039/b913657f" title="DOI URL">https://doi.org/10.1039/b913657f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/b913657f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fb913657f%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DEfficient%252Bone-pot%252Bsynthesis%252Bof%252B2%25252C4-di%252528het%252529aryl%252Band%252B2%25252C4-diamino%252Bpyrido%25255B3%25252C2-d%25255Dpyrimidines%252Binvolving%252Bregioselective%252BSNAr%252Band%252Bpalladium-catalyzed%252Breactions%26aulast%3DTikad%26aufirst%3DAbdellatif%26date%3D2009%26volume%3D7%26issue%3D24%26spage%3D5113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khaled  Abouzid</span>, <span class="hlFld-ContribAuthor ">Samia  Shouman</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2008,</strong> <em>16 </em>
                                    (16)
                                     , 7543-7551. <a href="https://doi.org/10.1016/j.bmc.2008.07.038" title="DOI URL">https://doi.org/10.1016/j.bmc.2008.07.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2008.07.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2008.07.038%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bin%252Bvitro%252Bantitumor%252Bactivity%252Bof%252B4-aminoquinoline%252Band%252B4-aminoquinazoline%252Bderivatives%252Btargeting%252BEGFR%252Btyrosine%252Bkinase%26aulast%3DAbouzid%26aufirst%3DKhaled%26date%3D2008%26volume%3D16%26issue%3D16%26spage%3D7543%26epage%3D7551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea J.  Gonzales</span>, <span class="hlFld-ContribAuthor ">Kenneth E.  Hook</span>, <span class="hlFld-ContribAuthor ">Irene W.  Althaus</span>, <span class="hlFld-ContribAuthor ">Paul A.  Ellis</span>, <span class="hlFld-ContribAuthor ">Erin  Trachet</span>, <span class="hlFld-ContribAuthor ">Amy M.  Delaney</span>, <span class="hlFld-ContribAuthor ">Patricia J.  Harvey</span>, <span class="hlFld-ContribAuthor ">Teresa A.  Ellis</span>, <span class="hlFld-ContribAuthor ">Danielle M.  Amato</span>, <span class="hlFld-ContribAuthor ">James M.  Nelson</span>, <span class="hlFld-ContribAuthor ">David W.  Fry</span>, <span class="hlFld-ContribAuthor ">Tong  Zhu</span>, <span class="hlFld-ContribAuthor ">Cho-Ming  Loi</span>, <span class="hlFld-ContribAuthor ">Stephen A.  Fakhoury</span>, <span class="hlFld-ContribAuthor ">Kevin M.  Schlosser</span>, <span class="hlFld-ContribAuthor ">Karen E.  Sexton</span>, <span class="hlFld-ContribAuthor ">R. Thomas  Winters</span>, <span class="hlFld-ContribAuthor ">Jessica E.  Reed</span>, <span class="hlFld-ContribAuthor ">Alex J.  Bridges</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Lettiere</span>, <span class="hlFld-ContribAuthor ">Deborah A.  Baker</span>, <span class="hlFld-ContribAuthor ">Jianxin  Yang</span>, <span class="hlFld-ContribAuthor ">Helen T.  Lee</span>, <span class="hlFld-ContribAuthor ">Haile  Tecle</span>, <span class="hlFld-ContribAuthor ">Patrick W.  Vincent</span>. </span><span class="cited-content_cbyCitation_article-title">Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2008,</strong> <em>7 </em>
                                    (7)
                                     , 1880-1889. <a href="https://doi.org/10.1158/1535-7163.MCT-07-2232" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-07-2232</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-07-2232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-07-2232%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DAntitumor%252Bactivity%252Band%252Bpharmacokinetic%252Bproperties%252Bof%252BPF-00299804%25252C%252Ba%252Bsecond-generation%252Birreversible%252Bpan-erbB%252Breceptor%252Btyrosine%252Bkinase%252Binhibitor%26aulast%3DGonzales%26aufirst%3DAndrea%2BJ.%26date%3D2008%26date%3D2008%26volume%3D7%26issue%3D7%26spage%3D1880%26epage%3D1889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin F.  Cravatt</span>, <span class="hlFld-ContribAuthor ">Aaron T.  Wright</span>, <span class="hlFld-ContribAuthor ">John W.  Kozarich</span>. </span><span class="cited-content_cbyCitation_article-title">Activity-Based Protein Profiling: From Enzyme Chemistry to Proteomic Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Biochemistry</span><span> <strong>2008,</strong> <em>77 </em>
                                    (1)
                                     , 383-414. <a href="https://doi.org/10.1146/annurev.biochem.75.101304.124125" title="DOI URL">https://doi.org/10.1146/annurev.biochem.75.101304.124125</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev.biochem.75.101304.124125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev.biochem.75.101304.124125%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Biochemistry%26atitle%3DActivity-Based%252BProtein%252BProfiling%25253A%252BFrom%252BEnzyme%252BChemistry%252Bto%252BProteomic%252BChemistry%26aulast%3DCravatt%26aufirst%3DBenjamin%2BF.%26date%3D2008%26volume%3D77%26issue%3D1%26spage%3D383%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>, <span class="hlFld-ContribAuthor ">Ojas A.  Namjoshi</span>, <span class="hlFld-ContribAuthor ">Jianming  Yu</span>, <span class="hlFld-ContribAuthor ">Michael A.  Ihnat</span>, <span class="hlFld-ContribAuthor ">Jessica E.  Thorpe</span>, <span class="hlFld-ContribAuthor ">Linda A.  Warnke</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of substituted pyrrolo[2,3-d]pyrimidines as multiple receptor tyrosine kinase inhibitors and antiangiogenic agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2008,</strong> <em>16 </em>
                                    (10)
                                     , 5514-5528. <a href="https://doi.org/10.1016/j.bmc.2008.04.019" title="DOI URL">https://doi.org/10.1016/j.bmc.2008.04.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2008.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2008.04.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bsubstituted%252Bpyrrolo%25255B2%25252C3-d%25255Dpyrimidines%252Bas%252Bmultiple%252Breceptor%252Btyrosine%252Bkinase%252Binhibitors%252Band%252Bantiangiogenic%252Bagents%26aulast%3DGangjee%26aufirst%3DAleem%26date%3D2008%26volume%3D16%26issue%3D10%26spage%3D5514%26epage%3D5528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiwei  Yu</span>, <span class="hlFld-ContribAuthor ">Titus J.  Boggon</span>, <span class="hlFld-ContribAuthor ">Susumu  Kobayashi</span>, <span class="hlFld-ContribAuthor ">Cheng  Jin</span>, <span class="hlFld-ContribAuthor ">Patrick C.  Ma</span>, <span class="hlFld-ContribAuthor ">Afshin  Dowlati</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Kern</span>, <span class="hlFld-ContribAuthor ">Daniel G.  Tenen</span>, <span class="hlFld-ContribAuthor ">Balázs  Halmos</span>. </span><span class="cited-content_cbyCitation_article-title">Resistance to an Irreversible Epidermal Growth Factor Receptor (EGFR) Inhibitor in EGFR-Mutant Lung Cancer Reveals Novel Treatment Strategies. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2007,</strong> <em>67 </em>
                                    (21)
                                     , 10417-10427. <a href="https://doi.org/10.1158/0008-5472.CAN-07-1248" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-07-1248</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-07-1248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-07-1248%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DResistance%252Bto%252Ban%252BIrreversible%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252B%252528EGFR%252529%252BInhibitor%252Bin%252BEGFR-Mutant%252BLung%252BCancer%252BReveals%252BNovel%252BTreatment%252BStrategies%26aulast%3DYu%26aufirst%3DZhiwei%26date%3D2007%26date%3D2007%26volume%3D67%26issue%3D21%26spage%3D10417%26epage%3D10427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathleen M.  Diehl</span>, <span class="hlFld-ContribAuthor ">Navdeep  Grewal</span>, <span class="hlFld-ContribAuthor ">Stephen P.  Ethier</span>, <span class="hlFld-ContribAuthor ">Kathleen M.  Woods-Ignatoski</span>. </span><span class="cited-content_cbyCitation_article-title">p38MAPK-Activated AKT in HER-2 Overexpressing Human Breast Cancer Cells Acts as an EGF-Independent Survival Signal. </span><span class="cited-content_cbyCitation_journal-name">Journal of Surgical Research</span><span> <strong>2007,</strong> <em>142 </em>
                                    (1)
                                     , 162-169. <a href="https://doi.org/10.1016/j.jss.2007.01.025" title="DOI URL">https://doi.org/10.1016/j.jss.2007.01.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jss.2007.01.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jss.2007.01.025%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Surgical%2520Research%26atitle%3Dp38MAPK-Activated%252BAKT%252Bin%252BHER-2%252BOverexpressing%252BHuman%252BBreast%252BCancer%252BCells%252BActs%252Bas%252Ban%252BEGF-Independent%252BSurvival%252BSignal%26aulast%3DDiehl%26aufirst%3DKathleen%2BM.%26date%3D2007%26volume%3D142%26issue%3D1%26spage%3D162%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">François  Crestey</span>, <span class="hlFld-ContribAuthor ">Valérie  Collot</span>, <span class="hlFld-ContribAuthor ">Silvia  Stiebing</span>, <span class="hlFld-ContribAuthor ">Jean-François  Lohier</span>, <span class="hlFld-ContribAuthor ">Jana Sopkova-de Oliveira  Santos</span>, <span class="hlFld-ContribAuthor ">Sylvain  Rault</span>. </span><span class="cited-content_cbyCitation_article-title">New practical access to 2-azatryptophans and dehydro derivatives via the Wittig–Horner reaction. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2007,</strong> <em>48 </em>
                                    (14)
                                     , 2457-2460. <a href="https://doi.org/10.1016/j.tetlet.2007.02.042" title="DOI URL">https://doi.org/10.1016/j.tetlet.2007.02.042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2007.02.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2007.02.042%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DNew%252Bpractical%252Baccess%252Bto%252B2-azatryptophans%252Band%252Bdehydro%252Bderivatives%252Bvia%252Bthe%252BWittig%2525E2%252580%252593Horner%252Breaction%26aulast%3DCrestey%26aufirst%3DFran%25C3%25A7ois%26date%3D2007%26volume%3D48%26issue%3D14%26spage%3D2457%26epage%3D2460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adriana  Chilin</span>, <span class="hlFld-ContribAuthor ">Giovanni  Marzaro</span>, <span class="hlFld-ContribAuthor ">Samuele  Zanatta</span>, <span class="hlFld-ContribAuthor ">Adriano  Guiotto</span>. </span><span class="cited-content_cbyCitation_article-title">A microwave improvement in the synthesis of the quinazoline scaffold. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2007,</strong> <em>48 </em>
                                    (18)
                                     , 3229-3231. <a href="https://doi.org/10.1016/j.tetlet.2007.03.027" title="DOI URL">https://doi.org/10.1016/j.tetlet.2007.03.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2007.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2007.03.027%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Bmicrowave%252Bimprovement%252Bin%252Bthe%252Bsynthesis%252Bof%252Bthe%252Bquinazoline%252Bscaffold%26aulast%3DChilin%26aufirst%3DAdriana%26date%3D2007%26volume%3D48%26issue%3D18%26spage%3D3229%26epage%3D3231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">François  Crestey</span>, <span class="hlFld-ContribAuthor ">Silvia  Stiebing</span>, <span class="hlFld-ContribAuthor ">Rémi  Legay</span>, <span class="hlFld-ContribAuthor ">Valérie  Collot</span>, <span class="hlFld-ContribAuthor ">Sylvain  Rault</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of a new indazole library: direct conversion of N-methoxy-N-methylamides (Weinreb amides) to 3-keto and 3-formylindazoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2007,</strong> <em>63 </em>
                                    (2)
                                     , 419-428. <a href="https://doi.org/10.1016/j.tet.2006.10.063" title="DOI URL">https://doi.org/10.1016/j.tet.2006.10.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2006.10.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2006.10.063%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Ba%252Bnew%252Bindazole%252Blibrary%25253A%252Bdirect%252Bconversion%252Bof%2525C2%2525A0N-methoxy-N-methylamides%252B%252528Weinreb%252Bamides%252529%252Bto%252B3-keto%252Band%252B3-formylindazoles%26aulast%3DCrestey%26aufirst%3DFran%25C3%25A7ois%26date%3D2007%26volume%3D63%26issue%3D2%26spage%3D419%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/medium/jm050936on00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/large/jm050936on00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm050936o&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm050936oc00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/medium/jm050936oc00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/large/jm050936oc00001.jpeg" id="rightTab-_i5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Chart 1.  Formulas </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/large/jm050936oc00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm050936o&amp;id=jm050936oc00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm050936oh00001" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/medium/jm050936oh00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/large/jm050936oh00001.jpeg" id="rightTab-_i9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1 <i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> (i) 1-Ethyl-3-(3‘-dimethylaminopropyl)carbodiimide hydrochloride (EDCI·HCl), pyridine, or DMF, 0−25 °C; (ii) HNR<sub>1</sub>R<sub>2</sub>, DMF, or CH<sub>3</sub>CN or THF, 25−85 °C; (iii) n-BuLi, THF, −78 °C, then CO<sub>2</sub>, ether, −78 to 25 °C.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/large/jm050936oh00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm050936o&amp;id=jm050936oh00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm050936of00001" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/medium/jm050936of00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/large/jm050936of00001.jpeg" id="rightTab-_i15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 A:  Inhibition of erbB1 tyrosine kinase activity in NIH 3T3 fibroblasts expressing human erbB1. B:  Inhibition of erbB2 tyrosine kinase activity in T24 NIH fibroblasts expressing a chimeric receptor with the extracellular binding domain of erbB1 and the intracellular kinase domain of erbB2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2006/jmcmar.2006.49.issue-4/jm050936o/production/images/large/jm050936of00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm050936o&amp;id=jm050936of00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><a name="jm004900401484" id="jm004900401484"></a><a name="jm004900401485" id="jm004900401485"></a></div><p class="rightTab-references-count">
            This article references 55 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-jm050936ob00001"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00001" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00001_1"><span><span class="NLM_string-ref">Lemmon, M. A. The EGF receptor family as therapeutic targets in breast cancer. <i>  Breast Dis.</i><b>2003</b>, <i>18</i>, 33−43.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=43&author=M.+A+Lemmon&title=The+EGF+receptor+family+as+therapeutic+targets+in+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLemmon%26aufirst%3DM.%2BA%26atitle%3DThe%2520EGF%2520receptor%2520family%2520as%2520therapeutic%2520targets%2520in%2520breast%2520cancer%26jtitle%3DBreast%2520Dis.%26date%3D2003%26volume%3D18%26spage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00002"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00002" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00002_1"><span><span class="NLM_string-ref">Ang, K. K.; Andratschke, N. H.; Milas, L. Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy. <i>  Int. J. Radiat. Oncol., </i><i>Biol., Phys</i>. <b>2004</b>, <i>58</i>, 959−965.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2004&pages=965&author=K.+K.+Ang&author=N.+H.+Andratschke&author=L+Milas&title=Epidermal+growth+factor+receptor+and+response+of+head-and-neck+carcinoma+to+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAng%26aufirst%3DK.%2BK.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%2520and%2520response%2520of%2520head-and-neck%2520carcinoma%2520to%2520therapy%26jtitle%3DInt.%2520J.%2520Radiat.%2520Oncol.%252C%2520Biol.%252C%2520Phys.%26date%3D2004%26volume%3D58%26spage%3D965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00003"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00003" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00003_1"><span><span class="NLM_string-ref">Meert, A. P.; Martin, B.; Paesmans, M.; Berghmans, T.; Mascaux, C.; Verdebout, J.-M.; Delmotte, P.; Lafitte, J.-J.; Sculier, J.-P. The Role of HER-2/neu expression on the survival of patients with lung cancer:  a systematic review of the literature<i>. Br. J. Cancer</i><b>2003</b>, <i>89</i>, 959−965.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2003&pages=965&author=A.+P.+Meert&author=B.+Martin&author=M.+Paesmans&author=T.+Berghmans&author=C.+Mascaux&author=J.-M.+Verdebout&author=P.+Delmotte&author=J.-J.+Lafitte&author=J.-P+Sculier&title=The+Role+of+HER-2%2Fneu+expression+on+the+survival+of+patients+with+lung+cancer%3A%E2%80%89+a+systematic+review+of+the+literature"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeert%26aufirst%3DA.%2BP.%26atitle%3DThe%2520Role%2520of%2520HER-2%252Fneu%2520expression%2520on%2520the%2520survival%2520of%2520patients%2520with%2520lung%2520cancer%253A%25E2%2580%2589%2520a%2520systematic%2520review%2520of%2520the%2520literature%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2003%26volume%3D89%26spage%3D965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00004"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00004" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00004_1"><span><span class="NLM_string-ref">Hynes, N. E.; Lane, H. A. ErbB receptors and cancer:  The complexity of targeted inhibitors. <i>  Nat. Rev. Cancer</i><b>2005</b>, <i>5</i>, 341−354.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=354&author=N.+E.+Hynes&author=H.+A+Lane&title=ErbB+receptors+and+cancer%3A%E2%80%89+The+complexity+of+targeted+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHynes%26aufirst%3DN.%2BE.%26atitle%3DErbB%2520receptors%2520and%2520cancer%253A%25E2%2580%2589%2520The%2520complexity%2520of%2520targeted%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00005"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00005" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00005_1"><span><span class="NLM_string-ref">Denny, W. A. The 4-anilinoquinazoline class of inhibitors of the erbB family of receptor tyrosine kinases. <i>  Farmaco</i><b>2001</b>, <i>56</i>, 51−56.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2001&pages=56&author=W.+A+Denny&title=The+4-anilinoquinazoline+class+of+inhibitors+of+the+erbB+family+of+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDenny%26aufirst%3DW.%2BA%26atitle%3DThe%25204-anilinoquinazoline%2520class%2520of%2520inhibitors%2520of%2520the%2520erbB%2520family%2520of%2520receptor%2520tyrosine%2520kinases%26jtitle%3DFarmaco%26date%3D2001%26volume%3D56%26spage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00006"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00006" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00006_1"><span><span class="NLM_string-ref">Cockerill, S.; Stubberfield, C.; Stables, J.; Carter, M.; Guntrip, S.; Smith, K.; McKeown, S.; Shaw, R.; Topley, P.; Thomsen, L.; Affleck, K.; Jowett, A.; Hayes, D.; Willson, M.; Woollard, P.; Spalding, D. Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and c-erbB-2. <i>  Bioorg. Med. Chem. Lett.</i><b>2001</b>, <i>11</i>, 1401−1405.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=1405&author=S.+Cockerill&author=C.+Stubberfield&author=J.+Stables&author=M.+Carter&author=S.+Guntrip&author=K.+Smith&author=S.+McKeown&author=R.+Shaw&author=P.+Topley&author=L.+Thomsen&author=K.+Affleck&author=A.+Jowett&author=D.+Hayes&author=M.+Willson&author=P.+Woollard&author=D+Spalding&title=Indazolylamino+quinazolines+and+pyridopyrimidines+as+inhibitors+of+the+EGFr+and+c-erbB-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCockerill%26aufirst%3DS.%26atitle%3DIndazolylamino%2520quinazolines%2520and%2520pyridopyrimidines%2520as%2520inhibitors%2520of%2520the%2520EGFr%2520and%2520c-erbB-2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D1405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00007"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00007" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00007_1"><span><span class="NLM_string-ref">Palmer, B. D.; Trumpp-Kallmeyer, S.; Fry, D. W.; Nelson, J. M.; Showalter, H. D. H.; Denny, W. A. Tyrosine kinase inhibitors. 11. Soluble analogues of pyrrolo- and pyrazinoquinazolines as EGFR inhibitors:  synthesis, biological evaluation, and modelling of the mode of binding. <i>  J. Med. </i><i>Chem. </i><b>1997</b>, <i>40</i>, 1519−1529.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1529&author=B.+D.+Palmer&author=S.+Trumpp-Kallmeyer&author=D.+W.+Fry&author=J.+M.+Nelson&author=H.+D.+H.+Showalter&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+11.+Soluble+analogues+of+pyrrolo-+and+pyrazinoquinazolines+as+EGFR+inhibitors%3A%E2%80%89+synthesis%2C+biological+evaluation%2C+and+modelling+of+the+mode+of+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DB.%2BD.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252011.%2520Soluble%2520analogues%2520of%2520pyrrolo-%2520and%2520pyrazinoquinazolines%2520as%2520EGFR%2520inhibitors%253A%25E2%2580%2589%2520synthesis%252C%2520biological%2520evaluation%252C%2520and%2520modelling%2520of%2520the%2520mode%2520of%2520binding%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00008"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00008" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00008_1"><span><span class="NLM_string-ref">Vansteenkiste, J. F. Gefitinib (Iressa):  a novel treatment for non-small-cell lung cancer. <i>  Expert Rev. Anticancer Ther.</i><b>2004</b>, <i>4</i>, 5−17.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=17&author=J.+F.+Vansteenkiste&author=+Gefitinib&title=a+novel+treatment+for+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVansteenkiste%26aufirst%3DJ.%2BF.%26atitle%3Da%2520novel%2520treatment%2520for%2520non-small-cell%2520lung%2520cancer%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2004%26volume%3D4%26spage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00009"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00009" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00009_1"><span><span class="NLM_string-ref">Tiseo, M.; Loprevite, M.; Ardizzoni, A. Epidermal growth factor receptor inhibitors:  a new prospective in the treatment of lung cancer. <i>  Curr. Med. </i><i>Chem:  Anti-Cancer Agents</i><b>2004</b>, <i>4</i>, 139−148.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+Tiseo&author=M.+Loprevite&author=A.+Ardizzoni&title=Epidermal+growth+factor+receptor+inhibitors%3A%E2%80%89+a+new+prospective+in+the+treatment+of+lung+cancer.+Curr.+Med.+Chem%3A%E2%80%89+Anti-Cancer+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DTiseo%26aufirst%3DM.%26btitle%3DEpidermal%2520growth%2520factor%2520receptor%2520inhibitors%253A%25E2%2580%2589%2520a%2520new%2520prospective%2520in%2520the%2520treatment%2520of%2520lung%2520cancer.%2520Curr.%2520Med.%2520Chem%253A%25E2%2580%2589%2520Anti-Cancer%2520Agents%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00010"><div class="reference"><div class="NLM_citation" id="rightTab-jm050936ob00010_1"><span><span class="NLM_string-ref">Bonomi, P. Erlotinib:  a new therapeutic approach for non-small-cell lung cancer. <i>  Expert Opin. Invest. Drugs</i><b>2003</b>, <i>12</i>, 1395−1401.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=1401&author=P.+Bonomi&author=+Erlotinib&title=a+new+therapeutic+approach+for+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonomi%26aufirst%3DP.%26atitle%3Da%2520new%2520therapeutic%2520approach%2520for%2520non-small-cell%2520lung%2520cancer%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2003%26volume%3D12%26spage%3D1401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00011"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00011" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00011_1"><span><span class="NLM_string-ref">Lynch, T. J.; Bell, D. W.; Sordella, R.; Gurubhagavatula, S.; Okimoto, R. A.; Brannigan, B. W.; Harris, P. L.; Haserlat, S. M.; Supko, J. G.; Haluska, F. G.; Louis, D. N.; Christiani, D. C.; Settleman, J.; Haber, D. A. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. <i>  N. Engl. J. Med.</i><b>2004</b>, <i>350</i>, 2129−2139.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=2139&author=T.+J.+Lynch&author=D.+W.+Bell&author=R.+Sordella&author=S.+Gurubhagavatula&author=R.+A.+Okimoto&author=B.+W.+Brannigan&author=P.+L.+Harris&author=S.+M.+Haserlat&author=J.+G.+Supko&author=F.+G.+Haluska&author=D.+N.+Louis&author=D.+C.+Christiani&author=J.+Settleman&author=D.+A+Haber&title=Activating+mutations+in+the+epidermal+growth+factor+receptor+underlying+responsiveness+of+non-small-cell+lung+cancer+to+gefitinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DT.%2BJ.%26atitle%3DActivating%2520mutations%2520in%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520underlying%2520responsiveness%2520of%2520non-small-cell%2520lung%2520cancer%2520to%2520gefitinib%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D2139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00012"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00012" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00012_1"><span><span class="NLM_string-ref">Paez, J. G.; Jaenne, P. A.; Lee, J. C.; Tracy, S.; Greulich, H.; Gabriel, S.; Herman, P.; Kaye, F. J.; Lindeman, N.; Boggon, T. J.; Naoki, K.; Sasaki, H.; Fujii, Y.; Eck, M. J.; Sellers, W. R.; Johnson, B. E.; Meyerson, M. EGFR mutations in lung cancer:  Correlation with clinical response to gefitinib therapy. <i>  Science</i><b>2004</b>, <i>304</i>, 1497−1500.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2004&pages=1500&author=J.+G.+Paez&author=P.+A.+Jaenne&author=J.+C.+Lee&author=S.+Tracy&author=H.+Greulich&author=S.+Gabriel&author=P.+Herman&author=F.+J.+Kaye&author=N.+Lindeman&author=T.+J.+Boggon&author=K.+Naoki&author=H.+Sasaki&author=Y.+Fujii&author=M.+J.+Eck&author=W.+R.+Sellers&author=B.+E.+Johnson&author=M+Meyerson&title=EGFR+mutations+in+lung+cancer%3A%E2%80%89+Correlation+with+clinical+response+to+gefitinib+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPaez%26aufirst%3DJ.%2BG.%26atitle%3DEGFR%2520mutations%2520in%2520lung%2520cancer%253A%25E2%2580%2589%2520Correlation%2520with%2520clinical%2520response%2520to%2520gefitinib%2520therapy%26jtitle%3DScience%26date%3D2004%26volume%3D304%26spage%3D1500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00013"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00013" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00013_1"><span><span class="NLM_string-ref">Pao, W.; Miller, V.; Zakowski, M.; Doherty, J.; Politi, K.; Sarkaria, I.; Singh, B.; Heelan, R.; Rusch, V.; Fulton, L.; Mardis, E.; Kupfer, D.; Wilson, R.; Kris, M.; Varmus, H. EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib. <i>  Proc. Natl. Acad. Sci. U.S.A.</i><b>2004</b>, <i>101</i>, 13306−13311.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=13311&author=W.+Pao&author=V.+Miller&author=M.+Zakowski&author=J.+Doherty&author=K.+Politi&author=I.+Sarkaria&author=B.+Singh&author=R.+Heelan&author=V.+Rusch&author=L.+Fulton&author=E.+Mardis&author=D.+Kupfer&author=R.+Wilson&author=M.+Kris&author=H.+Varmus&title=%E2%80%9Cnever+smokers%E2%80%9D+and+are+associated+with+sensitivity+of+tumors+to+gefitinib+and+erlotinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPao%26aufirst%3DW.%26atitle%3D%25E2%2580%259Cnever%2520smokers%25E2%2580%259D%2520and%2520are%2520associated%2520with%2520sensitivity%2520of%2520tumors%2520to%2520gefitinib%2520and%2520erlotinib%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D13311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00014"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00014" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00014_1"><span><span class="NLM_string-ref">Fabian, M. A.; Biggs, W. H., III; Treiber, D. K.; Atteridge, C. E.; Azimioara, M. D.; Benedetti, M. G.; Carter, T. A.; Ciceri, P.; Edeen, P. T.; Floyd, M.; Ford, J. M.; Galvin, M.; Gerlach, J. L.; Grotzfeld, R. M.; Herrgard, S.; Insko, D. E.; Insko, M. A.; Lai, A. G.; Lelias, J.-M.; Mehta, S. A.; Milanov, Z. V.; Velasco, A. M.; Wodicka, L. M.; Patel, H. K.; Zarrinkar, P. P.; Lockhart, D. J. A small molecule-kinase interaction map for clinical kinase inhibitors. <i>  Nat. Biotechnol</i>. <b>2005</b>, <i>23</i>, 329−336.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=336&author=M.+A.+Fabian&author=W.+H.+Biggs&author=D.+K.+Treiber&author=C.+E.+Atteridge&author=M.+D.+Azimioara&author=M.+G.+Benedetti&author=T.+A.+Carter&author=P.+Ciceri&author=P.+T.+Edeen&author=M.+Floyd&author=J.+M.+Ford&author=M.+Galvin&author=J.+L.+Gerlach&author=R.+M.+Grotzfeld&author=S.+Herrgard&author=D.+E.+Insko&author=M.+A.+Insko&author=A.+G.+Lai&author=J.-M.+Lelias&author=S.+A.+Mehta&author=Z.+V.+Milanov&author=A.+M.+Velasco&author=L.+M.+Wodicka&author=H.+K.+Patel&author=P.+P.+Zarrinkar&author=D.+J+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26spage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00015"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00015" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00015_1"><span><span class="NLM_string-ref">Sordella, R.; Bell, D. W.; Haber, D. A.; Settleman, J. Gefitinib-sensitizing mutations in lung cancer activate anti-apoptotic pathways. <i>  Science</i><b>2004</b>, <i>305</i>, 1163−1167.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=1167&author=R.+Sordella&author=D.+W.+Bell&author=D.+A.+Haber&author=J+Settleman&title=Gefitinib-sensitizing+mutations+in+lung+cancer+activate+anti-apoptotic+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSordella%26aufirst%3DR.%26atitle%3DGefitinib-sensitizing%2520mutations%2520in%2520lung%2520cancer%2520activate%2520anti-apoptotic%2520pathways%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D1167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00016"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00016" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00016_1"><span><span class="NLM_string-ref">Kobayashi, S.; Boggon, T. J.; Dayaram, T.; Jaenne, P. A.; Kocher, O.; Meyerson, M.; Johnson, B. E.; Eck, M. J.; Tenen, D. G.; Halmos, B. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. <i>  N. Engl. </i><i>J. Med.</i><b>2005</b>, <i>352</i>, 786−792.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=792&author=S.+Kobayashi&author=T.+J.+Boggon&author=T.+Dayaram&author=P.+A.+Jaenne&author=O.+Kocher&author=M.+Meyerson&author=B.+E.+Johnson&author=M.+J.+Eck&author=D.+G.+Tenen&author=B+Halmos&title=EGFR+mutation+and+resistance+of+non-small-cell+lung+cancer+to+gefitinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DS.%26atitle%3DEGFR%2520mutation%2520and%2520resistance%2520of%2520non-small-cell%2520lung%2520cancer%2520to%2520gefitinib%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00017"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00017" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00017_1"><span><span class="NLM_string-ref">Pao, W.; Miller, V. A.; Politi, K. A.; Riely, G. J.; Somwar, R.; Zakowski, M. F.; Kris, M. G.; Varmus, H. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. <i>  PLoS Med</i>. <b>2005</b>, <i>2</i>, 225−235.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=235&author=W.+Pao&author=V.+A.+Miller&author=K.+A.+Politi&author=G.+J.+Riely&author=R.+Somwar&author=M.+F.+Zakowski&author=M.+G.+Kris&author=H+Varmus&title=Acquired+resistance+of+lung+adenocarcinomas+to+gefitinib+or+erlotinib+is+associated+with+a+second+mutation+in+the+EGFR+kinase+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPao%26aufirst%3DW.%26atitle%3DAcquired%2520resistance%2520of%2520lung%2520adenocarcinomas%2520to%2520gefitinib%2520or%2520erlotinib%2520is%2520associated%2520with%2520a%2520second%2520mutation%2520in%2520the%2520EGFR%2520kinase%2520domain%26jtitle%3DPLoS%2520Med.%26date%3D2005%26volume%3D2%26spage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00018"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00018" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00018_1"><span><span class="NLM_string-ref">Rusnak, D. W.; Lackey, K.; Affleck, K.; Wood, E. R.; Alligood, K. J.; Rhodes, N.; Keith, B. R.; Murray, D. M.; Knight, W. B.; Mullin, R. J.; Gilmer, T. M. The effects of the novel, reversible epidermal growth factor receptor/erbB-2 tyrosine kinase inhibitor, GW572016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo. <i>  Mol. Cancer Ther</i>. <b>2001</b>, <i>1</i>, 85−94.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=94&author=D.+W.+Rusnak&author=K.+Lackey&author=K.+Affleck&author=E.+R.+Wood&author=K.+J.+Alligood&author=N.+Rhodes&author=B.+R.+Keith&author=D.+M.+Murray&author=W.+B.+Knight&author=R.+J.+Mullin&author=T.+M+Gilmer&title=The+effects+of+the+novel%2C+reversible+epidermal+growth+factor+receptor%2FerbB-2+tyrosine+kinase+inhibitor%2C+GW572016%2C+on+the+growth+of+human+normal+and+tumor-derived+cell+lines+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26atitle%3DThe%2520effects%2520of%2520the%2520novel%252C%2520reversible%2520epidermal%2520growth%2520factor%2520receptor%252FerbB-2%2520tyrosine%2520kinase%2520inhibitor%252C%2520GW572016%252C%2520on%2520the%2520growth%2520of%2520human%2520normal%2520and%2520tumor-derived%2520cell%2520lines%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2001%26volume%3D1%26spage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00019"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00019" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00019_1"><span><span class="NLM_string-ref">Wood, E. R.; Truesdale, A. T.; McDonald, O. B.; Yuan, D.; Hassell, A.; Dickerson, S. H.; Ellis, B.; Pennisi, C.; Horne, E.; Lackey, K.; Alligood, K. J.; Rusnak, D. W.; Gilmer, T. M.; Shewchuk, L. A unique structure for epidermal growth factor receptor bound to GW572016 (lapatinib):  Relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells. <i>  Cancer Res</i>. <b>2004</b>, <i>64</i>, 6652−6659.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=6659&author=E.+R.+Wood&author=A.+T.+Truesdale&author=O.+B.+McDonald&author=D.+Yuan&author=A.+Hassell&author=S.+H.+Dickerson&author=B.+Ellis&author=C.+Pennisi&author=E.+Horne&author=K.+Lackey&author=K.+J.+Alligood&author=D.+W.+Rusnak&author=T.+M.+Gilmer&author=L+Shewchuk&title=A+unique+structure+for+epidermal+growth+factor+receptor+bound+to+GW572016+%28lapatinib%29%3A%E2%80%89+Relationships+among+protein+conformation%2C+inhibitor+off-rate%2C+and+receptor+activity+in+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DE.%2BR.%26atitle%3DA%2520unique%2520structure%2520for%2520epidermal%2520growth%2520factor%2520receptor%2520bound%2520to%2520GW572016%2520%2528lapatinib%2529%253A%25E2%2580%2589%2520Relationships%2520among%2520protein%2520conformation%252C%2520inhibitor%2520off-rate%252C%2520and%2520receptor%2520activity%2520in%2520tumor%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D6659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00020"><div class="reference"><div class="NLM_citation" id="rightTab-jm050936ob00020_1"><span><span class="NLM_string-ref">Vite, G. D.; Gavai, A. V.; Fink, B. E.; Mastalerz, H.; Kadow, J. F. Preparation of C-6 Modified Indazolyl Pyrrolotriazines as Antiproliferative Agents. PCT Int. Appl. WO 2004054514 A2, 2004; 81 pp.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=054514&publication_year=2004&pages=2004&author=G.+D.+Vite&author=A.+V.+Gavai&author=B.+E.+Fink&author=H.+Mastalerz&author=J.+F+Kadow&title=Preparation+of+C-6+Modified+Indazolyl+Pyrrolotriazines+as+Antiproliferative+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVite%26aufirst%3DG.%2BD.%26atitle%3DPreparation%2520of%2520C-6%2520Modified%2520Indazolyl%2520Pyrrolotriazines%2520as%2520Antiproliferative%2520Agents%26jtitle%3DPCT%2520Int.%2520Appl.%2520WO%26date%3D2004%26volume%3D054514%26spage%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00021"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00021" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00021_1"><span><span class="NLM_string-ref">Borman, S. Hopes ride on drug candidates. Researchers reveal potential new medicines for thrombosis, anxiety, diabetes, and cancer. <i>  Chem. Eng. News</i><b>2005</b>, <i>83</i>, 40−44.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2005&pages=44&author=S+Borman&title=Hopes+ride+on+drug+candidates.+Researchers+reveal+potential+new+medicines+for+thrombosis%2C+anxiety%2C+diabetes%2C+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBorman%26aufirst%3DS%26atitle%3DHopes%2520ride%2520on%2520drug%2520candidates.%2520Researchers%2520reveal%2520potential%2520new%2520medicines%2520for%2520thrombosis%252C%2520anxiety%252C%2520diabetes%252C%2520and%2520cancer%26jtitle%3DChem.%2520Eng.%2520News%26date%3D2005%26volume%3D83%26spage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00022"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00022" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00022_1"><span><span class="NLM_string-ref">Mellinghoff, I. K.; Tran, C.; Sawyers, C. L. Growth Inhibitory effects of the dual ErbB1/ErbB2 Tyr kinase inhibitor PKI-166 on human prostate cancer xenografts. <i>  Cancer Res</i>. <b>2002</b>, <i>62</i>, 5254−5259.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=5259&author=I.+K.+Mellinghoff&author=C.+Tran&author=C.+L+Sawyers&title=Growth+Inhibitory+effects+of+the+dual+ErbB1%2FErbB2+Tyr+kinase+inhibitor+PKI-166+on+human+prostate+cancer+xenografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26atitle%3DGrowth%2520Inhibitory%2520effects%2520of%2520the%2520dual%2520ErbB1%252FErbB2%2520Tyr%2520kinase%2520inhibitor%2520PKI-166%2520on%2520human%2520prostate%2520cancer%2520xenografts%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D5259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00023"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00023" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00023_1"><span><span class="NLM_string-ref">Traxler, P.; Allegrini, P. R.; Brandt, R.; Brueggen, J.; Cozens, R.; Fabbro, D.; Grosios, K.; Lane, H. A.; McSheehy, P.; Mestan, J.; Meyer, T.; Tang, C.; Wartmann, M.; Wood, J.; Caravatti, G. AEE788:  A dual family epidermal growth factor receptor/erbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity. <i>  Cancer Res</i>. <b>2004</b>, <i>64</i>, 4931−4941.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=4941&author=P.+Traxler&author=P.+R.+Allegrini&author=R.+Brandt&author=J.+Brueggen&author=R.+Cozens&author=D.+Fabbro&author=K.+Grosios&author=H.+A.+Lane&author=P.+McSheehy&author=J.+Mestan&author=T.+Meyer&author=C.+Tang&author=M.+Wartmann&author=J.+Wood&author=G.+Caravatti&title=dual+family+epidermal+growth+factor+receptor%2FerbB2+and+vascular+endothelial+growth+factor+receptor+tyrosine+kinase+inhibitor+with+antitumor+and+antiangiogenic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP.%26atitle%3Ddual%2520family%2520epidermal%2520growth%2520factor%2520receptor%252FerbB2%2520and%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%2520with%2520antitumor%2520and%2520antiangiogenic%2520activity%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D4941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00024"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00024" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00024_1"><span><span class="NLM_string-ref">Stamos, J.; Sliwkowski, M. X.; Eigenbrot, C. Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. <i>  J. Biol. Chem</i>. <b>2002</b>, <i>277</i>, 46265−46272.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=46272&author=J.+Stamos&author=M.+X.+Sliwkowski&author=C+Eigenbrot&title=Structure+of+the+epidermal+growth+factor+receptor+kinase+domain+alone+and+in+complex+with+a+4-anilinoquinazoline+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStamos%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520kinase%2520domain%2520alone%2520and%2520in%2520complex%2520with%2520a%25204-anilinoquinazoline%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D46272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00025"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00025" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00025_1"><span><span class="NLM_string-ref">Shewchuk, L.; Hassell, A.; Wisely, B.; Rocque, W.; Holmes, W.; Veal, J.; Kuyper, L. F. Binding mode of the 4-anilinoquinazoline class of protein kinase inhibitor:  X-ray Crystallographic studies of 4-anilinoquinazolines bound to cyclin-dependent kinase 2 and p38 kinase. <i>  J. Med. Chem</i>. <b>2000</b>, <i>43</i>, 133−138.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=138&author=L.+Shewchuk&author=A.+Hassell&author=B.+Wisely&author=W.+Rocque&author=W.+Holmes&author=J.+Veal&author=L.+F+Kuyper&title=Binding+mode+of+the+4-anilinoquinazoline+class+of+protein+kinase+inhibitor%3A%E2%80%89+X-ray+Crystallographic+studies+of+4-anilinoquinazolines+bound+to+cyclin-dependent+kinase+2+and+p38+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShewchuk%26aufirst%3DL.%26atitle%3DBinding%2520mode%2520of%2520the%25204-anilinoquinazoline%2520class%2520of%2520protein%2520kinase%2520inhibitor%253A%25E2%2580%2589%2520X-ray%2520Crystallographic%2520studies%2520of%25204-anilinoquinazolines%2520bound%2520to%2520cyclin-dependent%2520kinase%25202%2520and%2520p38%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00026"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00026" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00026_1"><span><span class="NLM_string-ref">Wissner, A.; Berger, D. M.; Boschelli, D. H.; Floyd, M. B.; Greenberger, L. M.; Gruber, B. C.; Johnson, B. D.; Mamuya, N.; Nilakantan, R.; Reich, M. F.; Shen, R.; Tsou, H. R.; Upeslacis, E.; Wang, Y. F.; Wu, B.; Ye, F.; Zhang, N. 4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitors. <i>  J. Med. Chem</i>. <b>2000</b>, <i>43</i>, 3244−3256.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3256&author=A.+Wissner&author=D.+M.+Berger&author=D.+H.+Boschelli&author=M.+B.+Floyd&author=L.+M.+Greenberger&author=B.+C.+Gruber&author=B.+D.+Johnson&author=N.+Mamuya&author=R.+Nilakantan&author=M.+F.+Reich&author=R.+Shen&author=H.+R.+Tsou&author=E.+Upeslacis&author=Y.+F.+Wang&author=B.+Wu&author=F.+Ye&author=N.+Zhang&author=+Anilino&title=inhibitors+of+epidermal+growth+factor+receptor+kinase+and+their+bioisosteric+relationship+to+the+4-anilino-6%2C7-dialkoxyquinazoline+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00026_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26atitle%3Dinhibitors%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520kinase%2520and%2520their%2520bioisosteric%2520relationship%2520to%2520the%25204-anilino-6%252C7-dialkoxyquinazoline%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00027"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00027" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00027_1"><span><span class="NLM_string-ref">Singh, J.; Dobrusin, E. M.; Fry, D. W.; Haske, T.; Whitty, A.; McNamara, D. J. Structure-based design of a potent, selective, and irreversible inhibitor of the catalytic domain of the erbB receptor subfamily of protein tyrosine kinases. <i>  J. Med. Chem</i>. <b>1997</b>, <i>40</i>, 1130−1135.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1135&author=J.+Singh&author=E.+M.+Dobrusin&author=D.+W.+Fry&author=T.+Haske&author=A.+Whitty&author=D.+J+McNamara&title=Structure-based+design+of+a+potent%2C+selective%2C+and+irreversible+inhibitor+of+the+catalytic+domain+of+the+erbB+receptor+subfamily+of+protein+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00027_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DJ.%26atitle%3DStructure-based%2520design%2520of%2520a%2520potent%252C%2520selective%252C%2520and%2520irreversible%2520inhibitor%2520of%2520the%2520catalytic%2520domain%2520of%2520the%2520erbB%2520receptor%2520subfamily%2520of%2520protein%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00028"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00028" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00028_1"><span><span class="NLM_string-ref">Fry, D. W.; Bridges, A. J.; Denny, W. A.; Doherty, A.; Greis, K. D.; Hicks, J. L.; Hook, K. E.; Keller, P. R.; Leopold, W. R.; Loo, J. A.; McNamara, D. J.; Nelson, J. M.; Sherwood, V.; Smaill, J. B.; Trumpp-Kallmeyer, S.; Dobrusin, E. M. Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor. <i>  Proc. </i><i>Natl. Acad. Sci. U.S.A.</i><b>1998</b>, <i>95</i>, 12022−12027.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=12027&author=D.+W.+Fry&author=A.+J.+Bridges&author=W.+A.+Denny&author=A.+Doherty&author=K.+D.+Greis&author=J.+L.+Hicks&author=K.+E.+Hook&author=P.+R.+Keller&author=W.+R.+Leopold&author=J.+A.+Loo&author=D.+J.+McNamara&author=J.+M.+Nelson&author=V.+Sherwood&author=J.+B.+Smaill&author=S.+Trumpp-Kallmeyer&author=E.+M+Dobrusin&title=Specific%2C+irreversible+inactivation+of+the+epidermal+growth+factor+receptor+and+erbB2%2C+by+a+new+class+of+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00028_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DSpecific%252C%2520irreversible%2520inactivation%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520and%2520erbB2%252C%2520by%2520a%2520new%2520class%2520of%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D12027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00029"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00029" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00029_1"><span><span class="NLM_string-ref">Smaill, J. B.; Palmer, B. D.; Rewcastle, G. W.; Denny, W. A.; McNamara, D. J.; Dobrusin, E. M.; Bridges, A. J.; Zhou, H.; Showalter, H. D. H.; Winters, R. T.; Leopold, W. R.; Fry, D. W.; Nelson, J. M.; Slintak, V.; Elliot, W. L.; Roberts, B. J.; Vincent, P. W.; Patmore, S. J. Tyrosine kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[<i>d</i>]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor. <i>  J. Med. Chem.</i><b>1999</b>, <i>42</i>, 1803−1815.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1815&author=J.+B.+Smaill&author=B.+D.+Palmer&author=G.+W.+Rewcastle&author=W.+A.+Denny&author=D.+J.+McNamara&author=E.+M.+Dobrusin&author=A.+J.+Bridges&author=H.+Zhou&author=H.+D.+H.+Showalter&author=R.+T.+Winters&author=W.+R.+Leopold&author=D.+W.+Fry&author=J.+M.+Nelson&author=V.+Slintak&author=W.+L.+Elliot&author=B.+J.+Roberts&author=P.+W.+Vincent&author=S.+J+Patmore&title=Tyrosine+kinase+inhibitors.+15.+4-%28Phenylamino%29quinazoline+and+4-%28phenylamino%29pyrido%5Bd%5Dpyrimidine+acrylamides+as+irreversible+inhibitors+of+the+ATP+binding+site+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00029_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252015.%25204-%2528Phenylamino%2529quinazoline%2520and%25204-%2528phenylamino%2529pyrido%255Bd%255Dpyrimidine%2520acrylamides%2520as%2520irreversible%2520inhibitors%2520of%2520the%2520ATP%2520binding%2520site%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00030"><div class="reference"><div class="NLM_citation" id="rightTab-jm050936ob00030_1"><span><span class="NLM_string-ref">Smaill, J. B.; Rewcastle, G. W.; Bridges, A. J.; Zhou, H.; Showalter, H. D. H.; Fry, D. W.; Nelson, J. M.; Sherwood, V.; Elliott, W. L.; Vincent, P. W.; DeJohn, D.; Loo, J. A.; Gries, K. D.; Chan, O. H.; Reyner, E. L.; Lipka, E.; Denny, W. A. Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor:  4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-<i>d</i>]pyrimidine-6-acrylamides bearing additional solubilizing functions. <i>  J. Med. Chem.</i><b>2000</b>, <i>43</i>, 1380−1397.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1397&author=J.+B.+Smaill&author=G.+W.+Rewcastle&author=A.+J.+Bridges&author=H.+Zhou&author=H.+D.+H.+Showalter&author=D.+W.+Fry&author=J.+M.+Nelson&author=V.+Sherwood&author=W.+L.+Elliott&author=P.+W.+Vincent&author=D.+DeJohn&author=J.+A.+Loo&author=K.+D.+Gries&author=O.+H.+Chan&author=E.+L.+Reyner&author=E.+Lipka&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+17.+Irreversible+inhibitors+of+the+epidermal+growth+factor+receptor%3A%E2%80%89+4-%28phenylamino%29quinazoline-+and+4-%28phenylamino%29pyrido%5B3%2C2-d%5Dpyrimidine-6-acrylamides+bearing+additional+solubilizing+functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00030_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252017.%2520Irreversible%2520inhibitors%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%253A%25E2%2580%2589%25204-%2528phenylamino%2529quinazoline-%2520and%25204-%2528phenylamino%2529pyrido%255B3%252C2-d%255Dpyrimidine-6-acrylamides%2520bearing%2520additional%2520solubilizing%2520functions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D1397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00031"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00031" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00031_1"><span><span class="NLM_string-ref">Allen, L. F.; Eiseman, I. A.; Fry, D. W.; Lenehan, P. F. CI-1033, an irreversible pan-erbB receptor inhibitor and its potential application for the treatment of breast cancer. <i>  Semin. Oncol</i>. <b>2003</b>, <i>30 </i>(Suppl. 16), 65−78.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30+%28Suppl.+16&publication_year=2003&pages=78&author=L.+F.+Allen&author=I.+A.+Eiseman&author=D.+W.+Fry&author=P.+F.+Lenehan&title=an+irreversible+pan-erbB+receptor+inhibitor+and+its+potential+application+for+the+treatment+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00031_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DL.%2BF.%26atitle%3Dan%2520irreversible%2520pan-erbB%2520receptor%2520inhibitor%2520and%2520its%2520potential%2520application%2520for%2520the%2520treatment%2520of%2520breast%2520cancer%26jtitle%3DSemin.%2520Oncol.%26date%3D2003%26volume%3D30%2520%2528Suppl.%252016%26spage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00032"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00032" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00032_1"><span><span class="NLM_string-ref">Calvo, E.; Tolcher, A. W.; Hammond, L. A.; Patnaik, A.; de Bono, J. S.; Eiseman, I. A.; Olson, S. C.; Lenehan, P. F.; McCreery, H.; LoRusso, P.; Rowinsky, E. K. Administration of CI-1033, an irreversible pan-erbB tyrosine kinase inhibitor, is feasible on a 7-day on, 7-day off schedule:  a phase I pharmacokinetic and food effect study. <i>  Clin. Cancer Res</i>. <b>2004</b>, <i>10</i>, 7112−7120.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=7120&author=E.+Calvo&author=A.+W.+Tolcher&author=L.+A.+Hammond&author=A.+Patnaik&author=J.+S.+de+Bono&author=I.+A.+Eiseman&author=S.+C.+Olson&author=P.+F.+Lenehan&author=H.+McCreery&author=P.+LoRusso&author=E.+K+Rowinsky&title=Administration+of+CI-1033%2C+an+irreversible+pan-erbB+tyrosine+kinase+inhibitor%2C+is+feasible+on+a+7-day+on%2C+7-day+off+schedule%3A%E2%80%89+a+phase+I+pharmacokinetic+and+food+effect+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00032_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCalvo%26aufirst%3DE.%26atitle%3DAdministration%2520of%2520CI-1033%252C%2520an%2520irreversible%2520pan-erbB%2520tyrosine%2520kinase%2520inhibitor%252C%2520is%2520feasible%2520on%2520a%25207-day%2520on%252C%25207-day%2520off%2520schedule%253A%25E2%2580%2589%2520a%2520phase%2520I%2520pharmacokinetic%2520and%2520food%2520effect%2520study%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D7120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00033"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00033" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00033_1"><span><span class="NLM_string-ref">Smaill, J. B.; Showalter, H. D. H.; Zhou, H.; Bridges, A. J.; McNamara, D. J.; Fry, D. W.; Nelson, J. M.; Sherwood, V.; Vincent, P. W.; Roberts, B. J.; Elliott, W. L.; Denny, W. A. Tyrosine kinase inhibitors. 18. 6-Substituted 4-anilinoquinazolines and 4-anilinopyrido[3,4-<i>d</i>]pyrimidines as soluble, irreversible inhibitors of the epidermal growth factor receptor. <i>  J. Med. </i><i>Chem</i>. <b>2001</b>,<i> 44</i>, 429−440.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=440&author=J.+B.+Smaill&author=H.+D.+H.+Showalter&author=H.+Zhou&author=A.+J.+Bridges&author=D.+J.+McNamara&author=D.+W.+Fry&author=J.+M.+Nelson&author=V.+Sherwood&author=P.+W.+Vincent&author=B.+J.+Roberts&author=W.+L.+Elliott&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+18.+6-Substituted+4-anilinoquinazolines+and+4-anilinopyrido%5B3%2C4-d%5Dpyrimidines+as+soluble%2C+irreversible+inhibitors+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00033_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252018.%25206-Substituted%25204-anilinoquinazolines%2520and%25204-anilinopyrido%255B3%252C4-d%255Dpyrimidines%2520as%2520soluble%252C%2520irreversible%2520inhibitors%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00034"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00034" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00034_1"><span><span class="NLM_string-ref">Tsou, H. R.; Mamuya, N.; Johnson, B. D.; Reich, M. F.; Gruber, B. C.; Ye, F.; Nilakantan, R.; Shen, R.; Discafani, C.; DeBlanc, R.; Davis, R.; Koehn, F. E.; Greenberger, L. M.; Wang, Y. F.; Wissner, A. 6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activity. <i>  J. Med. Chem. </i><b>2001</b>,<i> 44</i>, 2719−2734.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2734&author=H.+R.+Tsou&author=N.+Mamuya&author=B.+D.+Johnson&author=M.+F.+Reich&author=B.+C.+Gruber&author=F.+Ye&author=R.+Nilakantan&author=R.+Shen&author=C.+Discafani&author=R.+DeBlanc&author=R.+Davis&author=F.+E.+Koehn&author=L.+M.+Greenberger&author=Y.+F.+Wang&author=A.+Wissner&author=+Substituted&title=as+putative+irreversible+inhibitors+of+the+epidermal+growth+factor+receptor+%28EGFR%29+and+human+epidermal+growth+factor+receptor+%28HER-2%29+tyrosine+kinases+with+enhanced+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00034_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DH.%2BR.%26atitle%3Das%2520putative%2520irreversible%2520inhibitors%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520and%2520human%2520epidermal%2520growth%2520factor%2520receptor%2520%2528HER-2%2529%2520tyrosine%2520kinases%2520with%2520enhanced%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00035"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00035" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00035_1"><span><span class="NLM_string-ref">Discafani, C. M.; Carroll, M. L.; Floyd, M. B.; Hollander, I. J.; Husain, Z.; Johnson, B. D.; Kitchen, D.; May, M. K.; Malo, M. S.; Minnick, A. A.; Nilakantan, R.; Shen, R.; Wang, Y.-F.; Wissner, A.; Greenburger, L. M. irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387, 785). <i>  Biochem. Pharmacol.</i><b>1999</b>, <i>57</i>, 917−925.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1999&pages=925&author=C.+M.+Discafani&author=M.+L.+Carroll&author=M.+B.+Floyd&author=I.+J.+Hollander&author=Z.+Husain&author=B.+D.+Johnson&author=D.+Kitchen&author=M.+K.+May&author=M.+S.+Malo&author=A.+A.+Minnick&author=R.+Nilakantan&author=R.+Shen&author=Y.-F.+Wang&author=A.+Wissner&author=L.+M+Greenburger&title=irreversible+inhibition+of+epidermal+growth+factor+receptor+tyrosine+kinase+with+in+vivo+activity+by+N-%5B4-%283-bromophenyl%29amino%5D-6-quinazolinyl%5D-2-butynamide+%28CL-387%2C+785%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00035_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiscafani%26aufirst%3DC.%2BM.%26atitle%3Dirreversible%2520inhibition%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520with%2520in%2520vivo%2520activity%2520by%2520N-%255B4-%25283-bromophenyl%2529amino%255D-6-quinazolinyl%255D-2-butynamide%2520%2528CL-387%252C%2520785%2529%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1999%26volume%3D57%26spage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00036"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00036" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00036_1"><span><span class="NLM_string-ref">Wissner, A.; Overbeek, E.; Reich, M. F.; Brawner Floyd, M.; Johnson, B. D.; Mamuya, N.; Rosfjord, E. C.; Discafani, C.; Davis, R.; Shi, X.; Rabindran, S. K.; Gruber, B. C.; Ye, F.; Hallett, W. A.; Nilakantan, R.; Shen, R.; Wang, Y.-F.; Greenberger, L. M.; Tsou, H.-R. Synthesis and structure−activity relationships of 6,7-disubstituted 4-anilinoquinoline-3-carbonitriles. The design of an orally active, irreversible inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and the human epidermal growth factor receptor-2 (HER-2).<i> J. Med. Chem. </i><b>2003</b>,<i> 46</i>, 49−63.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=63&author=A.+Wissner&author=E.+Overbeek&author=M.+F.+Reich&author=M.+Brawner+Floyd&author=B.+D.+Johnson&author=N.+Mamuya&author=E.+C.+Rosfjord&author=C.+Discafani&author=R.+Davis&author=X.+Shi&author=S.+K.+Rabindran&author=B.+C.+Gruber&author=F.+Ye&author=W.+A.+Hallett&author=R.+Nilakantan&author=R.+Shen&author=Y.-F.+Wang&author=L.+M.+Greenberger&author=H.-R+Tsou&title=Synthesis+and+structure%E2%88%92activity+relationships+of+6%2C7-disubstituted+4-anilinoquinoline-3-carbonitriles.+The+design+of+an+orally+active%2C+irreversible+inhibitor+of+the+tyrosine+kinase+activity+of+the+epidermal+growth+factor+receptor+%28EGFR%29+and+the+human+epidermal+growth+factor+receptor-2+%28HER-2%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00036_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%25206%252C7-disubstituted%25204-anilinoquinoline-3-carbonitriles.%2520The%2520design%2520of%2520an%2520orally%2520active%252C%2520irreversible%2520inhibitor%2520of%2520the%2520tyrosine%2520kinase%2520activity%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520and%2520the%2520human%2520epidermal%2520growth%2520factor%2520receptor-2%2520%2528HER-2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00037"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00037" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00037_1"><span><span class="NLM_string-ref">Nunes, M.; Shi, C.; Greenberger, L. M. Phosphorylation of extracellular signal-regulated kinase 1 and 2, protein kinase B, and signal transducer and activator of transcription 3 are differently inhibited by an epidermal growth factor receptor inhibitor, EKB-569, in tumor cells and normal human keratinocytes. <i>  Mol. Cancer Ther</i>. <b>2004</b>, <i>3</i>, 21−27.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=27&author=M.+Nunes&author=C.+Shi&author=L.+M+Greenberger&title=Phosphorylation+of+extracellular+signal-regulated+kinase+1+and+2%2C+protein+kinase+B%2C+and+signal+transducer+and+activator+of+transcription+3+are+differently+inhibited+by+an+epidermal+growth+factor+receptor+inhibitor%2C+EKB-569%2C+in+tumor+cells+and+normal+human+keratinocytes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00037_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNunes%26aufirst%3DM.%26atitle%3DPhosphorylation%2520of%2520extracellular%2520signal-regulated%2520kinase%25201%2520and%25202%252C%2520protein%2520kinase%2520B%252C%2520and%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25203%2520are%2520differently%2520inhibited%2520by%2520an%2520epidermal%2520growth%2520factor%2520receptor%2520inhibitor%252C%2520EKB-569%252C%2520in%2520tumor%2520cells%2520and%2520normal%2520human%2520keratinocytes%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26spage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00038"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00038" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00038_1"><span><span class="NLM_string-ref">Wissner, A.; Hamann, P. R.; Nilakantan, R.; Greenberger, L. M.; Ye, F.; Rapuano, T. A.; Loganzo, F. Syntheses and EGFR kinase inhibitory activity of 6-substituted-4-anilino [1,7] and [1,8] naphthyridine-3-carbonitriles. <i>  Bioorg. Med. Chem. Lett.</i><b>2004</b>, <i>14</i>, 1411−1416.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1416&author=A.+Wissner&author=P.+R.+Hamann&author=R.+Nilakantan&author=L.+M.+Greenberger&author=F.+Ye&author=T.+A.+Rapuano&author=F+Loganzo&title=Syntheses+and+EGFR+kinase+inhibitory+activity+of+6-substituted-4-anilino+%5B1%2C7%5D+and+%5B1%2C8%5D+naphthyridine-3-carbonitriles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00038_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWissner%26aufirst%3DA.%26atitle%3DSyntheses%2520and%2520EGFR%2520kinase%2520inhibitory%2520activity%2520of%25206-substituted-4-anilino%2520%255B1%252C7%255D%2520and%2520%255B1%252C8%255D%2520naphthyridine-3-carbonitriles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D1416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00039"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00039" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00039_1"><span><span class="NLM_string-ref">Tsou, H.-R.; Overbeek-Klumpers, E. G.; Hallett, W. A.; Reich, M. F.; Brawner Floyd, M.; Johnson, B. D.; Michalak, R. S.; Nilakantan, R.; Discafani, C.; Golas, J.; Rabindran, S. K.; Shen, R.; Shi, X.; Wang, Y.-F.; Upeslacis, J.; Wissner, A. Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity. <i>  J. Med. Chem</i>. <b>2005</b>, <i>48</i>, 1107−1131.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1131&author=H.-R.+Tsou&author=E.+G.+Overbeek-Klumpers&author=W.+A.+Hallett&author=M.+F.+Reich&author=M.+Brawner+Floyd&author=B.+D.+Johnson&author=R.+S.+Michalak&author=R.+Nilakantan&author=C.+Discafani&author=J.+Golas&author=S.+K.+Rabindran&author=R.+Shen&author=X.+Shi&author=Y.-F.+Wang&author=J.+Upeslacis&author=A+Wissner&title=Optimization+of+6%2C7-disubstituted-4-%28arylamino%29quinoline-3-carbonitriles+as+orally+active%2C+irreversible+inhibitors+of+human+epidermal+growth+factor+receptor-2+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00039_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsou%26aufirst%3DH.-R.%26atitle%3DOptimization%2520of%25206%252C7-disubstituted-4-%2528arylamino%2529quinoline-3-carbonitriles%2520as%2520orally%2520active%252C%2520irreversible%2520inhibitors%2520of%2520human%2520epidermal%2520growth%2520factor%2520receptor-2%2520kinase%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00040"><div class="reference"><div class="NLM_citation" id="rightTab-jm050936ob00040_1"><span><span class="NLM_string-ref">Kwak, E. L.; Sordella, R.; Bell, D. W.; Godin-Heymann, N.; Okimoto, R. A.; Brannigan, B. W.; Harris, P. L.; Driscoll, D. R.; Fidias, P.; Lynch, T. J.; Rabindran, S. K.; McGinnis, J. P.; Wissner, A.; Sharma, S. V.; Isselbacher, K. J.; Settleman, J.; Haber, D. A. Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib. <i>  Proc. Natl. Acad. Sci. </i><i>U.S.A.</i><b>2005</b>, <i>102</i>, 7665−7670.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=7670&author=E.+L.+Kwak&author=R.+Sordella&author=D.+W.+Bell&author=N.+Godin-Heymann&author=R.+A.+Okimoto&author=B.+W.+Brannigan&author=P.+L.+Harris&author=D.+R.+Driscoll&author=P.+Fidias&author=T.+J.+Lynch&author=S.+K.+Rabindran&author=J.+P.+McGinnis&author=A.+Wissner&author=S.+V.+Sharma&author=K.+J.+Isselbacher&author=J.+Settleman&author=D.+A+Haber&title=Irreversible+inhibitors+of+the+EGF+receptor+may+circumvent+acquired+resistance+to+gefitinib"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00040_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKwak%26aufirst%3DE.%2BL.%26atitle%3DIrreversible%2520inhibitors%2520of%2520the%2520EGF%2520receptor%2520may%2520circumvent%2520acquired%2520resistance%2520to%2520gefitinib%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D7670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00041"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00041" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00041_1"><span><span class="NLM_string-ref">Rewcastle, G. W.; Denny, W. A.; Bridges, A. J.; Zhou, H.; Cody, D. R.; McMichael, A.; Fry, D. W. Tyrosine kinase inhibitors. 5. Synthesis and structure−activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5‘-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth factor receptor. <i>  J. Med. Chem.</i><b>1995</b>, <i>38</i>, 3482−3487.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=3487&author=G.+W.+Rewcastle&author=W.+A.+Denny&author=A.+J.+Bridges&author=H.+Zhou&author=D.+R.+Cody&author=A.+McMichael&author=D.+W+Fry&title=Tyrosine+kinase+inhibitors.+5.+Synthesis+and+structure%E2%88%92activity+relationships+for+4-%5B%28phenylmethyl%29amino%5D-+and+4-%28phenylamino%29quinazolines+as+potent+adenosine+5%E2%80%98-triphosphate+binding+site+inhibitors+of+the+tyrosine+kinase+domain+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00041_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%25205.%2520Synthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520for%25204-%255B%2528phenylmethyl%2529amino%255D-%2520and%25204-%2528phenylamino%2529quinazolines%2520as%2520potent%2520adenosine%25205%25E2%2580%2598-triphosphate%2520binding%2520site%2520inhibitors%2520of%2520the%2520tyrosine%2520kinase%2520domain%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D3487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00042"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00042" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00042_1"><span><span class="NLM_string-ref">Rewcastle, G. W.; Palmer, B. D.; Thompson, A. M.; Bridges, A. J.; Cody, D. R.; Zhou, H.; Fry, D. W.; McMichael, A.; Kraker, A. J.; Denny, W. A. Tyrosine kinase inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]pyrido[d]pyrimidines are potent ATP Binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptor. <i>  J. Med. Chem</i>. <b>1996</b>, <i>39</i>, 1823−1835.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1835&author=G.+W.+Rewcastle&author=B.+D.+Palmer&author=A.+M.+Thompson&author=A.+J.+Bridges&author=D.+R.+Cody&author=H.+Zhou&author=D.+W.+Fry&author=A.+McMichael&author=A.+J.+Kraker&author=W.+A+Denny&title=Tyrosine+kinase+inhibitors.+10.+Isomeric+4-%5B%283-bromophenyl%29amino%5Dpyrido%5Bd%5Dpyrimidines+are+potent+ATP+Binding+site+inhibitors+of+the+tyrosine+kinase+function+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00042_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252010.%2520Isomeric%25204-%255B%25283-bromophenyl%2529amino%255Dpyrido%255Bd%255Dpyrimidines%2520are%2520potent%2520ATP%2520Binding%2520site%2520inhibitors%2520of%2520the%2520tyrosine%2520kinase%2520function%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00043"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00043" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00043_1"><span><span class="NLM_string-ref">Olomucki, M.; Marszak, I. The unsaturated amino acids. Synthesis of 4-dimethylamino-2-butynoic acid and 5-dimethylamino-2-pentynoic acid as well as their corresponding esters. <i>  C. R.</i><i>Hebd. Seances Acad. Sci.</i><b>1956</b>, <i>242</i>, 1338−1340.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=242&publication_year=1956&pages=1340&author=M.+Olomucki&author=I+Marszak&title=The+unsaturated+amino+acids.+Synthesis+of+4-dimethylamino-2-butynoic+acid+and+5-dimethylamino-2-pentynoic+acid+as+well+as+their+corresponding+esters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00043_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlomucki%26aufirst%3DM.%26atitle%3DThe%2520unsaturated%2520amino%2520acids.%2520Synthesis%2520of%25204-dimethylamino-2-butynoic%2520acid%2520and%25205-dimethylamino-2-pentynoic%2520acid%2520as%2520well%2520as%2520their%2520corresponding%2520esters%26jtitle%3DC.%2520R.%2520Hebd.%2520Seances%2520Acad.%2520Sci.%26date%3D1956%26volume%3D242%26spage%3D1340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00044"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00044" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00044_1"><span><span class="NLM_string-ref">Johnson, C. D.; Lane, S.; Edwards, P. N.; Taylor, P. J. Prodrugs based on masked lactones. Cyclization of γ-hydroxy amides. <i>  J. Org. Chem</i>. <b>1988</b>, <i>53</i>, 5130−5139.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1988&pages=5139&author=C.+D.+Johnson&author=S.+Lane&author=P.+N.+Edwards&author=P.+J+Taylor&title=Prodrugs+based+on+masked+lactones.+Cyclization+of+%CE%B3-hydroxy+amides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00044_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BD.%26atitle%3DProdrugs%2520based%2520on%2520masked%2520lactones.%2520Cyclization%2520of%2520%25CE%25B3-hydroxy%2520amides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1988%26volume%3D53%26spage%3D5139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00045"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00045" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00045_1"><span><span class="NLM_string-ref">Apodaca, R.; Xiao, W.; Jablonoski, J. A. Preparation of substituted phenylalkynes for use in histamine-mediated disorders. PCT Int. Appl. WO 2003050099 A1, 2003.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=050099&publication_year=2003&pages=2003&author=R.+Apodaca&author=W.+Xiao&author=J.+A+Jablonoski&title=Preparation+of+substituted+phenylalkynes+for+use+in+histamine-mediated+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00045_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DApodaca%26aufirst%3DR.%26atitle%3DPreparation%2520of%2520substituted%2520phenylalkynes%2520for%2520use%2520in%2520histamine-mediated%2520disorders%26jtitle%3DPCT%2520Int.%2520Appl.%2520WO%26date%3D2003%26volume%3D050099%26spage%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00046"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00046" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00046_1"><span><span class="NLM_string-ref">Turner, S. C.; Esbenshade, T. A.; Bennani, Y. L.; Hancock, A. A. A new class of histamine H3-receptor antagonists:  synthesis and structure−activity relationships of 7,8,9,10-tetrahydro-6<i>H</i>-cyclohepta[<i>b</i>]quinolines. <i>  Bioorg. </i><i>Med. Chem. Lett</i>. <b>2003</b>, <i>13</i>, 2131−2135.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2135&author=S.+C.+Turner&author=T.+A.+Esbenshade&author=Y.+L.+Bennani&author=A.+A+Hancock&title=A+new+class+of+histamine+H3-receptor+antagonists%3A%E2%80%89+synthesis+and+structure%E2%88%92activity+relationships+of+7%2C8%2C9%2C10-tetrahydro-6H-cyclohepta%5Bb%5Dquinolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00046_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DS.%2BC.%26atitle%3DA%2520new%2520class%2520of%2520histamine%2520H3-receptor%2520antagonists%253A%25E2%2580%2589%2520synthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%25207%252C8%252C9%252C10-tetrahydro-6H-cyclohepta%255Bb%255Dquinolines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00047"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00047" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00047_1"><span><span class="NLM_string-ref">Comess, K. M.; Erickson, S. A.; Henkin, J.; Kalvin, D. M.; Kawai, M.; Kim, K. H.; Bamaung, N. Y.; Park, C. H.; Sheppard, G. S.; Vasudevan, A.; Wang, J.; Barnes, D. M.; Fidanze, S. D.; Kolaczkowsi, L.; Mantei, R. A.; Park, D. C.; Sanders, W. J.; Tedrow, J. S.; Wang, G. T. Preparation of sulfonamides having antiangiogenic and anticancer activity. PCT Int. Appl. WO 2004033419 A1, 2004.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=033419&publication_year=2004&pages=2004&author=K.+M.+Comess&author=S.+A.+Erickson&author=J.+Henkin&author=D.+M.+Kalvin&author=M.+Kawai&author=K.+H.+Kim&author=N.+Y.+Bamaung&author=C.+H.+Park&author=G.+S.+Sheppard&author=A.+Vasudevan&author=J.+Wang&author=D.+M.+Barnes&author=S.+D.+Fidanze&author=L.+Kolaczkowsi&author=R.+A.+Mantei&author=D.+C.+Park&author=W.+J.+Sanders&author=J.+S.+Tedrow&author=G.+T+Wang&title=Preparation+of+sulfonamides+having+antiangiogenic+and+anticancer+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00047_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DComess%26aufirst%3DK.%2BM.%26atitle%3DPreparation%2520of%2520sulfonamides%2520having%2520antiangiogenic%2520and%2520anticancer%2520activity%26jtitle%3DPCT%2520Int.%2520Appl.%2520WO%26date%3D2004%26volume%3D033419%26spage%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00048"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00048" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00048_1"><span><span class="NLM_string-ref">Chou, T. C.; Talalay, P. Applications of the Median-Effect Principle for the Assessment of Low-Dose Risk of Carcinogens and for the Quantitation of Synergism and Antagonism of ChemotherapeuticAgents. <i>  Bristol-Myers </i><i>Cancer Symp., New Ave. Dev. Cancer Chemother.</i><b>1987</b>, <i>8</i>, 37−64.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1987&pages=64&author=T.+C.+Chou&author=P+Talalay&title=Applications+of+the+Median-Effect+Principle+for+the+Assessment+of+Low-Dose+Risk+of+Carcinogens+and+for+the+Quantitation+of+Synergism+and+Antagonism+of+ChemotherapeuticAgents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00048_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DT.%2BC.%26atitle%3DApplications%2520of%2520the%2520Median-Effect%2520Principle%2520for%2520the%2520Assessment%2520of%2520Low-Dose%2520Risk%2520of%2520Carcinogens%2520and%2520for%2520the%2520Quantitation%2520of%2520Synergism%2520and%2520Antagonism%2520of%2520ChemotherapeuticAgents%26jtitle%3DBristol-Myers%2520Cancer%2520Symp.%252C%2520New%2520Ave.%2520Dev.%2520Cancer%2520Chemother.%26date%3D1987%26volume%3D8%26spage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00049"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00049" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00049_1"><span><span class="NLM_string-ref">Cohen, B. D.; Goldstein, D. J.; Rutledge, L.; Vass, W. C.; Lowy, D. R.; Schlegel, R.; Schiller, J. T. Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain. <i>  J. Virol.</i><b>1993</b>, <i>67</i>, 5303−5511.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1993&pages=5511&author=B.+D.+Cohen&author=D.+J.+Goldstein&author=L.+Rutledge&author=W.+C.+Vass&author=D.+R.+Lowy&author=R.+Schlegel&author=J.+T+Schiller&title=Transformation-specific+interaction+of+the+bovine+papillomavirus+E5+oncoprotein+with+the+platelet-derived+growth+factor+receptor+transmembrane+domain+and+the+epidermal+growth+factor+receptor+cytoplasmic+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00049_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DB.%2BD.%26atitle%3DTransformation-specific%2520interaction%2520of%2520the%2520bovine%2520papillomavirus%2520E5%2520oncoprotein%2520with%2520the%2520platelet-derived%2520growth%2520factor%2520receptor%2520transmembrane%2520domain%2520and%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520cytoplasmic%2520domain%26jtitle%3DJ.%2520Virol.%26date%3D1993%26volume%3D67%26spage%3D5511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00050"><div class="reference"><div class="NLM_citation" id="rightTab-jm050936ob00050_1"><span><span class="NLM_string-ref">Fry, D. W.; Nelson, J. M.; Slintak, V.; Keller, P. R.; Rewcastle, G. W.; Denny, W. A.; Zhou, H.; Bridges, A. J. Biochemical and antiproliferative properties of 4-[ar(alk)ylamino]pyridopyrimidines, a new chemical class of potent and specific epidermal growth factor receptor tyrosine kinase inhibitor. <i>  Biochem. Pharmacol</i>. <b>1997</b>, <i>54</i>, 877−887.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1997&pages=887&author=D.+W.+Fry&author=J.+M.+Nelson&author=V.+Slintak&author=P.+R.+Keller&author=G.+W.+Rewcastle&author=W.+A.+Denny&author=H.+Zhou&author=A.+J+Bridges&title=Biochemical+and+antiproliferative+properties+of+4-%5Bar%28alk%29ylamino%5Dpyridopyrimidines%2C+a+new+chemical+class+of+potent+and+specific+epidermal+growth+factor+receptor+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00050_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DBiochemical%2520and%2520antiproliferative%2520properties%2520of%25204-%255Bar%2528alk%2529ylamino%255Dpyridopyrimidines%252C%2520a%2520new%2520chemical%2520class%2520of%2520potent%2520and%2520specific%2520epidermal%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1997%26volume%3D54%26spage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00051"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00051" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00051_1"><span><span class="NLM_string-ref">Schabel, F. M., Jr.; Griswold, D. P., Jr.; Laster, W. R., Jr.; Corbett, T. H.; Lloyd, H. H. Quantitative evaluation of anticancer agent activity in experimental animals. <i>  Pharmacol. Ther</i>. <b>1977</b>, <i>1</i>, 411−435.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1977&pages=435&author=F.+M.+Schabel&author=+Jr&author=+Jr&author=+Jr&author=H.+H+Lloyd&title=Quantitative+evaluation+of+anticancer+agent+activity+in+experimental+animals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00051_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchabel%26aufirst%3DF.%2BM.%26atitle%3DQuantitative%2520evaluation%2520of%2520anticancer%2520agent%2520activity%2520in%2520experimental%2520animals%26jtitle%3DPharmacol.%2520Ther.%26date%3D1977%26volume%3D1%26spage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00052"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00052" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00052_1"><span><span class="NLM_string-ref">Leopold, W. R.; Nelson, J. M.; Plowman, J.; Jackson, R. C. Anthrapyrazoles, a new class of intercalating agents with high-level, broad spectrum activity against murine tumors. <i>  Cancer Res</i>. <b>1985</b>, <i>45</i>, 5532−5539.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1985&pages=5539&author=W.+R.+Leopold&author=J.+M.+Nelson&author=J.+Plowman&author=R.+C+Jackson&title=Anthrapyrazoles%2C+a+new+class+of+intercalating+agents+with+high-level%2C+broad+spectrum+activity+against+murine+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00052_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeopold%26aufirst%3DW.%2BR.%26atitle%3DAnthrapyrazoles%252C%2520a%2520new%2520class%2520of%2520intercalating%2520agents%2520with%2520high-level%252C%2520broad%2520spectrum%2520activity%2520against%2520murine%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D1985%26volume%3D45%26spage%3D5539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00053"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00053" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00053_1"><span><span class="NLM_string-ref">Elliott, W. L.; Howard, C. T.; Dykes, D. J.; Leopold, W. R. Sequence and schedule-dependent synergy of trimetrexate in combination with 5-fluorouracil in vitro and in mice. <i>  Cancer Res</i>. <b>1989</b>, <i>49</i>, 5586−5590.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1989&pages=5590&author=W.+L.+Elliott&author=C.+T.+Howard&author=D.+J.+Dykes&author=W.+R+Leopold&title=Sequence+and+schedule-dependent+synergy+of+trimetrexate+in+combination+with+5-fluorouracil+in+vitro+and+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00053_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElliott%26aufirst%3DW.%2BL.%26atitle%3DSequence%2520and%2520schedule-dependent%2520synergy%2520of%2520trimetrexate%2520in%2520combination%2520with%25205-fluorouracil%2520in%2520vitro%2520and%2520in%2520mice%26jtitle%3DCancer%2520Res.%26date%3D1989%26volume%3D49%26spage%3D5590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00054"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00054" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00054_1"><span><span class="NLM_string-ref">Elliott, W. L.; Roberts, B. J.; Howard, C. T.; Leopold, W. R. Chemotherapy with [SP-4-3-(<i>R</i>)]-[1,1-cyclobutanedicarboxylato (2-)] (2-methyl-1,4-butanediamine-N,N‘) platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo. <i>  Cancer </i><i>Res</i>. <b>1994</b>, <i>54</i>, 4412−4418.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1994&pages=4418&author=W.+L.+Elliott&author=B.+J.+Roberts&author=C.+T.+Howard&author=W.+R.+Leopold&author=+Chemotherapy&author=+N%E2%80%98&title=in+combination+with+standard+agents+against+murine+tumors+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00054_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElliott%26aufirst%3DW.%2BL.%26atitle%3Din%2520combination%2520with%2520standard%2520agents%2520against%2520murine%2520tumors%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D1994%26volume%3D54%26spage%3D4418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm050936ob00055"><div class="reference"><strong class="refLabel"><a href="#jm050936ob00055" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-jm050936ob00055_1"><span><span class="NLM_string-ref">Bridges, A. J.; Denny, W. A.; Dobrusin, E. M.; Doherty, A. M.; Fry, D. W.; McNamara, D. J.; Showalter, H. D. H.; Smaill, J. B.; Zhou, H. Preparation of N-quinazolinylacrylamides and analogues as tyrosine kinase inhibitors. PCT Int. Appln<i>.</i> WO 9738983 A1, 1997; 194 pp.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=A.+J.+Bridges&author=W.+A.+Denny&author=E.+M.+Dobrusin&author=A.+M.+Doherty&author=D.+W.+Fry&author=D.+J.+McNamara&author=H.+D.+H.+Showalter&author=J.+B.+Smaill&author=H.+Zhou&title=Preparation+of+N-quinazolinylacrylamides+and+analogues+as+tyrosine+kinase+inhibitors.+PCT+Int.+Appln.+WO+9738983+A1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm050936ob00055_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26btitle%3DPreparation%2520of%2520N-quinazolinylacrylamides%2520and%2520analogues%2520as%2520tyrosine%2520kinase%2520inhibitors.%2520PCT%2520Int.%2520Appln.%2520WO%25209738983%2520A1%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="NLM_notes" id="rightTab-"><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19"><a href="/doi/suppl/10.1021%2Fjm050936o">Supporting Information Available</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42425" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42425" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Combustion analytical data. This material is available free of charge via the Internet at <a class="ext-link" href="http://pubs.acs.org" target="_blank">http://pubs.acs.org</a>. </div></div></div><div class="article_supporting-info" id=""><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm050936o/suppl_file/jm050936osi20051122_022554.pdf">jm050936osi20051122_022554.pdf (13.78 kb)</a></li></ul></div></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm050936o&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2006.49.issue-4%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm050936o" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm050936o" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                189KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b382529e43d7c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
